Fong-CV May 2011

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 89

CURRICULUM VITAE

NAME:

Harry H.S. Fong

BORN:
MARITAL STATUS:
CHILDREN:

CITIZENSHIP:
EDUCATION:
Elementary:
Secondary:
College:

China and Erie, Pennsylvania


Academy High School, Erie, Pennsylvania
B.S.
University of Pittsburgh, School of Pharmacy
M.S.
University of Pittsburgh, School of Pharmacy
Ph.D.
The Ohio State University

POSITIONS HELD:

Professor Emeritus of Pharmacognosy, Department of Medicinal Chemistry and Pharmacognosy,


University of Illinois at Chicago, 2004-present.
Honorary Professor, RMIT University, Melbourne, Australia, 2011- 2014.
Adjunct Professor, RMIT University, Melbourne, Australia, 2006- present.
Professor of Pharmacognosy, Department of Medicinal Chemistry and Pharmacognosy, University of
Illinois at Chicago, 1982 2004.
Acting Head, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at
Chicago, September 2002 October 2003.
Associate Head, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at
Chicago, May September, 2002.
Director, University of Illinois Pharmacognosy Field Station, 1981 2003

Associate Director, Program for Collaborative Research in the Pharmaceutical Sciences, College of
Phramcy, University of Illinois at Chicago, 1998-2004.
Associate Director, WHO Collaborating Centre for Traditional Medicine, College of Pharmacy,
University of Illinois at Chicago, 2000-present
Assistant Head, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at
Chicago, 1991 1995.
Director, Graduate Studies in Pharmacognosy, Graduate College, University of Illinois at Chicago,
1997-1999.
Professor of Pharmacognosy, Department of Pharmacognosy and Pharmacology, College of Pharmacy,
University of Illinois, 1972-1982
Acting Director, University of Illinois Pharmacognosy and Horticulture Field Station, 1974 - 1977
Associate Professor of Pharmacognosy, Department of Pharmacognosy and Pharmacology College of
Pharmacy, University of Illinois, 1970 - 1972
Associate Professor of Pharmacognosy, Department of Pharmacognosy, School of Pharmacy,
University of Pittsburgh, 1968 - 1970
Research Assistant Professor of Pharmacognosy, Department of Pharmacognosy, School of Pharmacy,
University of Pittsburgh, 1965 - 1968
Research Fellow, The Ohio State University, College of Pharmacy, 1961 - 1965
Graduate Teaching Assistant, Department of Pharmacognosy, School of Pharmacy, University of
Pittsburgh, 1959 - 1961

HONORS:
Honorary Visiting Research Fellow, Institute of Science and Technology, The Chinese University of
Hong Kong, 1977
President, American Society of Pharmacognosy, 1978-1979.
President, Society for Economic Botany, 1981-1982
Visiting Professor, Guangzhou College of Traditional Chinese Medicine, Guangzhou, People's
Republic of China, 1993 -1995; 1997-2001; 2001-2004.
Jack L. Beal Post Baccalaureate Alumnae Award, The Ohio State University, College of Pharmacy,
1997

Visiting Professor of the Universidad Nacional Mayor de San Marcos, Facultad de Medicina, Lima,
Peru, 1997.
Member, WHO Expert Panel on Traditional Medicine, 1997-present.
Member, International Advisory Board on Hong Kong Regulatory Standards for Chinese Materia
Medica, Hong Kong, SAR, China, 2002-present.
Member, Strategic Advisory Panel, Hong Kong Jockey Club Institute of Chinese Medicine Ltd, Hong
Kong, SAR, China, 2002-2006.
Member, Scientific Advisory Board, University Grants Committee, Area of Excellence Chinese
Medicine Research and Further Development, Hong Kong, SAR, China, 2002.
Chair, Panel for Accreditation of Professional Diploma of Pharmacy in Chinese Medicine, Hong Kong
Baptist University, 4-6 November 2002.
Member , Advisory Board of the Tang Center for Herbal Medicine Research, University of Chicago,
2003-present
Member, Working Group on Medicinal Plants of the Pan American Network of Drug Regulatory
Harmonization (PANDRH), PAHO, 2003-2004.
Honorary Member, American Society of Pharmacognosy, 2004-indefinite
Honorary Professor, Hong Kong Baptist University, Hong Kong, SAR, China, 2004-2006.
Member, Steering Committee, International Natural Products Repository Network, 2004.
<http://www.inprn.org/>
Natural Products Association, 2008 Burton Kallman Scientific Award.

LICENSE:
Pharmacist, Pennsylvania Registered, 1959 1988, Illinois Registered, 1974 - 1998

MEMBERSHIP IN ORGANIZATIONS:
American Society of Pharmacognosy (Charter and Honorary Member)

Rho Chi Pharmaceutical Society

TEACHING EXPERIENCE:

Undergraduate/Professional:
Pharmacognosy
1965-1970, University of Pittsburgh, School of Pharmacy
1970-1984, University of Illinois at Chicago, College of Pharmacy
Microbiology
1965-1970, University of Pittsburgh, School of Pharmacy
Medicinal Chemistry and Pharmacognosy
1992-2004, University of Illinois at Chicago, College of Pharmacy
Graduate:
Biosynthesis of Natural Products
1965-1970 Univ. of Pittsburgh
1970-1980 Univ. of Illinois
Phytochemical Isolation Procedures
1965-1970 Univ. of Pittsburgh
1970-2002 Univ. of Illinois
Chemotaxonomy
1965-1970 Univ. of Pittsburgh
1970-2002 Univ. of Illinois
Phytochemical Screening
1965-1970 Univ. of Pittsburgh

Continuing Education/Extension/Training:
International Training Program in New Crops: Aromatic and Medicinal Plants. 1993,
1995, 1997, 1999, 2000 (A Purdue University-Continuing Education Program in
collaboration with the PCRPS, College of Pharmacy,University of Illinois at Chicago)
UIC Herbal Course for Pharmacists - Sydney, Australia, Feb. 22-23, 1997.

UIC, College of Pharmacy Continuing Education- "Herbal Medications: Issues for


Pharmacists", April 4-5, 1997.

External Examiner:
Chinese University of Hong Kong, 2000-2001, 2003- present.
Jadavpur University, Kolkata, India, 2004.
University of Western Sydney, Australia, 2007.

External Evaluator/Academic Promotions:


University of West Indies, 2001-2002.
Hong Kong Baptist University, 2004,
Hong Kong Polytechnic University, 2006.

MAJOR RESEARCH INTERESTS:


Major research interests are in the areas of drug discovery from higher plants, which include the
acquisition of source materials through good agriculture and field collection practice (GACP) and the
bioassay-directed phytochemical isolation and biology of potentially active antitumor, cancer
chemopreventive, anti-malarial, and anti-TB agents; of qualitative and quantitative QA/QC of natural
products and herbal medicine; of standardization of botanical dietary supplements and traditional
herbal medicines; of basic and translational evidence-based traditional herbal medicine; and of
monographing medicinal plants; of development of pharmacopoeia and standards for medicinal plants.

GRADUATE STUDENTS:

POST DOCTORAL FELLOWS:

VISITING SCHOLARS AND SClENTISTS:

WORLD HEALTH ORGANIZATION RESEARCH TRAINEES/FELLOWS:

PROFESSIONAL ORGANIZATION ACTIVITlES:


Academy of Pharmaceutical Sciences, Section on Pharmacognosy and Natural Products, Member,
Publicity Committee, 1968-1969.
Referee for Scientific Program Committee, the 1971 F.I.P. Congress-Academy of Pharmaceutical
Sciences Joint Meeting, 1970-1971.
Academy of Pharmaceutical Sciences, Section of Pharmacognosy and Natural Products, Member,
Program Committee, 1973-1974.
Academy of Pharmaceutical Sciences, Kilmer Prize Committee, 1980-1981.
American Society of Pharmacognosy, Member, Constitution and By-Laws Committee, 1968-1969.
American Society of Pharmacognosy, Member, Nominating Committee, 1969-1970
American Society
1969-1970.

of Pharmacognosy, Chairman, Ad Hoc Committee on Pharmacognosy Titles,

American Society of Pharmacognosy, Member, Publicity Committee, 1971-1972.


American Society of Pharmacognosy, Member, Nominating Committee, 1972-1973.
American Society of Pharmacognosy, Chairman, Auditing Committee, 1972-1973.
American Society of Pharmacognosy, Chairman, Scientific Program Committee, 1973-1974.
American Society of Pharmacognosy, Member, Local Program Committee, 1973-1974.

American Society of Pharmacognosy, Chairman, Nominating Committee, 1974-1975.


American Society of Pharmacognosy, Vice President, 1977-1978.
American Society of Pharmacognosy, President, 1978-1979.
American Society of Pharmacognosy, Past President, (Executive Committee) 1979-1980.
American Society of Pharmacognosy, Chairman, Nominating Committee, 1986-1987.
American Society of Pharmacognosy, Chairman, Local Committee, 32nd Annual Meeting, 1990-1991.
American Society of Pharmacognosy, Associate Editor, Journal of Natural Products, 1993-1998.
American Society of Pharmacognosy, Publication Committee, 1994-1999.
American Society of Pharmacognosy, Auditing Committee, 1997-1998.
Society for Economic Botany, Treasurer, 1975-1977.
Society for Economic Botany, Vice President and President-Elect, 1980-1981.
Society for Economic Botany, President, 1981-1982
Society for Economic Botany, Past-President and Member of Council, 1982-1983.
Society for Economic Botany, Chair, Nominating Committee, 1982-1983
Society for Economic Botany, Member, Nominating Committee, 1984-1985
Society for Economic Botany, Member, Nominating Committee, 1986-1987
Member, Informal group of scientists interested in the potentialities of plant extracts and other natural
products in future treatment of cancer, in connection with the National Panel of Consultants on the
Conquest of Cancer, 1976-1977.
American Society of Pharmacognosy, Auditing Committee, 2007-2010.

INTERNATIONAL ORGANIZATION ACTIVITlES:


World Health Organization, Special Programme of Research in Human Reproduction, Task Force on
Use of Indigenous Plants for Fertility Regulation, Consultant, 1977.

World Health Organization, Special Programme of Research in Human Reproduction, Task Force on
Plants for Fertility Regulation, Temporary Advisor, 1979, 1980, 1982, 1984.
UNIDO, Roster of Experts, 1981-1985.
Academic Council, Riyad University, Saudi Arabia, 1981, 1986 (Academic Promotion Referee).
World Bank, Consultant, 1983.
Qinghai Province Public Health Bureau, Xining, Qinghai Province, PRC, 1992.
2nd International Congress of Natural Medicine, Budapest, Hungary, Member, Scientific Advisory
Board, 1993.
Research Grants Council, Hong Kong, Grant Reviewer, 1995, 1998, 1999.
Panjab University, India, External Examiner, 1993, 1995, 1996.
97 U.S.-China Symposium on Chinese Herbal Medicine, Member, Organizing Committee, 1997.
98 U.S.-China Symposium on Chinese Herbal Medicine, Member, Organizing Committee, 1998.
Baptist University, Hong Kong, Steering Committe Meeting On Research on Chinese Materia Medica,
1998.
99 U.S.-China Symposium on Chinese Herbal Medicine, Member, Organizing Committee, 1999.
Academic Committee, Interantional Congress on Traditional Medicine (Beijing 2000). Beijing, China
April 22-24, 2000.
World Health Organization, Programme on Traditional Medicine-Temporary Advisor, 1983, 1990,
1996, 1999, 2003.
World Health Organization, Programme on Traditional Medicine-Consultant, 1985.
World Health Organization, Regional Office for the Western Pacifics, Consultant (TRM-AIDS, PRC)
1990.
World Health Organization, Eastern Mediterranean Regional Office, Consultant (TRM, Saudi Arabia),
1994.
World Health Organization, Eastern Mediterranean Regional Office, Consultant (TRM, Sudan), 1995.
World Health Organization, Regional Office for the Western Pacifics, Consultant (TRM, Cambodia)
1995.

World Health Organization, Traditional Medicine Programme, Consultation on Model


Monographs of Widely Used Medicinal Plants, Munich, Germany, 8-10 July 1996.
World Health Organization, Programme on Traditional Medicine, Conference on Research
Methodology on Traditional Medicine, Rockville, MD, USA. August, 1997
World Health Organization, Programme on Traditional Medicine, Consultation on WHO Monographs
on Selected Medicinal Plants, Vol. 1, Munich, 1997.
World Health Organization, Programme on Traditional Medicine, Consultation on WHO Monographs
on Selected Medicinal Plants, Vol. 2, (Salerno-Rovello, Italy), 1999.
World Health Organization, Regional Office for the Western Pacifics, Consultant (TRM, Vietnam)
1999.
World Health Organization, Regional Office for the Western Pacifics, Consultant (TRM, Papua New
Guinea) 1999.
World Health Organization, Programme on Traditional Medicine, Consultation on methodologies for
Research and Evaluation of Traditional Medicine (Hong Kong, SAR) 2000.
World Health Organization, Regional Office for the Western Pacifics, Consultant (TRM, Samoa) 2000.
World Health Organization, Regional Office for South East Asia, Consultant (TRM, Jakarta,
Indonesia) 2000.
World Health Organization, Pan American Health Organization, Consultant (TRM, Jamaica) 2000.
World Health Organization, Pan American Health Organization, Consultant (TRM, Guatemala) 2001.
World Health Organization, Programme on Traditional Medicine, Third Consultation on WHO
Monographs on Selected Medicinal Plants, Vol. 3, (Ottawa, Canada), 16-19 July, 2001.
World Health Organization, Programme on Traditional Medicine,
Informal Meeting on
Methodologies for Quality Control of Finished Herbal Products, (Ottawa, Canada), 20-21 July, 2001.
World Health Organization, Western Pacific Regional Office, Consultant, The Working Group on
Harmonization of Standards and Regulatory Framework of Herbal Medicines meeting (Seoul,
Republic of Korea) 27-30 November 2001.
Chinese University of Hong Kong, External Examiner (Wong Pak Ki, M. Phil), 2000-2001.
Hong Kong Standard on Chinese Materia Medica Scientific Committee Meetings IAB Member, 6-7
June 2002, 1 Nov. 2002.
Hong Kong Jockey Club Institute of Chinese Medicine, Strategic Advisory Committee Meeting 4-5
June 2002.

University Grants Committee of Hong Kong, Areas of Excellence (AoE) Scheme Third Round
Review, Hong Kong, SAR, PRC, 2002.
Hong Kong Baptist University, Chairman, Accreditation Panel on Diploma in Chinese Medicine
Pharmacy Programme, Hong Kong, SAR, PRC, 4-6 November, 2002
PATH , Program for Appropriate Technology in Health, India Microbicides Project, Winter Expert
meeting, 22 January 2003, Washington, DC.
PAHO/WHO Regional Meeting on Traditional Medicine, Guatemala City, Guatemala, 18-20 February
2003
Meeting of the Working Group on Medicinal Plants of the Pan American Network of Drug Regulatory
Harmonization (PANDRH), Guatamela City, Guatemala, 20 February 2003.
Chinese University of Hong Kong, External Examiner (Woo Ka Yan, Ph.D.), 2002-2003
World Health Organization, Programme on Traditional Medicine, Consultation on Good Agricultural
and Field Collection Practices for Medicinal Plants (WHO HQ) 2003.
WHO/WPRO, The Second Consultation Meeting on Traditional and Modern Medicine:
Harmonizing the Two Approaches, Gyeongju, Republic of Korea, 17-20 September 2003,
WHO/PAHO, Traditional, Complementary and Alternative Medicine and Therapies into
National Health Systems Workgroup, Washington, D.C. 15-17 December 2003
Hong Kong Baptist University, Academic Staff Promotion Referee, Hong Kong, SAR, PRC, May,
2004.
World Health Organization, Programme on Traditional Medicine, Consultation on Contaminants and
Residues in Herbal Medicines, Milan-Loveno di Menaggios, Italy, 12-14 July 2004.
Hong Kong Chinese Materia Medica Standards, Scientific Committee Meetings IAB Member,
January, February, June, November, 2004.
Hong Kong Chinese Materia Medica Standards, IAB Meeting, April, 2004.
Hong Kong Jockey Club Institute of Chinese Medicine, Strategic Advisory Committee Meeting
November, 2004.
Stichting Technologie Rating, Amsterdam, Netherlands, Feb 18, 2005.
Chinese Academy of Science, Diagnostic Evaluator of Kunming Institute of Botany, January, 2005.
Hong Kong Chinese Materia Medica Standards, Scientific Committee Meetings IAB Member,
February, June, September, 2005.

Hong Kong Polytechnic University, Faculty Promotion External Assessor, Hong Kong, SAR, PRC,
April, 2005.
World Health Organization, Programme on Traditional Medicine, Consultation on Selected Medicinal
Plants. Vol. 4, Salerno-Paestum, Italy, 3-7 October 2005.
Hong Kong Chinese Materia Medica Standards, Phase 2 - IAB Meeting, Hong Kong, SAR, China, 811 November, 2005.
Hong Kong Baptist University, Academic Staff Promotion Referee, Hong Kong, SAR, PRC,
November, 2005.
Chinese University of Hong Kong, External Examiner, "Master of Science in Chinese Medicines and
Herbal Drugs", School of Chinese Medicine. 2005 2007.
Hong Kong Polytechnic University, Department of Applied Biology and Chemical Technology,
Advisor on research and development program on herbal medicine, Hong Kong, SAR, PRC, 2006.
Kunming Institute of Botany, Kunming, PRC, External Evaluator.
International Advisory Committee, 2006 World Congress on Chinese Medicine - Charting the
Course of Development, 23 - 25 November 2006, Kowloon Shangri-La Hotel, Hong Kong, SAR,
PRC.
GOVERNMENTAL / NGO ACTIVITlES:
Congress of the United States, Office of Technology Assessment, 1990 ( Review of position paper:
"Unconventional Cancer Treatment")
Congress of the United States, Office of Technology Assessment, 1991 ( Review of position paper:
"Science Information and Methodologies for Assessing the Safety of Genetically Modified Foods and
Feeds")
Food and Drug Administration, 1996, Consultant, (Food Advisory Committee Meeting on Dietary
Spplements Containing Ephedrine Alkaloids, August 27 and 28, 1996, Washington, DC)
Office of Alternative Medicine, NIH, 1997, Consultant, Conference on International Research
Agenda on Traditional Medicine, Rockville, MD, USA, August.
National Center for Complementary and Alternative Medicine, Ad Hoc Review Committee, June 18,
1999 (Bethesda, MD).
SBIR Ad Hoc Review Committee, November 15-16, 1999 (Bethesda, MD).
National Center for Complementary and Alternative Medicine, Ad Hoc Review Committee, February
10-11, 2000 (Rockville, MD).

National Center for Complementary and Alternative Medicine, Ad Hoc Review Committee, March 9,
2000 (teleconference).
Department of Health and Human Services, U.S. Public Health Service, Public Meeting on The Safety
of Dietary Supplements Containing Ephedrine Alkaloids, Washington DC, August 8-9, 2000.
Member, Complementary and Alternative Medicine for Urological Ssymptoms Data and Safety
Monitoring Board (CAMUS DSMB), A Multicenter Trial of Phytotherapy for BPH. (NIDDKD,
NCCAM, and ODS, NIH), 2003- 2011.
Member, Expert Panel to Review the ODS Analytical Methods and Reference Materials. (ODS, NIH),
2006.
External Reviewer, Draft Report by the Committee on Dietary Supplement Use by Military Personnel.
(Institute of Medicine of the National Academies), 2008.

CONSULTANCIES:
Amazon Natural Products Company, 1965
Coca Cola Company, 1973
Celestial Seasonings, Boulder, CO., 1987
Emprise, Inc., Washington, DC, 1989-1990
Herb Research Foundation, Boulder, CO., 1990-1991
Naprotech, Inc., Chicago, IL., 1993-1994
NOW Natural Foods, Glendale Heights, IL., 1998
Stichting TechnologyRating, Amsterdam, Netherlands, 2005
Pharmaflip Corporation, USA, 2005-2006
New York Financial (International) Corp, 2006-2008.
Caleco Pharma Corp. USA, 2009-2010
NatProPharm Services, Ltd., USA (President), 2005-present.

EDITORSHIP:
Pharmacognosy Titles, Associate Editor, 1971 - 1975.
International Traditional Medicine Newsletter, 1989 - 1991
Journal of Natural Products, Associate Editor, 1993-1998
Journal of Natural Products, Guest Editor, 2005-2006
Chinese Medicine Modern Practice, Annals of Traditional Chinese Medicine, Vol.2, 3 (Co-editor) ,
2006-present

EDITORIAL BOARD:
Oriental Pharmacy and Experimental Medicine, 2003- 2006
Mahidol University Journal of Pharmaceutical Sciences, 2003-2006
American Journal of Chinse Medicine, 2003-present

JOURNAL REFEREE:
Journal of Pharmaceutical Sciences, 1966-1982, 1985-1997.
Journal of Natural Products (Lloydia), 1976-present
American Journal of Pharmaceutical Education, 1984-1998.
Journal of Ethnopharmacology, 1985-present
Economic Botany, 1980-1990
Annals of Pharmacotherapy, 1993
Phytochemistry, 1998, 1999, 2000 -present
Journal of Pharmaceutical Biology, 2000
Phytomedicine, 2001-present
Journal of Agricultural and Food Chemistry, 2001-2007
Natural Products Letters, 2001

The Journal of Alternative and Complementary Medicine, 2002-present


Oriental Pharmacy and Experimental Medicine, 2003- present
Bioroganic and Medicinal Chemistry Letters, 2003-present
American Journal of Chinse Medicine, 2003-present
Hong Kong Medical Journal, 2005-2006
Journal of AOAC INTERNATIONAL, 2007
Cellular and Molecular Neurobiology, 2008-2009

COMMUNITY ACTIVITlES:
Glenbard West High School Orchestra Parents Association, Vice President (1982-1983).
Glenbard West High School Orchestra Parents Association, Treasurer (1983-1985).
Glenbard West High School Orchestra Parents Association, President (1985-1986).

UNIVERSITY COMMITTEES:
A. CAMPUS:
Senate, 1970-1978.
Executive Committee, Graduate College, 1974-1977.
Executive Committee, Graduate College, Sub-Committee on Membership, 1974-1976.
Executive Committee, Graduate College, Sub-Committee on Courses and Curriculum,
1976-1977.
NMR Advisory Committee, RRC, 1985-1986.
B.

COLLEGE:
Aministrative Officers Committee, 2002-2003
Executive Committee, 1973-1977, 1989-1991, 1992-1993

Strategic Planning Committee, 1990


Committee on Committee, 1991-1992, 1996-1998, 1997-1998
Committee to Review Organization of the Departments of the College of Pharmacy, 1993-1994
Committee, Search for the Dean of College of Pharmacy, 1994-1995
Committee, Search for the Associate Dean, Research and Graduate Education, College of
Pharmacy, 1997-1998
Alternate Delegate to USP Convention, 2000 (1999-2000)

C. DEPARTMENT/UNIT:

1.

Department of Pharmacognosy and Pharmacology:


Advisory Committee, 1970-1977
Research and Graduate Education Committee, 1970-1977, 1978-1982
1972-1977)

2.

Department of Medicinal Chemistry and Pharmacognosy:


Advisory Committee, 1982-1983, 1984-1985, 1990-1991;
1996-1998.

3.

(Chairman,

Ex officio, 1992-1995;

Program in Pharmacognosy, Graduate College:


Graduate Education Committee, 1982-1999 (Chairman, 1997-1999)

4.

Program for Collaborative Research in the Pharmaceutical Sciences


Research Committee 1985-2003.
Departmental Review and Compliance Committee (Human Subjects), 1983 - 1994.

INVITED LECTURES:
Alfred Benzon Symposium, 20th, Copenhagen, Denmark, August 1983, "Current Status of Gossypol,
Zoapatanol and other Plant Derived Fertility Regulating Agents"
Sichuan Institute of Chinese Materia Medica, Chongqing, PRC, January 1984, "Recent Studies on
Aristolochia indica and Gossypol,'

Mahidol University, Bangkok, Thailand, January 1984, "The Plant Kingdom as a Potential Source
of New Drugs for Fertility Regulation".
Biwako, Institute, Otsuka Pharmaceutical Company, Ltd, Japan, June 1984," Search for Fertility
Regulating Agents from Plants".
Tokushima University, Faculty of Pharmacy, Tokushima, Japan, June 1984, "Search for Fertility
Regulating Agents from Plants".
Kobe Women's College of Pharmacy, Kobe, Japan, June 1984, "Search for Fertility Regulating Agents
from Plants".
Okayama University, Faculty of Pharmaceutical Sciences, Okayama, Japan, June 1984, "Search for
Fertility Regulating Agents from Plants".
Beijing Medical College, Beijing, PRC, May 1985, "Program for Collaborative Research in the
Pharmaceutical Sciences'' and "Fertility Regulating Agents from Plants".
Guangzhou College of Traditional Chinese Medicine, Guangzhou, PRC, June 1985, "Current Progress
in the Search for Bioactive Principles from Plants in the Program for Collaborative Research in the
Pharmaceutical Sciences, College of Pharmacy, University of Illinois".
WHO/DANIDA Inter-Regional Workshop, Bangkok, Thailand, November-December, 1985,
"Appropriate Methodology for Selection, and Use of Traditional Remedies in National Health Care
Programmes"
WHO/DANIDA Inter-Regional
"Global Status of Herbal Drugs"

Workshop,

Bangkok,

WHO/DANIDA Inter-Regional Workshop, Bangkok,


"Requirements for a Herbal Formulary"

Thailand,

Thailand,

November-December, 1985,

November-December, 1985,

WHO/DANIDA Inter-Regional Workshop, Bangkok, Thailand, November-December, 1985,


"Information Sources and Their Relatives Importance to Decision Making"
Otsuka Pharmaceutical Co. Ltd, Osaka, Japan, September, 1986, "Progress in the Search for FertilityRegulating Agents from Senecio vulgaris and Montanoa tomentosa"
Kobe Women's College of Pharmacy, Kobe, Japan, September, 1986, "Recent Progress on the Search
for Bioactive Natural Products''
Guangzhou College of Tradition Chinese Medicine, Guangzhou, China, September, 1986, "The
Importance of Plant-Derived Agents in Therapy and Medical Research"
Chinese Pharmacological Society, Beijing, China, October, 1986, "Phytochemical and Biological
Studies on Montanoa tomentosa"

The First Princess Chulabhorn Science Congress Bangkok, Thailand, December, 1987, "Search for
Fertility Regulating Agents from Larrea tridentata"
Eidgenossische Technische Hochschule, Zurich, Switzerland, June, 1988, "Search for Fertility
Regulating Agents from Plants - A 10 Year Odyssey"
International Symposium on East-West Medicine, Kyung Hee University, Seoul, Korea, Oct. 1989,
"The Napralert database as an information source for Traditional Medicine"
The Second International Symposium in Recent Advances in National Products Research Institute,
Seoul National University, Seoul, Korea, Oct. 1989," The Search for Fertility Regulating Agents from
Plants - an Odyssey"
China Medical College, Taichung, Taiwan, Oct. 1989," The Search for Fertility Regulating Agents
from Plants - an Odyssey"
Kaoshiung Medical College, Kaoshiung, Taiwan, Oct. 1989, "Napralert Database as an Information
Source for Traditional Medicine"
Chulalonghorn University, Faculty of Pharmacy, Bangkok, Thailand, May, 1991, "Research Training
and Bioactivity Driven Natural Products Research"
Hong Kong University of Science and Technology, Hong Kong, February, 1992, "Bioactivity- Driven
Collaborative Natural Products Research".
Qinghai Pharmaceutical Society, Xining, Qinghai Province, PRC, February, 1992, (1) " The Program
for Collaborative Research in the Pharmaceutical Sciences and Bioactivity
Driven Natural Products Research", (2) "Effect of Flax Meal Supplementation on Fatty Acid
Metabolism", and (3) "Application of the NAPRALERT Database in Traditional Chinese Medicine".
International Congress on Complementary Medicine - Traditional Medicine and European Medical
Sciences, Budapest, Hungary, May 20-24, 1992, (1) " Effect of Flax Seed Supplementation on Fatty
Acid Metabolism", and (2) "Application of the NAPRALERT Database to Traditional Medicine"
Prague Institute of Chemical Technology, Faculty of Chemical Technology, Department of Organic
Chemistry, Prague, Czechoslovakia, May 27, 1992, "Bioactivity Driven Collaborative Natural
Products Research and the NAPRALERT Database".
2nd International Congress of Natural Medicines, Budapest, Hungary, May 20-23, 1993, "Current
Status of Medicinal Plant Based Complementary Medicine".
Central Laboratory for Drug and Food Analysis, Ministry of Health, Kingdom of Saudi Arabia, Oct.
15, 1994, "Microbial Contamination of Herbal Medicine"
Central Laboratory for Drug and Food Analysis, Ministry of Health, Kingdom of Saudi Arabia, Oct.
16, 1994, "Quality Control Testing of Herbal Medicine".

Central Laboratory for Drug and Food Analysis, Ministry of Health, Kingdom of Saudi Arabia, Oct.
18, 1994, "Stability and Adulteration of Herbal Medicines and Methods of Detection".
Central Laboratory for Drug and Food Analysis, Ministry of Health, Kingdom of Saudi Arabia, Oct.
19, 1994, "Quantitative Analysis of Some Active Constituents of Herbal Medicines".
Central Laboratory for Drug and Food Analysis, Ministry of Health, Kingdom of Saudi Arabia, Oct.
22, 1994, "Adverse Reactions and Toxicity of Herbal Medicines".
Aromatic and Medicinal Plant Research Institute, National Research Centre, Khartoum, Sudan, April
5, 1995, "Microbial Contamination of Herbal Medicine"
Aromatic and Medicinal Plant Research Institute, National Research Centre, Khartoum, Sudan, April
6, 1995, "Quality Control Testing of Herbal Medicine".
Aromatic and Medicinal Plant Research Institute, National Research Centre, Khartoum, Sudan, April
7, 1995, "Stability and Adulteration of Herbal Medicines and Methods of Detection".
Aromatic and Medicinal Plant Research Institute, National Research Centre, Khartoum, Sudan, April
7, 1995, "Quantitative Analysis of Some Active Constituents of Herbal Medicines".
Aromatic and Medicinal Plant Research Institute, National Research Centre, Khartoum, Sudan, April
8, 1995, "Adverse Reactions and Toxicity of Herbal Medicines".
World Health Organization, Phnom Penh, Cambodia, May 24, 1995, "Perspectives on the Efficacy,
Safety and Quality Control of Herbal Medicine".
Standardization and Validation of Methods for Characterizing and Analyzing Dietary Supplements,
(Jointly Sponsored by the AOAC International, American Herbal Products Association, U.S.
Pharmacopeial Convention, and U.S. Food and Drug Administration) Baltimore, MD, Oct. 20-21,
1996, "Standardization of Botanicals and Their Extracts: What It Really Means".
First Indo-China Congress on the Harmonization of Pharmacy, Faculty of Pharmacy, Mahidol
University, Bangkok, Thailand, May, 1997, Discovery and Characterization of Natural Product
Cancer Chemopreventive Agents.
Pharmaton, SA, Lugano, Switzeretland, June 10, 1997, Program for Collaborative Research in the
Pharmaceutical Sciences, College of Pharmacy, UIC.
Eidgenossische Technische Hochschule, Zurich, Switzerland, June 12, 1997. Collaborative Drug
Discovery Research: 2+2 = 4+1?.
97 U.S.-China Symposium on Chinese Herbal Medicine, Univ. Of Chicago, Chicago, IL., Oct. 13-15,
1997, WHO Monographs on Selected Medicinal Plants.

Functiuonal Foods for Health, University of Illinois, 7th Annual Retreat, Monticello, Illinois, May 1113, 1998, The FFH Program Natural Product Quality Control Laboratory
UCLA College of Medicine, Course on East-West Integrative Medicine, UCLA, Los Angeles, CA.,
Aug 28-29, 1998, Botanicals in health and disease - research and regulatory aspects in the United
States,
UCLA College of Medicine, Course on East-West Integrative Medicine, UCLA, Los Angeles, CA.,
Aug 28-29, 1998, Herbal medicine in aging
98 U.S.-China Symposium on Chinese Herbal Medicine, Univ. Of Chicago, Chicago, IL., Sept. 21-23,
1998, Botanicals in health and disease - research and regulatory aspects in the United States
98 U.S.-China Symposium on Chinese Herbal Medicine, Univ. Of Chicago, Chicago, IL., Sept. 21-23,
1998, Collaborative search for natural products cancer chemopreventive agents
Department of Biology, Sekong University, Seoul, Korea, Sept. 22, 1998, Ginseng - Regulatory and
quality issues in the USA
7Th International Symposium on Ginseng Research, Seoul, Korea, Sept. 23, 1998, Perspectives on
the quality assurance of ginseng products in North AmericA
Guangzhou University of Traditional Chinese Medicine, Guangzhou, PRC, Sept. 28, 1998,
Botanicals in health and disease - research and regulatory aspects in the United States
National Center for Science and Technology of Vietnam, Seminar on Sustainable Developement and
Conservation of Biodiversity in Vietnam, Hanoi, Vietnam, Oct. 2-3, 1998, Perspectives on
Phytochemical Collaborative Research and Research Training in a Natural Product Drug Discovery
Program.
Dept. Of Pharmacognosy and Central Laboratory for Research, HoChiMinh City University of
Medicine and Pharmacy,Ho Chi Minh City, Vietnam, Oct. 6, 1998, Collaborative search for natural
products cancer chemopreventive agents
Pharmaceutical Institute, University of Freiburg, Freiburg, Germany, Oct. 14, 1998, Collaborative
search for natural products cancer chemopreventive and other biologically active agents
Institut de Pharmacognosie et Phytochemie, University of Lausanne, Lausanne, Switzerland, Oct. 16,
1998, Collaborative search for natural products cancer chemopreventive and other biologically active
agents: 2+2 =5
Iowa State University, Extended and Continuing Education, Videoconference on Herbal Remedies,
April 15, 1999, Botanicals in Health and Diseases: Quality, Research and Regulatory Aspects in the
USA
American Society of Pharmacognosy Interim Meeting, Tunica, Mississippi, April 29-May 1, 1999,
Quality Assessment of Ginseng Products in North America

Ministry of Health, Viet Nam - WHO Trining Course on Traditional Pharmacy, Ninh Binh, Viet Nam.
27 - 30 September 1999. Post Harvest Handling of Botanicals
Ministry of Health, Viet Nam - WHO Trining Course on Traditional Pharmacy, Ninh Binh, Viet Nam.
27 - 30 September 1999. Microbial Contamination of Herbal Medicine.
Ministry of Health, Viet Nam - WHO Trining Course on Traditional Pharmacy, Ninh Binh, Viet Nam.
27 - 30 September 1999. Herbal Products in Modern Dosage Forms
Ministry of Health, Viet Nam - WHO Trining Course on Traditional Pharmacy, Ninh Binh, Viet Nam.
27 - 30 September 1999. Edible Plants as Sources for Cancer Chemopreventive Agents
International Forum on Traditional Medicine, Toyama, Japan, October 16-17, 1999. Edible Plants as
Sources for Cancer Chemopreventive Agents
Society of Cosmetic Chemists. Midwest Chapter, 1999 Fall Technical Symposium, Chicago, IL.,
October 22, 1999. Quality Control of Botanicals: What Does it Really Means?
99 U.S.-China Symposium on Chinese Herbal Medicine, Univ. Of Chicago, Chicago, IL., Dec. 6-8,
1999, Botanicals in USA - Past, Present and Future
Seminar Nasional XVII.Tumbuhan Obat Indonesia, Bandung, Indonesia, 28-30 March 2000, Quality
Control of Herbal Medicine: From Raw Material to Finished Products
Bandung Institute of Biology, Dept. Of Pharmacy, Bandung, Indonesia, 31 March 2000,
Complementary and Alternative Medicine in the USA.
Bandung Institute of Biology, Dept. Of Pharmacy, Bandung, Indonesia, 31 March 2000, Quality
Control of Botanicals.
Guangzhou University of Traditonal Chinese Medicine, Guangzhou, PRC, 3 April 2000,
Complementary and Alternative Medicine in the USA.
Seminar in the Regulatory Control of Herbal Medicine, Hong Kong, SAR, 10 April 2000, Regulatory
Control of Herbal Products in the USA.
Purdue-UIC International Training Program in New Crops: Aromatic and Medicinal Plants, 27 June
2000, Collaborative Research on Botanicals: From Drug Discovery to Dietary Supplements.
Purdue-UIC International Training Program in New Crops:Aromatic and Medicinal Plants, 27 June
2000, Extraction, Separation , and Isolation of Biologically Active Natural Products from Plants.
Purdue-UIC International Training Program in New Crops:Aromatic and Medicinal Plants, 27 June
2000, A Regulatory Dilemma: The Current Stayus of Botanical Dietary Supplements.

Department of Health and Human Services, U.S. Public Health Service, Public Meeting on The Safety
of Dietary Supplements Containing Ephedrine Alkaloids, Washington DC, 8-9 August 2000, Ephedra
Containing Compounds: Historical and Pharmacologic Context.
World Health Organization, Programme on Traditional Medicine- Hong Kong Department of Health.
Consultation on methodologies for Research and Evaluation of Traditional Medicine-Preconsultation
Seminar (Hong Kong, SAR) 2000. Regulatory control of herbal medicine products in the USA.
Ministry of Health, Jakarta, Indonesia, 20 September 2000, A Regulatory Dilemma: The Current
Status of Botanical Dietary Supplements
Ministry of Health, Jakarta, Indonesia, 20 September 2000, Quality Control of Herbal Medicine.
WHO/WPRO Regional Workshop on Traditional Practice of Medicine and Health Sector
Development, Apia, Samoa, 7 November 2000. Efficay and Safety of Herbal Medicine
WHO/PAHO Workshop on Traditional Medicine, Kingston, Jamaica, November, 2000, Research
Activities on Herbal Medicine and Botanical Dietary Supplements at the PAHO/WHO Collaborating
Center for Traditional Medicine
WHO/PAHO Workshop on Traditional Medicine, Kingston, Jamaica, November, 2000, DSHEA and
Botanical Dietary Supplements in the USA
Pan American Health Organization, World Health Organization Workshop on Policies, Plans, and
Programs on Traditional and Complementary Medicine in the Americas, 19-20 May, 2001,
Guatemala, Research and Research Training on the use of Medicinal Plants in Primary Health Care.
Pritzker School of Medicine, University of Chicago, Chicago, IL, 10 April 2001, Current Status of
Herbal Products in the USA.
University of Torino, Torino, Italy, 14 May 2001, Biodiversity Conservation Based Drug Discovery
Research in an ICBG Program
Indonesia Institute of Science (LIPI). Seminar on Natural Products Drug Discovery in the Framework
of the Convention on Biological Diversity (CBD) in Indonesia and Launching of BIMAPS Webb and
BICHEMS Webb Services, Jakarta Indonesia, 21 May, 2001, Biodivesity Conservation and Drug
Discovery Research
WHO/WPRO Regional Meeting of The Working Group on Harmonization of Standards and
Regulatory Framework of Herbal Medicines, Seoul, Republic of Korea, 27-30 November 2001,
Harmonization of Herbal Medicine: Quality, Safety and Efficacy.
WHO/WPRO Regional Meeting of The Working Group on Harmonization of Standards and
Regulatory Framework of Herbal Medicines, Seoul, Republic of Korea, 27-30 November 2001, ICH:
A Model for the Harmonization of Herbal Medicine?

American Herbal Products Association, International Symposium on the Role of Botanicals in


Womens Health, Rutgers, the State University of New Jersey, New Brunswick, New Jersey, USA, 1618 February 2002, Efficacy Validation of Botanicals in Womens Health.
International Advisory Board on Hong Kong Regulatory Standards for Chinese Medicinal Herbs,
Health Department, Hong Kong, SAR, China, 25 February 1 March, 2002, Recent Research and
Development of Herbal Standards in the USA
APEC Symposium on Traditional Medicine, Intellectual Property Department , Hong Kong, SAR,
China, 19 22 March, 2002, Research Aspects of the Development of Traditional Medicine in the
USA
Enhancing the Evidence-base for TCM Practice Methodology and Grantsmanship Workshop
(NIH/NCCAM-Univ. Maryland-Hong Kong Health, Welfare and Food Bureau), Hong Kong, SAR,
China, 30-31 October 2002 Safety and Efficacy Study of TCM and CAM Botanicals (Phase I and II
Studies)
Enhancing the Evidence-base for TCM Practice Methodology and Grantsmanship Workshop
(NIH/NCCAM-Univ. Maryland-Hong Kong Health, Welfare and Food Bureau), Hong Kong, SAR,
China, 30-31 October 2002 Case Study I (Practical Examples of Phase I and Phase II studies)
PAHO/WHO Regional Meeting on Traditional Medicine, Guatemala City, Guatemala, 18-20 February
2003, WHO Guideline onGood Agricultural and Field Collection Practices (GACP).
PAHO/WHO Regional Meeting on Traditional Medicine, Guatemala City, Guatemala, 18-20 February
2003, Methods for Analysis of Cases of Adverse Effects of Herbal Medicine.
Second Consultation Meeting on Traditional and Modern Medicine: Harmonizing the Two
Approaches, Gyeongju, Korea, 17-20 September 2003, Methods/Approaches for Non-clinical
Research on Herbal Medicine: From GAP to GMP
WHO/WPRO, Second Consultation Meeting on Traditional and Modern Medicine: Harmonizing the
Two Approaches, Gyeongju, Korea,17-20 September 2003,Potential Multi-disciplinary Collaborative
Research Model and Network on Traditional Medicine
2003 International Seminar, Daegu Haany University, Daegu, Korea , Sept. 22, 2003, Botanicals for
Health. A Regulatory Dilema in the USA
MRRC, Wonkwang University, Korea. Sept. 23, 2003. Recent Experiences in Collaborative Natural
Products Research: From Drug Discovery to Botanical Dietary Supplements.
Center for Plant Diversity Research, KRIBB, Daegeon, Korea, September 24, 2003, Collaborative
Natural Products Research
Ewha Womens University, College of Pharmacy, Seoul, Korea, September 26, 2003, Perspectives on
Botanical Dietary Supplements Research

International Advisory Board, Hong Kong Chinese Materia Medica Standards, Department of Health,
Hong Kong, SAR, Feb. 22, 2004, Botanicals in the USA- Current Regulatory Status
Zhejiang University, Hangzhou, China, March 15, 2004. Collaborative Natural Products Research:
From Drug Discovery to Botanical Dietary Supplements
Shanghai Institute of Materia Medica, Shanghai, China, March 17, 2004. Collaborative Natural
Products Research: From Drug Discovery to Botanical Dietary Supplements
Shangahi University of Traditional Chinese Medicine, Shanghai, China,
Perspectives on Herbal Medicine and Dietary Supplements Research.

March 16, 2004.

Tung Wah Group of Hospitals, 1st TWGHs Eddie Wang International Symposium on Complementary
Chinese and Western Medicine Integrated Approach, Hong Kong, SAR, China, 4-5 November, 2005,
Evidence Based Herbal Medicine: Challenges in Efficacy and Safety Assessments.
International Advisory Board on Hong Kong Regulatory Standards for Chinese Medicinal Herbs,
Health Department, Hong Kong, SAR, China, 11 November, 2005, Current Status of QA/QC of
Botanicals in the USA.
Hong Kong Polytechnic University, Department of Applied Biology and Chemical Technology,
Graduate Course ABCT 519, Hong Kong, SAR, China, 30 April 2006, Botanicals in the USACurrent Regulatory Status
Hong Kong Polytechnic University, Department of Applied Biology and Chemical Technology,
Graduate Course ABCT 519, Hong Kong, SAR, China, 30 April 2006, Quality Control,
Standardization, GACP, GLP, GMP, & GCP on TCM and CAM Botanicals
Hong Kong Polytechnic University, Department of Applied Biology and Chemical Technology, Hong
Kong, SAR, China, 1 March 2006, Evidence Based Herbal Medicine: From Drug Discovery to
Botanical Dietary Supplements
University of South Pacific, Institute of Applied Sciences, Suva, Fiji, 1 June 2006, Herbal Medicines:
Is the Glass Half-ful or Half-empty?.
RMIT University, Melbourne, Australia, 6 June 2006, Herbal Medicines: Risks and Benefits
University of Western Sydney, Sydney, Australia, 8 June 2006, Evidence Based Herbal Medicine:
From Drug Discovery to Botanical Dietary Supplements
University of Technology and Science, Sydney, Australia, 9 June 2006, Collaborative Botanical Drug
Discovery and Herbal Medicine Research: 2+2 = 5?
Tsao Foundation Distingguished Scholar Programme 2006 on TCM and Integrative Medicine: The US
Experience. Singapore, 17 June, 2006, Botanicals in Health: Back to the Future
Singapore General Hospital, Singapore, 19 June 2006, Integrative Medicine: Herbal Perspective

National University of Singapore, Singapore 20 June 2006, Evidence Based Herbal Medicine: From
Drug Discovery to Botanical Dietary Supplements
2006 CAM/TM Professional Training Program, China Medical University, Taichun, Taiwan, 18
September 3 October 2006, Herbal Medicines: Risks and Benefits
2006 CAM/TM Professional Training Program, China Medical University, Taichun, Taiwan, 18
September 3 October 2006, Evidence Based Herbal Medicine: From Drug Discovery to Botanical
Dietary Supplements
2006 CAM/TM Professional Training Program, China Medical University, Taichun, Taiwan, 18
September 3 October 2006, WHO Strategy in Traditional Medicine
RMIT University, Melbourne, Australia, 6 Sept 2007, Potential Role of Chinese Herbal Medicine in
the Management of IBS: Basic and Clinical Studies
RMIT University, Melbourne, Australia, 6 Sept 2007, FDA IND
International Advisory Board on Hong Kong Regulatory Standards for Chinese Medicinal Herbs,
Health Department, Hong Kong, SAR, China, 20 November, 2008, Botanicals in the USA- An Update
on Regulatory and Research Issues.
The 4th International Symposium of the Western Pacific Regional Forum for the Harmonization of
Herbal Medicine, Hong Kong, China, 30 Oct. 2010. Perspectives on the Current Regulation and
Research on Herbs/Botanicals in the USA.

PUBLICATIONS:
A.

Research Articles:
1.

N.R. Farnsworth, H.H.S. Fong, R.N. Blomster and F.J. Draus. Studies on Vinca major
(Apocynaceae), II. Phytochemical Investigation. J. Pharm. Sci., 51:217-224 (1962).

2.

H.H.S. Fong, J.L. Beal and M.P. Cava. Alkaloids of Thalictum. Vll. Isolation of alkaloids
from the roots of Thalictrum rochebrunianum. Lloydia, 29:94-100 (1966).

3.

N.R. Farnsworth, H.H.S. Fong, and R.N. Blomster. Cantharanthus alkaloids. XII. Isolation of
catharanthine, ammocalline, and vincoline from Catharanthus lanceus roots. Lloydia, 29:343347 ( 1966).

4.

G.J. Persinos, M.W. Quimby, A.R. Mott, N.R. Farnsworth, D.J. Abraham, H.H.S. Fong, and
R.N. Blomster. Studies on Nigerian plants. III. Biological and phytochemical screening of
Lophira lanceolata (Ochnaceae), and the isolation of benzamide. Planta Medica, 15:361-365
(1967).

5.

N.R. Farnsworth, I.K. Henry, G.H. Svoboda, R.N. Blomster, H.H.S. Fong, M.W. Quimby and
M.J. Yates. Biological and phytochemical evaluation of plants. II. Test results from an
additional two hundred accessions. Lloydia, 31:237-248 (1968).

6.

N.R. Farnsworth, H. Wagner, L. Horhammer, H.-P. Horhammer and H.H.S. Fong. Euphorbia
esula (Euphorbiaceae). I. Preliminary phytochemical and biological evaluation. Journal of
Pharmaceutical Sciences, 57:933-939 (1968).

7.

E.M. Maloney, H.H.S. Fong, N.R. Farnsworth, R.N. Blomster and D.J. Abraham.
Catharanthus alkaloids. XV. Isolation of vindolinine from C. Lanceus leaves. Journal of
Pharmaceutical Sciences, 57:1035-1036 (1968).

8.

M. Tin-Wa, H.H.S. Fong, R.N. Blomster and N.R. Farnsworth. Catharanthus alkaloids.
XXI. Isolation of lochnerinine, one of the cytotoxic principles of C. pusillus, Journal of
Pharmaceutical Sciences, 57:2167-2169 (1968).

9.

H.H.S. Fong, N.R. Farnsworth and G.H. Svoboda. Alkaloids of Acronychia baueri (Bauerella
australiana). IV. Chromatographic separation of alkaloids. Lloydia., 32:110-112 (1969).

10.

N.R Farnsworth and H.H.S. Fong. Identity of pericalline, tabernoschizine, apparicine, and
gomezine. Journal of Pharmaceutical Sciences, 58:280 (1969).

11.

H.K. Kim, N.R. Farnsworth, R.N. Blomster and H.H.S. Fong. Biological and phytochemical
evaluation of plants. V. Isolation of two cytotoxic alkaloids from Chelidonium majus.
Journal of Pharmaceutical Sciences, 58:372-374 (1969).

12.

M. Tin-Wa, N.R. Farnsworth and H.H.S. Fong. Biological and phytochemical evaluation of
plants. VI. Isolation of kampferitrin from Lespedeza capitata. Lloydia, 32:509-511 (1969).

13.

H.K. Kim, R.N. Blomster, H.H.S. Fong and N.R. Farnsworth. Catharanthus alkaloids.
XXIII. The isolation of tetrahydroalstonine, vindorosine, and ursolic acid from C.
trichophyllus. Econ. Bot.. 24:42-46 (1970).

14.

A.B. Segelman, N.R. Farnsworth, H.H.S. Fong and D.J. Abraham. Catharanthus alkaloids.
XXIV. Isolation and synthesis of 3,4-dimethoxyphenyl acetamide from C. lanceus, Lloydia.
33:25-29 (1970).

15.

H.K. Kim, N.R. Farnsworth, H.H.S. Fong, R.N. Blomster and G.J. Persinos. Biological and
phytochemical evaluation of plants. Vll. Isolation and identification of a tumor inhibitor from
Wallenia yunquensis (Myrsinaceae) as Myrsine-saponin. Lloydia, 33:30-35 (1970).

16.

M. Tin-Wa, N.R. Farnsworth, H.H.S. Fong and J, Trojanek. Catharanthus alkaloids. XXV.
Isolation of leurosine and ursolic acid from C. pusillus. Lloydia, 33:261-263 (1970).

17.

M. Tin-Wa, N.R. Farnsworth, H.H.S. Fong and J. Trojanek. Biological and phytochemical
evaluation of plants. VIII. Isolation of a new alkaloid from Sanguinaria canadensis
(Papaveraceae). Lloydia, 33:267-269 (1970).

18.

H.K. Kim, N.R. Farnsworth, J. Trojanek and H.H.S. Fong.


arabinopyranoside. Lloydia. 33:484-485 (1970).

19.

M. Tin-Wa, N.R. Farnsworth, H.H.S. Fong, R.N. Blomster, J. Trojanek, D.J. Abraham, G.J.
Persinos and O.B. Dokosi.
Biological and phytochemical evaluation of plants. IX.
Antitumor activity of Maytenus senegalensis (Celastraceae) and a preliminary phytochemical
investigation. Lloydia, 34:79-87 (1971).

20.

D.J. Abraham, J. Trojanek, H.-P. Munzing, H.H.S. Fong and N.R. Farnsworth. Structure
elucidation of maytenonic acid, a new triterpene from Maytenus senegalensis (Celastraceae). J.
Pharm. Sci. 60:1085-1087 (1971).

21.

G.Aynilian, N.R. Farnsworth, R.L. Lyon and H.H.S. Fong. Catharanthus alkaloids. XXVI.
Isolation of cathanneine, a new alkaloid from C. lanceus. J. Pharm Sci., 61:298 (1972).

22.

H.H.S. Fong, N.R. Farnsworth, L.K. Henry, G.H. Svoboda and M.J. Yates. Biological and
phytochemical evaluation of plants. X. Test results from a third two hundred accessions.
Lloydia, 35:35-48 (1972).

23.

M. Tin-Wa, H.K. Kim, H.H.S. Fong, N.R. Farnsworth, J. Trojanek and D.J. Abraham. The
structure of chelidimerine, a new alkaloid from Chelidonium majus (Papaveraceae). Lloydia,
35:87-89 (1972).

24.

D.J. Abraham, R.D. Rosenstein, R.L. Lyon and H.H.S. Fong. The structure elucidation of
rhazinilam, a new class of alkaloids from the Apocynaceae, by X-ray analysis. Tetrahedron
Lett., 1972(10):909-912 (1972).

Synthesis of stigmasterol- -L-

25.

H.H.S. Fong, M. Trojankova, J. Trojanek and N.R. Farnsworth.


Lloydia, 35:117-149 (1972).

Alkaloids screening. II.

26.

M. Tin-Wa, H.H.S. Fong, D.J. Abraham, J. Trojanek, and N.R. Farnsworth. The structure of
sanguidimerine, a new major alkaloid from Sanguinaria canadensis (Papaveraceae). Journal
of Pharmaceutical Sciences, 61:1846-1847 (1972).

27.

W.M. Messmer, M. Tin-Wa, H.H.S. Fong, C. Bevelle, N.R. Farnsworth, D.J. Abraham, and J.
Trojanek. Fagaronine, a new tumor inhibitor isolated from Fagara zanthoxyloides (Rutaceae).
Journal of Pharmaceutical Sciences. 61:1858 (1972).

28.

H.H.S. Fong, W.H. Bhatti and N.R. Farnsworth. Antitumor activity of certain plants due to
tannins. Journal of Pharmaceutical Sciences, 61:1818 (1972).

29.

W.D. Loub, H.H.S. Fong, M. Theiner, and N.R. Farnsworth. Partial characterization of the
antitumor tannin isolated from Calycogonium squamulosum (Melastomaceae). Journal of
Pharmaceutical Sciences, 62:149-150 (1973).

30.

G.R. Ickes, H.H.S. Fong, P.L. Schiff, Jr., R.E. Purdue, Jr. and N.R. Farnsworth. Antitumor
activity and preliminary phytochemical examination of Tagetes minuta (Compositae). Journal
of Pharmaceutical Sciences, 62:1009-1011 (1973).

31.

R.L. Lyon, H.H.S. Fong, N.R. Farnsworth and G.H. Svoboda. Biological and phytochemical
evaluation of plants. XI. The isolation of aspidospermine, quebrachidine, rhazinilam, (-)pyrifolidine, and akaummidine from Aspidoserma quebracho-blanco (Apocynaceae). Journal
of Pharmaceutical Sciences., 62:218-221 (1973).

32.

R.L. Lyon, H.H.S. Fong, and N.R. Farnsworth. Biological and phytochemical evaluation of
plants. XII. The isolation of acetylakuammidine from Aspidosperma quebracho-blanco
leaves. Journal of Pharmaceutical Sciences, 62:833 (1973).

33.

P.S. Benoit, G, Angry, R.L. Lyon, H.H.S. Fong and N.R. Farnsworth. Biological and
phytochemical evaluation of plants. XIII. A preliminary estimation of the analgesic activity of
rhazinilam, a novel alkaloid isolated from Aspidosperma quebracho-blanco leaves. Journal of
Pharmaceutical Sciences, 62:1889 (1973).

88.

M. Tin-Wa, C.L. Bell, C. Bevelle, H.H.S. Fong and N.R. Farnsworth. Potential anticancer
agents I: Confirming evidence for the structure of fagaronine. Journal of Pharmaceutical
Sciences, 63:1476-1477 (1974).

89.

H.T. Tai, G.H. Aynilian, M. Tin-Wa, H.H.S. Fong and N. R. Farnsworth. Isolation of
erythrodiol monopalmitate from Tagetes cv. "Sen. Dirksen." Phytochemistry, 14:293-294
(1975).

36.

W.H. Marks, M. Tin-Wa, H.H.S. Fong and N.R. Farnsworth. The cytotoxic principles of
Parquetina nigrescens (Asclepiadaceae). Journal of Pharmaceutical Sciences 64: 1674-1676
(1975).

37.

P.T.O. Chang, G.H. Aynilian, M. Tin-Wa, H.H.S. Fong, R.E. Perdue, Jr. and N.R. Farnsworth.
Isolation of Flindersiamine and two new alkaloids, heliparvifoline and isoflindersiamine from
Helietta parvifolia (Rutaceae Journal of Pharmaceutical Sciences, 65:561-563 (1976).

38.

P.T.O. Chang, G.A. Cordell, G.H. Aynilian, H.H.S. Fong and N.R. Farnsworth. Alkaloids
and coumarins of Thamnosma montana. Lloydia, 39:134-140 (1976).

39.

P.S. Benoit, H.H.S. Fong, G.H. Svoboda and N.R. Farnsworth.


Biological and
phytochemical evaluation of plants. XIV. Antiinflammatory evaluation of 163 species of
plants. Lloydia, 39:160-171 (1976).

40.

R.H. Dobberstein, M. Tin-Wa, H.H.S. Fong, F.A. Crane and N.R. Farnsworth. Flavonoid
constituents from Eupatorium altissimum L. (Compositae). Journal of Pharmaceutical
Sciences, 66:600-602 (1977).

41.

G.A. Cordell,R.L. Lyon, H.H.S. Fong, P.S. Benoit and N.R. Farnsworth. Biological and
phytochemical investigations of Dianthus barbatus c.v. "China Doll," (Caryophyllaceae).
Lloydia, 40:361-363 (1977).

42.

G.A. Cordell, P.T.O. Chang, H.H.S. Fong and N.R. Farnsworth. Xylosmacin, a new
phenolic glucoside ester from Xylosma velutina (Flacourtiaceae). Lloydia, 40:340-343 (1977).

43.

P.T.O. Chang, G.A. Cordell, H.H.S. Fong and N.R. Farnsworth. Velutinic acid, a new
friedelane derivative from Xylosma velutina (Flacourtiaceae). Phytochemistry, 16:1443-1445
(1977).

44.

E.B. Thompson,G.H. Aynilian, R.H. Dobberstein, G.A. Cordell, H.H.S. Fong and N.R.
Farnsworth. Biological and phytochemical investigation of plants. XV. Pteryxia terebinthina
var. terebinthina (Umbelliferae). Journal of Natural Products. (Lloydia), 42:120-125 (1979).

45.

C.L. King, Y.C. Kong, N.S. Wong, H.W. Yeung, H.H.S. Fong and U. Sankawa. Uterotonic
effect of Evodia rutaecarpa alkaloids. Journal of Natural Products (Lloydia), 43:577-582
(1980).

46.

C.-t. Che, K. Koike, G.A. Cordell, H.H.S. Fong and R.H. Dobberstein. Triterpenes of
Pouteria torta (Sapotaceae). Journal of Natural Products (Lloydia), 43:420-421 (1980).

47.

D.P. Waller, L.J.D. Zaneveld and H.H.S. Fong.


Contraception, 22:183-187 (1980).

48.

C.-C. Hsu, R.H. Dobberstein, A.S. Bingel, H.H.S. Fong, N.R. Farnsworth and J.F. Morton.
1981. Biological and phytochemical investigation of plants. XVI. Strumpfia maritima
(Rubiaceae). Journal of Pharmaceutical Sciences, 70:682-683 (1981).

In vitro spermicidal activity of gossypol.

49.

M.S. Ahmed, H.H.S. Fong, D.D. Soejarto, R.H. Dobberstein, D.P. Waller and R. MorenoAzorero.
High-performance liquid chromatographic separation and quantitation of
maytansinoids in Maytenus ilicifolia. J. Chromatography, 213:340-344 (1981).

50.

D.P. Waller, H.H.S. Fong, G.A. Cordell and D.D. Soejarto. Antifertility effects of gossypol
and its impurities on male hamster. Contraception, 23:653-660 (1981).

51.

S.Y.C. Chu, R.H. Dobberstein, H.H.S. Fong and N.R. Farnsworth. Oxoaporphine alkaloids
from Siparuna gilgiana Aubl. Journal of Natural Products 45:229-230 (1982).

52.

S.-M. Wong, M.B. Slaytor, H.H.S. Fong, G.A. Cordell and N.R. Farnsworth. 14C-Gossypol:
Optimum conditions for synthesis by cotton seedlings. Acta Pharm. Sinica. 18:57-63 (1983).

53.

C.-t. Che, G.A. Cordell, H.H.S. Fong, and C.A. Evans. Aristolindiquinone - A new
naphthaquinone from Aristolochia indica L. (Aristolochiaceae). Tetrahedron Letters,
24:1333-1336 (1983).

54.

S. Mukhopadhyay, S. Funayama, G.A. Cordell and H.H.S. Fong. Studies on Aristolochia I.


Conversion for aristolochic acid-l to aristolic acid - One step removal of a nitro group. Journal
of Natural Products 46:507-509 (1983).

55.

D.P. Waller, N. Bunyapraphatsara, A. Martin, C.J. Vournazos, M.S. Ahmed, D.D. Soejarto,
G.A. Cordell, H.H.S. Fong, L.D. Russel and J.P. Malone. Effect of (+)-gossypol on fertility in
male hamsters. J. Andrology. 4:276-279 (1983).

56.

D.D. McPherson, G.A. Cordell, D.D. Soejarto, J.M. Pezzuto and H.H.S. Fong.
New
Peltogynoids and homoisoflavonoids from Caesalpinia pulcherrima.
Phytochemistry.
22:2835-2838 (1983).

57.

C.-t. Che, M.S. Ahmed, S.S. Kang, D.P. Waller, A.S. Bingel, A. Martin, P. Rajamahendran,
N. Bunyapraphatsara, D.C. Lankin, G.A. Cordell, D.D. Soejarto, R.O.B. Wijesekera and
H.H.S. Fong. Studies on Aristolochia III. Isolation and biological evaluation of constituents of
Aristolochia indica roots for fertility-regulating activity. Journal of Natural Products 47:331341 (1984).

58.

G.B. Marcelle, M.S. Ahmed, J.M. Pezzuto, G.A. Cordell, D.P. Waller, D.D. Soejarto and
H.H.S. Fong. Analysis of gossypol and gossypol acetic acid by high-performance liquid
chromatography. Journal of Pharmaceutical Sciences 73:396-398 (1984).

59.

M. Arisawa, S.S. Handa, D.D. McPherson, D.C. Lankin, G.A. Cordell, Harry H.S. Fong and
N.R. Farnsworth. Plant anticancer agents XXIX. Cleomiscosin A from Simaba multiflora,
Soulamea soulameoides and Matayba arborescens. Journal of Natural Products. 47:300-307
(1984).

60.

A.E. Adjaye, R.H. Dobberstein, D.L. Venton, and H.H.S. Fong. Phytochemical investigation
of Laurelia novae-zelandae. Journal of Natural Products 47: 553-554 (1984).

61.

X. Fang, C.H. Phoebe, Jr., J.M. Pezzuto, H.H.S. Fong, N.R. Farnsworth, B. Yellin, and Sidney
M. Hecht. Plant anticancer agents XXXIV. Cucurbitacins from Elaeocarpus dolichostylus.
Journal of Natural Products, 47:988-993 (1984).

62.

I.C. Kim, D.P. Waller, G.B. Marcelle, G.A. Cordell, H.H.S. Fong, W.H. Pirkle, L. Pilla and
S.A. Matlin. Comparative in vitro spermicidal effects of ()-gossypol, (+)-gossypol, (-)gossypol, and gossypolone. Contraception. 30:253-259 (1984).

63.

S.S. Kang, G.A. Cordell, D.D. Soejarto and H.H.S. Fong. Alkaloids and flavonoids from
Ricinus communis (Euphorbiaceae). Journal of Natural Products, 48:155-156 (1985).

64.

G.B. Marcelle, G.A. Cordell, D.D. Soejarto and H.H.S. Fong. Isolation of (+)-Gossypol from
Montezuma speciosissima. Journal of Natural Products, 48:162-163 (1985).

65.

G.B. Marcelle, N. Bunyapraphatsara, G.A. Cordell, H.H.S. Fong, K.C. Nicolaou and R.E.
Zipkin. Study of Zoapatle I. The extraction of Zoapatle (Montanoa tomentosa) and the
identification of 21-Nor-Montanol as the initial decomposition product of zoapatanol. Journal
of Natural Products 48:739745 (1985).

66.

I.C. Kim, D.P. Waller, and H.H.S. Fong. Inhibition of LDH-X by gossypol optical isomers.
Journal of Andrology, 6(6):344-347 (1985).

67.

S.M. Wong, J.M. Pezzuto, H.H.S. Fong, and N.R. Farnsworth.


Isolation, structural
elucidation and chemical synthesis of 2-hydroxy-3-octadecy1-4-methoxy-1,4-benzoquinone
(Irisoquin), a cytotoxic constituent of Iris missouriensis. Journal of Pharmaceutical Sciences,
74:1114-1116 (1985).

68.

D.D. McPherson, C.-T. Che, G.A. Cordell, D.D. Soejarto,.J.M. Pezzuto, and H.H.S. Fong.
Diterpenoids from Caesalpinia pulcherrima. Phytochemistry. 25:167-170 (1986).

69.

Y.S. Chang, J.M. Pezzuto, H.H.S. Fong, and N.R. Farnsworth. Evaluation of the mutagenic
potential of American gnseng (Panax quinquefolius L.). Planta Medica 1986:338-339 (1986).

70.

H.J. Cowe, P.J. Cox, G.A. Cordell, C.T. Che and H.H.S. Fong. Structure of 2,5-dihydroxy3,8-dimethy1-1,4-naphthalenedione (Aristoliniquinone). Acta. Cryst. 1986:1533-1535 (1986).

71.

Y. Oshima, S.M. Wong, C. Konno, G.A. Cordell, D.P. Waller, D.D. Soejarto and H.H.S. Fong.
Studies on Zoapatle. II. Leucanthanolide, a novel sesquiterpene lactone from Montanoa
leucantha ssp. leucantha. Journal of Natural Products 49:313-317 (1986).

72.

S.M. Wong, J.M. Pezzuto, H.H.S. Fong and N.R. Farnsworth. Isolation and characterization of
a new triterpene from Iris Missouriensis Journal of Natural Products 49:330-333 (1986).

73.

Y. Oshima, G.A. Cordell and H.H.S. Fong. Studies on zoapatle. III. Flavonoid glycosides
from Montanoa tomentosa ssp.tomentosa Journal of Natural Products 49:552-553 (1986).

74.

C.-t. Che, D.D. McPherson, G.A. Cordell and H.H.S. Fong. Pulcherralpin, a new diterpene
ester from Caesalpinia pulcherrima. Journal of Natural Products 49:561-569 (1986).

75.

S.M. Wong, Y. Oshima, Pezzuto, J.M., Fong, H.H.S. and N.R. Farnsworth. Plant anticancer
agents. XXXIX. Triterpenes from Iris missouriensis (Iridaceae). Journal of Pharmaceutical
Sciences 75:317-320 (1986).

76.

Y. Oshima, G.A. Cordell and H.H.S. Fong. Oxepane diterpenes from Montanoa tomentosa.
Phytochemistry 25:2567-2568 (1986).

77.

I.C. Kim, D.P. Waller, and H.H.S. Fong. Subchronic treatment with gossypol and liver
microsomal drug metabolizing enzyme system of male hamsters. Adv. Contra. Delv. Sys.
3:183-193 (1986).

78.

Z. Luo, L. Boonyaratanakornkit, C.T. Che, C.J. Erdelmeier, H.H.S. Fong and N.R.
Farnsworth. Biologically active coumarins from Enkleia siamensis Kurz Journal of Natural
Products, 49:1161-1162 (1986).

79.

D.P. Waller, A. Martin, Y. Oshima, and H.H.S. Fong. Studies on zoapatle V. Correlation
between in vitro uterine and in vivo pregnancy interruption activities in guinea pig.
Contraception 35:147-153 (1987).

80.

I. Kim, G.B. Marcelle, D.P. Waller, G.A. Cordell and H.H.S. Fong. Inhibition of lactate
dehydrogenase-X by imino-derivatives of gossypol:
structure activity relationship.
Contraception, 35:289-297 (1987).

81.

S.M. Wong, C. Konno, Y. Oshima, J.M. Pezzuto, H.H.S. Fong and N.R. Farnsworth.
Irisones A and B: Two new isoflavones from Iris missouriensis Nutt. (Iridaceae). Journal of
Natural Products 50:178-180 (1987).

82.

H.H.S. Fong, Y. Oshima, A. Martin, S. Kasnick, Y. Zhu, C. Konno, Z. Tu, Z. Lin, D.D.
Soejarto, G.A. Cordell, and D.P. Waller. Phytochemical and biological studies on Montanoa
tomentosa ssp. tomentosa. Proc. Intern. Symp. Trad. Med. Modern Pharmacol., Beijing, Oct.
6-10, 1986. Chinese Pharmacology Society and Chinese Association for Science and
Technology, Beijing, 1987:100-105 (1987).

83.

Z.Z. Lu, H.-Z. Xue, Z.-B. Tu, C. Konno, D.P. Waller, D.D. Soejarto, G.A. Cordell and H.H.S.
Fong. Studies on Zoapatle Vll. Angeloylgrandifloric acid, a spontaneous uterine contraction
inhibition (SUCI) from Montanoa tomentosa ssp. tomentosa. Journal of Natural Products,
50:995-997 (1987).

84.

H.-Z. Xue, Z.-Z. Lu, C. Konno, D.D. Soejarto, G.A. Cordell, H.H.S. Fong and W. Hodgson.
3-(3,4-Dihydroxycinnamoyl)-erythrodiol and 3-(4-hydroxycinnamoyl)-erythrodiol from
Larrea tridentata. Phytochemistry 27:233-235, (1988).

85.

L. Boonyaratanakornkit, C.-T. Che, H.H.S. Fong, and N.R. Farnsworth. Constituents of


Croton crassifolius roots. Planta Medica 1988:61-64, (1988).

86.

Z.-B. Tu, C. Konno, D.D. Soejarto, D.P. Waller, A.S. Bingel, R.J. Molyneux, J. Edgar, G.A.
Cordell and H.H.S. Fong. Identification of senecionine and senecionine N-oxide as antifertility
constituents in Senecio vulgaris L. (Compositae). Journal of Pharmaceutical Sciences,
77:461-463, (1988).

87.

J.M. Pezzuto, S.M. Swanson, W. Mar, C.-T. Che, G.A. Cordell and H.H.S. Fong. Evaluation
of the mutagenic and cytotoxic activity of aristolochic acid and several derivatives. Biochem.
Pharmacol., 206:447-454, (1988).

88.

G. Topcu, G.A. Cordell, N.R. Farnsworth and H.H.S. Fong. Studies on Zoapatle VIII. Novel
cytotoxic sesquiterpene lactones from Montanoa tomentosa ssp. microcephalia. Journal of
Pharmaceutical Sciences, 77:553-556, (1988).

89.

Z. Luo, D. Meksuriyen, C.A.J. Erdelmeier, H.H.S. Fong and G.A. Cordell. Larreantin, a
novel, cytotoxic naphthaquinone from Larrea tridentata. J. Org. Chem., 53:2183-2185,
(1988).

90.

G.-Q. Han, C.-T. Che, H.H.S. Fong, N.R. Farnsworth and C.H. Phoebe, Jr.
constituents of Macaranga carolinensis. Fitoterapia 59:242-244, (1988).

91.

C. Konno, Martin, A., Ma, B.-X., Lu, Z.-Z. Xue, H.-Z., Erdelmeier, C.A.J., Nuzzo, N.A.,
Soejarto, D.D., Cordell, G.A., D.P. Waller and H.H.S. Fong. Search for fertility regulating
agents from Larrea tridentata. Proc. The First Princess Chulabhorn Science Congress,
Bangkok,
Thailand, Dec. 10-13, 1987. Chulalonghorn Foundation and Mahidol
University, pp. 328-337 (1989)

92.

X. Dong, M.O. Hamburger, G.A. Cordell, and H.H.S. Fong. Studies on zoapatle IX. HPLC
analysis of Montanoa species for pharmacologically-active constituents. Plant Med., 55:185187, (1989).

93.

C. Konno, H.-Z. Xue, Z.-Z. Lu, B.-X. Ma, C.A.J. Erdelmeier, G.A. Cordell, D.D. Soejarto,
D.P. Waller and H.H.S. Fong. 1-Aryl tetralin lignans from Larrea tridentata. Journal of
Natural Products, 52:1113-1117, (1989).

94.

L.T. Jonathan, C.-T. Che, J.M. Pezzuto, H.H.S. Fong and N.R. Farnsworth. 7-OMethylhorminone and other cytotoxic diterpene quinones from Lepechinia bullata. Journal of
Natural Products, 52:571-575, (1989).

95.

X. Dong, I.-O. Mondranondra, C.-T. Che, H.H.S. Fong and N.R. Farnsworth. Kmeriol and
other aromatic constituents of Kmeria duperreana. Pharm. Res., 6:637-640, (1989).

96.

H.H.S. Fong, N.R. Farnsworth and C.W.W. Beecher. The NAPRALERT database as an
information source for traditional medicine. Proc. Intern. Symp. on East-West Medicine, Seoul,
Korea, 10-11 Oct. 1989, WHO Collaborating Centre for Traditional Medicine, East-West
Medical Research Institute, Seoul, Korea, pp. 255-265, (1989).

Chemical

97.

H.H.S. Fong, D.D. Soejarto, G.A. Cordell, D.P. Waller and A.S. Bingel. The search for
fertility regulating agents from plants - an odyssey. Proc. Second Int. Symp. Adv. Nat. Prod.
Res. 50th Ann. Nat. Prod. Res. Inst., Seoul National University, Seoul, Korea, 12-14 Oct. 1989,
Natural Products Research Institute, SNU, Seoul, Korea, pp. 104-115, (1989).

98.

C. Konno,Z.-Z. Lu, H.-Z. Xue, C.A.J. Erdelmeier, D. Meksuriyen, C.-T. Che, G.A. Cordell,
D.D. Soejarto, D.P. Waller and H.H.S. Fong. Furanoid lignans from Larrea tridentata.
Journal of Natural Products, 53:396-406 (1990).

99.

I.-O. Mondranondra, C.-T. Che, A.M. Rimondo, S. Vajrodaya, H.H.S. Fong and N.R.
Farnsworth. Sesquiterpene lactones and other constituents from a cytotoxic extract of Michelia
floribunda. Pharm. Res. 7: 1269-1272 (1990).

100.

L.T. Jonathan, M. Gbeassor, C.T. Che, H.H.S. Fong, N.R. Farnsworth, G.C. Le Breton and
D.L. Venton. Pseudosemiglabrin, a platelet aggregation inhibitor from Tephrosia semiglabra.
Journal of Natural Products, 53: 1572-1574 (1990).

101.

Y. Zong, K. Lowell, P. Jiang, C.T. Che, J.M. Pezzuto and H.H.S. Fong. Phenolic Consitutents
of Rhodiola coccinea, a Tibetan folk medicine. Planta Medica, 57:589 (1991).

102.

L. Boonyaratanakornkit, C.T. Che, G.A. Cordell, H.H.S. Fong and N.R. Farnsworth. Enkleine,
an isoquinolone from Enkleia siamensis. Planta Medica 57:582-583 (1991).

103.

J.-L. Yuan, Z.-Z. Lu, G.-X. Chen, W.-P. Ding, B.-N. Zhou, C.A. J. Erdelmeier, M.O.
Hamburger, H.H.S. Fong and G.A. Cordell. The pregnane glycoside marsdekoiside A from
Marsdenia koi. Phytochemistry 31:1058-1060 (1992).

104.

J.-L. Yuan, W.-P. Ding, J.-P. Shi, Z.-Z. Lu, B.-N. Zhou, C.A. J. Erdelmeier, G.A. Cordell,
H.H.S. Fong and N.R. Farnsworth. Studies on the antifertility components from Marsdenia koi.
J. Tonji Med. Univ. 11:165-168 (1991).

105.

Z.-Z. Lu, J.-L.Yuan, W.-P. Ding, B.-N. Zhou, Y.-S. Gao, C.A. J. Erdelmeier, M.O.
Hamburger, H.H.S. Fong and G.A. Cordell. Studies on a pregnane glycoside from Marsdenia
koi. Progress on Terrestrial and Marine Natural Products of Medicinal and Biological
Interest, Pezzuto, J.M., A.D. Kinghorn, H.H.S. Fong, and G.A. Cordell (eds), American
Botanical Council, Austin, TX, pp 104-107 (1992).

106.

P.E. Bowen, A. Druetzler, B. Libelt, W. Hwang, H. Fong, D. Waller and M.C. Moon. Effect
of flax seed supplementation on arachidonic acid metabolism. Proc. 54th Flax Inst., USA,
January 30-31,1992, 18-23 (1992).

107.

L. Luyengi, C.-t. Che, P.E. Bowen, D.P. Waller, C.W.W. Beecher, J.M. Pezzuto and H.H.S.
Fong. Linusitamarin, a new phenylpropanoid glucoside from Linum usitatissimum L., Journal
of Natural Products. 56:2012-2015 (1993).

108.

A. Amarquaye, C.-t. Che, E. Bejar, M.H. Malone and H.H.S. Fong. A new glycolipid from
Byrsonima crassifolia. Planta Medica 60:85-86 (1994).

109.

T. Pengsuparp, L. Cai, A. D. Kinghorn, H.H.S. Fong, J.M. Pezzuto, M.C. Wani and M.E. Wall.
Pentacyclic triterpenes derived from Maprounea africana are potent inhibitors of HIV-1
reverse transcriptase. Journal of Natural Products 57:415-418 (1994).

110.

L. Luyengi, I.-K. Lee, W. Mar, H.H.S. Fong, J.M. Pezzuto and A.D. Kinghorn. Rotenoids and
chalcones from Mundulea sericea that inhibit phorbol ester-induced ornithine decarboxylase
activity. Phytochemistry 36:1523-1526 (1994).

111.

N. Bunyapraphatsara, S. Kasnick, A.T. Elvin, G.A. Cordell, H.H.S. Fong, S.A. Matlin, Z.-R.
Hua, S. Roshdy, H.K. Kim, P.N. Rao, W.-M. Zhou, L.-B. Long, W.-J. Shen and H. Liang.
Studies on the stability of ()-gossypol, ()-gossypol acetic acid and (+)-gossypol. Thai J.
Phytopharmacy . 1:1-9 (1994).

112.

E. Bejar, A. Amarquaye, C.-t. Che, M.H. Malone, and H.H.S. Fong. Constituents of Byrsonima
crassifolia and their spasmogenic activity. Int. J. Pharmacog. 33:25-32 (1995)

113.

S.K. Chaudhuri, F. Fullas, D.M. Brown, M.C. Wani, M.E. Wall, L. Cai, Y. Luo, K. Zaw,
H.H.S. Fong, J. M. Pezzuto, and A.D. Kinghorn. Isolation and Structural Elucidation of
Pentacyclic triterpenoids from Maprounea africana . Journal of Natural Products 58:1-9
(1995)

114.

C. Gerhauser, W.Mar, S.K. Lee, N. Suh, Y. Luo, J. Kosmeder, L. Luyengi, H.H.S. Fong, A.
D. Kinghorn, R.M. Moriarty, R.G. Mehta, A. Constantinou, R.C. Moon, and J.M. Pezzuto.
Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of
ornithine decarboxylase. Nature Medicine, 1:260-266 (1995).

115.

C. Gerhauser, W.Mar, S.K. Lee, N. Suh, Y. Luo, J. Kosmeder, R.M. Moriarty, L. Luyengi, A.
D. Kinghorn, H.H.S. Fong, R.G. Mehta, R.C. Moon, and J.M. Pezzuto. Rotenoid-mediated
inhibition of phorbol ester-induced ornithine decarboxylase activity as a mechanism of cancer
chemoprevention. Nature Medicine, 1:1046-1051 (1995).

116.

N. Suh, L. Luyengi, H.H.S. Fong, A.D. Kinghorn, and J.M. Pezzuto. Discovery of natural
product chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer
Research, 14:1-7 (1995).

117.

T. Pengsuparp, L. Cai, H. Constant, H.H.S. Fong, L.-Z. Lin, A. D. Kinghorn, J.M. Pezzuto,
G.A. Cordell, K. Ingolfsdottir, H. Wagner, and S.H. Hughes. Mechanistic evaluation of new
plant-derived compounds that inhibit HIV-1 reverse transcriptase. Journal of Natural Products
58: 1024-1031 (1995).

118.

Pisha E, Chai H, Lee I-S, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CWW, Fong
HHS, Kinghorn AD, Brown DM, Wani MC, Wall ME, Hieken TJ, Dad Gupta TK, Pezzuto JM.
Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by
induction of apotosis. Nature Medicine. 1995, 1:1046-1051

118.

R.B. van Breemen, C.-R. Huang, Z.-Z. Lu, A. Rimando, H.H.S. Fong, and J.F. Fitzloff.
Electrospray liquid chromatography/mass spectrometry of ginsenosides. Analytical Chemistry
67: 3985-3989 (1995)

119.

S.E. Rickard, L.J. Orcheson, M.M. Seidl, L. Luyengi, H.H.S. Fong and L. U. Thompson. Dosedependent production of mammalian lignan in rats and in vitro from the purified precursor
secoisolariciresinol diglycoside in flaxseed Journal of Nutrition, 126:2012-2019 (1996).

120.

H.-d. Sun, Z.-y. Wang, Z.-w. Lin, S.-x. Qiu, L.-z. Lin, T. Pengsuparp, J. M. Pezzuto, H.H.S.
Fong, G.A. Cordell and N.R. Farnsworth. Nigranoic acid, a triterpenoid inhibiting HIV-1
reverse transcriptase from Schisandra sphaerabdra. Journal of Natural Products 59: 525-527
(1996)

121.

B.-Y. Yu, S.X. Qiu, K. Zaw, G-J Xu, Y. Hirai, J. Shoji, H.H.S. Fong and A. D. Kinghorn.
Steroidal glycosides from the subterranean parts of Liriope spicata var. prolifera.
Phytochemistry, 43: 201-206 (1996).

122.

L. Luyengi, N. Suh, H.H.S. Fong, J. M. Pezzuto and A. D. Kinghorn. Constituents of Brucea


javanica that induce differentiation with cultured HL-60 promyelocytic leukemia cells.
Phytochemistry, 43:409-412 (1996).

123.

L.U. Thompson, M.M. Seidl, S.E. Rickard, L. J. Orcheson and H.H.S. Fong. Antitumorigenic
effect of a mammalian lignan precursor from flaxseed. Nutr. Cancer 26: 159-165 (1996).

124. H. Mehdi, G.T. Tan, J.M. Pezzuto, H.H.S. Fong, N.R. Farnsworth, F.S. El-Feraly, M.A. AlYahya, J.S. Mossa, M.E. Peeples, M.R. Kernan, and E.J. Rozhon. Cell culture assay system for the
evaluation of natural product-mediated anti-hepatitis B virus activity. Phytomedicine, III:369-377
(1999)
l
125.

126. H.-d. Sun, S.-x. Qiu, L.-z. Lin, R.-p. Zhang, Y.-s. Zhou, Q.-t. Zheng, M.E. Johnson,
H.H.S. Fong, N.R. Farnsworth and G.A. Cordell. Crystal structure of a 1:1 complex of natural
diterpenoids: Absolute configurations and unambiguous NMR spectral assignments of
neoangustifolin and epinodesinol. Journal of Natural Products 60: 203-206 (1997).

127.

J.M. Pezzuto, C.W.W. Beecher, H.H.S. Fong, N.R. Farnsworth, R.G. Mehta, R.C. Moon, S.
Hedayat, G.O. Udeani, R.M. Moriarty and A.D. Kinghorn. Discovery and characterization of
natural product cancer chemopreventive agents. Proc. 6Th Intern. Symp. Nat. Prod. Chem.,
Karachi, Pakistan, Jan., 1996.

128.

J.S. Mossa, F.S. El-Feraly, I. Muhammad, K. Zaw, Z. Mbwambo, J. M. Pezzuto, and H.H.S.
Fong. Sesquiterpene lactones and thymol esters from Vicoa pentanema. Journal of Natural
Products 60:550-555 (1997).

129.

S.-x. Qiu, Z.-Z. Lu, L. Luyengi, S.K. Lee, J. M. Pezzuto, N.R. Farnsworth, L. U. Thompson,
and H.H.S. Fong. Isolation and characterization of flaxseed (Linum usitatissimum) constituents.
Pharm. Biol. 36:1-7 (1998).

130.

C. Peng, G. Bodenhausen, S. Qiu, H.H.S. Fong, N.R. Farnsworth, S. Yuan and C. Zheng.
Computer-assisted structure elucidation: Application of CISOC-SES to the resonance
assignment and structure generation of betulinic acid. Mag. Res. Chem. 36: 1998.

131.

S.-x. Qiu, C. Liu, S.-x. Zhao, Z.-c. Xia, N.R. Farnsworth and H.H.S. Fong. (1R,2S)-(-)Mangochinine, a naturally-occurring dibenzopyrrocoline alkaloid from Manglietia chingii.
Tetrahedron Letters, 39:4167-4170 (1998) .

132.

E. J. C. Gamez, L. Luyengi, S. K. Lee, L.-F. Zhu, B.-N. Zhou, H.H.S. Fong, J. M. Pezzuto, and
A.D. Kinghorn. Antioxidant flavonoid glycosides from Daphniphyllum calycinum. Journal of
Natural Products 61: 706-708 (1998).

133.

S.-x. Qiu, H.-D. Sun, E. Lobkovsky, H. Chai, J. Clardy, N.R. Farnsworth, J.M. Pezzuto, and
H.H.S. Fong. Megathyrin B, a cytotoxic diterpene from Isodon megathyrsus. Planta Medica ,
64:1-4 (1998).

134.

S.-x. Qiu, H.-D. F. Ge, Y. Zhou, J. Jia, N.R. Farnsworth, M.E. Johnson, and H.H.S. Fong.
Isolation, stereochemical assignments and molecular mechanics calculation of ethyl --Larabinopyranoside. Carbohydrate Research, 311:85-88 (1998).

135.

S.K. Lee, W.G. Qing, W. Mar, L. Luyengi, R.G. Mehta, K. Kawanishi, H.H.S. Fong, C.W.W.
Beecher, A.D. Kinghorn, and J.M. Pezzuto. Angoline and chelerythrine, benzophenanthridine
alkaloids that do not inhibit protein kinase C. Journal of Biological Chemistry, 273:1982919833 (1998).

136.

L.C. Chang, K. P. L. Bhat, E. Pisha, E. Kennelly, H.H.S. Fong, J.M. Pezzuto and A.D.
Kinghorn. Activity-guided isolation of antiestrogen binding site inhibitors of Pachysandra
procumbens. Journal of Natural Products 61:1257-1262 (1998).

137.

A. Ito, L.A. Shamon, B. Yu, E. Mata-Greenwood, S K. Lee, R. A. Van Breemen, R.G. Mehta,
N.R, Farnsworth, H.H.S. Fong, J.M. Pezzuto and A.D. Kinghorn. Antimutagenic constituents
of Casimiroa edulis with potential cancer chemopreventive activity. Journal of Agricultural
Food Chemistry, 46:3509-3516 (1998)

138.

S.K. Lee, W.G. Qing, W. Mar, L. Luyengi, R.G. Mehta, K. Kawanishi, HHS Fong, CWW
Beecher, A D Kinghorn, and J.M. Pezzuto. Angoline and chelerythrine, benzophenanthridine
alkaloids that do not inhibit protein kinase C. Journal of Biological Chemistry, (1998)

139.

Tuyen, N.v., DSHL Kiim, HHS Fong, DD Soejarto, TC Khanh, M.V. Tri, and L.T. Xuan.
Structure elucidation of two new triterpenoids from Ficus fistulosa. Phytochemistry (1998)

140.

Kinghorn, A.D., Fong, H.H.S., Farnsworth, N.R., Mehta, R.G., Moon, R.C., Moriarty., R.M.,
and Pezzuto, J.M. Cancer chemopreventive agents discovered by activity-guided fractionation:
A review. Cur. Org. Chem. 1998:597-612 (1998).

141.

J.F. Fitzloff, P. Yat, Z.Z. Lu, D.V.C. Awang, J. T.Arnason, R. B. van Breemen, T. Hall, M.
Blumenthal and H.H.S. Fong. Perspectives on the quality assurance of ginseng products in
North America. Proc. 7th Intern. Ginseng Symp., Sept. 22-25, 1998, Seoul, Korea (1998).

142.

Lotulung, P.D.N, Udin, L.Z., Kardono, L.B.S., Qiu, S-x, Pezzuto, J.M., Fong, H.H.S.,
Farnsworth, N.R., Kyaw, H., Chai, H., Riswan, S. Cytotoxic constituents of the fruits of
Tricosanthes bracteata. Bull. Implementasi dan Pemanfaatan Teknologi. 1998, 4(3):29-32.

143.

Fong HHS, Kosmeder JW, Faransworth NR, Soejarto DD, Kinghorn AD, Pezzuto JM. Edible
plants as sources of cancer chemopreventive agents. Proceeding of International Forum on
Traditional Medicine, Toyama, Oct. 16-17, 1999.

144.

Qiu, S-X, Hung NV, Xuan LT, Gu J-Q, Lobkosky E, Khanh TC, Soejarto DD, Clardy J,
Pezzuto JM, Dong YM, Tri MV, Huong LM, Fong HHS. A pregnane steroid from Aglaia lawii
and structyure confirmation of cabraleadiol monoacetate by X-ray crystallography.
Phytochemistry , 2001, 56:775-780.

145.

Chang LC, Bhat KPL, Fong HHS, Pezzuto JM, Kinghorn AD. Novel bioactive steroidal
alkaloids from Pachysandra procumbens. Tetrahedron , 2000, 56: 3133-3138.

146.

Li S-H, Zhang H-J, Ping Y, Sun H-D, Fong HHS. Rearranged taxanes from the bark of Taxus
yunanensis. Journal of Natural Products. 2000, 63:1488-1491.

147.

Soejarto DD, Gyllenhaal C, Regalado JC, Pezzuto JM, Fong HHS, Ghee TT, Nguyen TH, Le
TX, Do QB, Nguyen VH, Truong QB, Nguyen NT, Phan KL, Bui MV, Southavong BH,
Sydara K, Bouamanivong S, ONeill MJ, Lewis J, Xie XM, Dietzman G. Studies on
biodiversity of Vietnam and Laos: The UIC-based ICBG program. Pharmaceutical Biology,
1999, 37:1-14.

148.

Qiu S-X, Li X-C, Xiong Y, Dong Y, Chai H., Farnsworth NR, Pezzuto JM, Fong HHS.
Isolation and characterization of cytotoxic saponin chloromaloside A from Chlorophytum
malayense. Planta medica, 2000, 66:587-590.

149.

Li W-k, Gu C-g, Zhang H-j, Awang DVC, Fitzloff JF, Fong HHS, van Breemen RB. Use of
high performance liquid chromatography-tandem mass spectrometry to distinguish Panax
ginseng C.A. Meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng).
Analytical Chemistry , 72: 5417-5422, 2000.

150.

Westenburg HE, Lee K-J, Lee SK, Fong HHS, van Breemen RB, Pezzuto JM, Kinghorn AD.
Activity-guided isolation of antioxidative constituents of Cotinus coggygria. Journal of
Natural Products. 63: 1696-1698, 2000.

151.

Chang LC, Chvez D, Gills JJ, Fong HHS, Pezzuto JM, Kinghorn AD. Rubiasins A-C, new
anthracene derivatives from the roots and stems of Rubia cordifolia. Tetrahedron Letters. 2000,
41:7157-7162.

152.

Adeniyi BA, Fong HHS, Pezzuto JM, Luyengi L, Odelola HA. Antibacterial activity of
diospyrin, isodiospyrin and bisisodiospyrin from the root of Diospyros piscatoria Gurke
(Ebenaceae). Phytotherapy Research, 2000, 14:112-117.

153.

Liu J, Burdette JE, Xu H, Gu C, van Breemen RBv, Bhat, K, Booth N, Constantinou AI,
Pezzuto JM, Fong HHS, Farnsworth NR, Bolton JL. Evaluation of estrogrnic activity of plant
extracts for the potential treatment of menopausal symptoms. Journal of Agricultural Food
Chemistry, 2001, 49:2472-2479.

154.

Lee D, Park EJ, Cuendet M, Axelrod F, Chavez PI, Fong HHS, Pezzuto, JM, Kinghorn AD.
Cyclooxygenase-inhibitory and antioxidant constituents of the aerial parts of Antirhea acutata.
Bioorganic and Medicinal Chemistry Letters, 2001, 11:1565-1568.

155.

Sun H-D, Qiu S-X, Lobkovsky EB, Lin L-Z, Farnsworth NR, Clardy J, Fong HHS. Crystal and
molecular structure of a natural equimolecular mixture of two epimeric diterpenes.
Tetrahedon, 2001, 57:65-70.

156.

Lee D, Cuendet M, Graham J, Cabieses F, Schunke Vigo J, Fong HHS, Pezzuto JM, Kinghorn
AD. A novel cyclooxygenase-inhibitory stilbenolignan from the seeds of Aiphanes aculeata.
Organic Letters. 2001, 3:2169-2171.

157.

Li S-H, Zhang H-J, Yao P, Sun H-D, Fong HHS. Taxane diterpenoids from the bark of Taxus
yunanensis. Phytochemistry, 2001, 58:369-374.

158.

Zhang H-J, Tamez PA, Vu DH, Tan GT, Nguyen VH, Le TX, Le MH. Nguyen MC, Do TT,
Soejarto DD, Fong HHS, Pezzuto JM. Antimalarial compounds from Raphidophora decursiva.
Journal of Natural Products , 2001, 64:772-777.

159.

Gyllenhaal C, Soejarto DD, Xuan LT, Vu BM, Hung NV, Southavong BH, Bouamanivong S,
Syddara K, Pezzuto JM, Fong HHS, ONeil MJ, Tarzian Sorenson J, Tan G. Ethnobotanical
aspects of an internastional cooperative biodiversity group project in Asia. Economic Botany,
2001 (in press).

160.

Lee D, Cuendet M, Axelrod F, Chavez PI, Fong HHS, Pezzuto JM, Kinghorn AD. Novel 29nor-3,4-seco-cycloartane triterpene methyl esters from the aerial parts of Antirhea acutata.
Tetrahedron, 2001, 57:7107-7112.

161.

Hall T, Lu Z-Z, Yat PN, Fitzloff JF, Arnason JT, Awang DVC, Fong HHS, Blumenthal M. An
introduction to the ginseng evaluation program. HerbalGram, 2001, 52:27-30.

162.

Hall T, Lu Z-Z, Yat PN, Fitzloff JF, Arnason JT, Awang DVC, Fong HHS, Blumenthal M.
Evaluation of consistency of standardized Asian ginseng products in the ginseng evaluation
program. HerbalGram, 2001, 52:31-45.

163.

Hoang, VD, Tan GT, Zhang H-J, Tamez PA, Hung NV, Cuong NM, Soejarto DD, Fong HHS,
Pezzuto JM. Natural anti-HIV agents. Part I. (+)-demethoxyepiexcelsin and verticillatol from
Litsea verticillata. Phytochmeistry 2001, 59:325-329.

164.

Hong-Jie Zhang, Ghee Teng Tan, Vu Dinh Hoang, Nguyen Van Hung, Nguyen Manh Cuong,
Do Thi Thao, Djaja Doel Soejarto, John Michael Pezzuto, Harry HS Fong. Natural anti-HIV
agents. Part II. Litseaverticillol A, a prototypic litseane sesquiterpene from Litsea verticillata.
Tetrahedron Letters 2001, 42:8587-8591.

165.

Soejarto DD, Pezzuto JM, Fong HHS, Tan GT, Franzblau S, Gyllenhaal C, Regalado J, Hiep
NT, Xuan LT, Hung NV, Bich TQ, Loc PK, Vu BM, Southavong BH, Sydara K,
Bouamanivong S, O'Neill MJ, Dietzman G. (2001) Busqueda de compuestos bioactivos.
Memorias del Primer Simposio de Biodiversidad Como Fuente de Medicamentos en el Futuro,
VII Congreso Colombiano de Farmacologia y Terapeutica, Cali, Colombia, 16-19 Agosto,
2001. Published and distributed in CD Rom format by Organizacion de las Naciones Unidas
para la Educacion, la Ciencia y la Cultura (UNESCO), August 19, 2001.

166.

Su B-N, Cuendet M, Hawthorne ME, Kardono LBS, Riswan S, Fong HHS, Mehta RG, Pezzuto
JM, Kinghorn AD. Constituents of the bark and twigs of Artocarpus dadah with
cyclooxygenase inhibitor activity. Journal of Natural Products, 2001, 65:163-169.

167.

Lee D, Bhat KPL, Fong, HHS, Farnsworth NR, Pezzuto JM, Kinghorn AD. Aromatase
inhibitors from Broussonetia papyrifera. Journal of Natural Products, 2001, 64:1286-1293.

168.

Soejarto DD, Tarzian-Sorensen J, Gyllenhaal C, Cordell GA, Farnsworth NR, Fong HHS,
Kinghorn AD, Pezzuto JM. The evolution of the University of Illinois policy of benefitsharing in research on natural products. Proceedings of the 7th International Congress on
Ethnobiology, Athens, Georgia, October 23-27, 2000. Stepp JR, Wyndham FS, Zarger RK
(eds), The International Society of Ethnobiology, University of Georgia Press, 2002, pp. 21-30.

169.

V.D.Hoang, T.T. Ghee, N.V.Hung, H.H. Fong, Ph.G. Dien, Structure elucidation of a new
Sesquiterpenoid from Litsea verticillata Hance (Lauraceae). Journal of Chemistry
(Vietnamese). 2002, 40 (DB): 180-183.

170.

Li S-H, Zhang H-j, Niu X-M, Yao P, Sun H-D, Fong HHS. Taxuyunnanines S-V, new taxoids
from Taxus yunnanensis. Planta Medica, 2002, 68:253-257.

171.

Hongjie Zhang, Shengxiang Qiu, Pamela Tamez, Ghee Teng Tan, Zeynep Agdomus, Nguyen
Van Hung, Nguyen Manh Cuong, Cindy Angerhofer, D. Doel Soejarto, John M. Pezzuto, Harry
H.S. Fong, Indole alkaloids from Rhaphidophora decursiva. Journal of Pharmaceutical
Biology, 2002, 40:221-224.

172.

Vu DH, Tan GT, Zhang HJ, Tamez A, Nguyen VH, Nguyen MC, Soejarto DD, Fong HHS,
Pezzuto JM. Natural anti-HIV agents-part 1: (+)-demethoxyepiexcelsin and verticillatol from
Litsea verticillata. Phytochemistry , 2002, 59, 325-329.

173.

Su B-N, Chang LC, Park EJ, Cuendet M, Santarsiero BD, Mesecar AD, Mehta RG, Fong HHS,
Pezzuto JM, Kinghorn AD. Bioactive constituents of the the seeds of Brucea javenica. Planta
medica, 2002, 68:730-733.

174.

Zhang H, Fan Z, Tan GT, Chai H-B, Pezzuto JM, Sun H, Fong HHS. Pseudoirroratin A, a new
cytotoxic ent-kaurene diterpene from Isodon pseudo-irrorata. Journal of Natural Products,
2002, 65: 215-217.

175.

Zhang H, Lu ZZ, Tan GT, Qiu S-x, Farnsworth NR, Pezzuto JM, Fong HHS.
Polyacetylginsenoside, a novel triterpenes saponin from Panax ginseng. Tetrahedron Letters,
2002, 43:973-977.

176.

Gu JQ, Gills JJ, Park EJ, Mata-Greenwood E, Hawthorne ME, Axelrod F, Chavez PI, Fong
HHS, Mehta RG, Pezzuto JM, Kinghorn, AD. Sesquiterpenoids from Tithonia diversifolia
with potential cancer chemopreventive activity. Journal of Natural Products, 2002, 65: 532536.

177.

Su B-N, Misico R, Park EJ, Santarsiero BD, Meseca A, Fong HHS, Pezzuto JM, Kinghorn,
AD. Isolation and characterization of bioactive principles of the leaves and stems of Physalis
philadelphica. Tetrahedron, 2002, 58: 3453-3466.

178.

Chen S-N, Li W, Fabricant DS, Santiarsiero BD, Mesecar A, Fitzloff JF, Fong HHS,
Farnsworth NR. Isolation, structure elucidation and absolute configuration of 26-deoxyactein
from Cimicifuga racemosa and clarification of nomenclature associated with 27-deoxyactein.
Journal of Natural Products, 2002, 65:601-605.

179.

Soejarto DD, Gyllenhaal C, Regalado JC, Pezzuto JM, Fong HHS, Tan GT, Nguyen Tien Hiep,
Le Thi Xuan, Nguyen Van Hung, Truong Quang Bich, Phan Ke Loc, Bui Minh Vu,
Southavong, BH, Sydara K, Bouamanivong S, O'Neill MJ, Dietzman G. An international
collaborative program to discover new drugs from tropical biodiversity of Vietnam and Laos.
Advances in Natural Sciences . 2002, 8:1-15.

180.

Li SH, Zhang HJ, Qiu SH, Niu XM, Santarsiero BD, Mesecar AD, Fong HHS, Farnsworth NR,
Sun HD. Vitexlactam A, a novel labdane diterpene lactam from the fruits of Vitex agnuscastus. Tetrahedron Letters, 2002, 43:5131-5134.

181.

Li W, Fong HHS, Singletary KW, Fitzloff JF. Determination of catechins in commercial gape
seed extract. Journal of Liquid Chromatography & Related Technology, 2002, 25:397-407.

182.

Gu J-Q, Park EJ, Totura S, Riswan S, Fong HHS, Pezzuto JM, Kinghorn AD. Constituents of
the twigs of Hernandia ovigera that inhibit the transformation of JB6 murine epidermal cells.
Journal of Natural Products, 2002, 65:1065-1068.

183.

Chen S-N, Fabricant DS, Fong HHS, Lu ZZ, Farnsworth NR. Cimiracemosides I-P, new 9,19cycloartane triterpenes glycosides from Cimicifuga racemosa. Journal of Natural Products,
2002, 65:1391-1397.

184.

Li W, Fitzloff JF, Farnsworth NR, Fong HHS. Evaluation of commercial Ginkgo biloba dietary
supplements for the presence of colchicine by high-performance liquid chromatography.
Phytomedicine, 2002, 9:442-446.

185.

Zhang H-J, Ghee Teng Tan, Vu Dinh Hoang, Nguyen Van Hung, Nguyen Manh Cuong,
Soejarto DD, Pezzuto JM, Fong HHS. Natural anti-HIV agents. Part IV. Anti-HIV constituents
fromVatica cinerea. Journal Natural Products. 2003, 66: 263-268.

186.

Zhang H-J, Tamez PA, Aydogmus Z, Ghee Teng Tan, Saikawa Y, Hashimoto K, Nakata M,
Nguyen Van Hung, Le Thi Xuan, Nguyen Manh Cuong, Soejarto DD, Pezzuto JM, Fong HHS.
Antimalarial Agents from Plants. III. Trichothecenes from Ficus fistulosa and Rhaphidophora
decursiva. Planta Medica , 2002, 68:1088-1091.

187.

Chen S-N, Fabricant DS, Lu ZZ, Zhang H-J, Fong HHS, Farnsworth NR. Cimiracemates A-D,
novel phenylpropanoid esters from the rhizomes ofCimicifuga racemosa. Phytochemistry,
2002, 61:409-413.

188.

Su B-N, Cuendet M, Farnsworth NR, Fong HHS, Pezzuto JM, Kinghorn AD. Activity-guided
fractionation of the seeds of Ziziphus jujuba using a cyclooxygenase-2 inhibitory assay. Planta
medica, 2002, 68:1125-1128.

189.

Jang DS, Park EJ, Hawthorne ME, Schunke Vigo J, Graham JG, Cabieses F, Santarsiero BD,
Mesecar AD, Fong HHS, Mehta RG, Pezzuto JM, Kinghorn AD. Constituents of Musa
sapientum (Banana) with the potential to induce the phase II enzyme, quinone reductase.
Journal Agricultural Food Chemistry, 2002, 50:6330-6334.

190.

Su B-N, Park EJ, Mbwambo ZH, Santarsiero BD, Mesecar AD, Fong HHS, Pezzuto JM,
Kinghorn AD. New chemical constituents of Euphorbia quinquecostata and absolute
configuration assignment by a convenient Mosher ester procedure carried out in NMR tubes.
Journal of Natural products, 2002, 65:1278-1282.

191.

Gu J-Q, Park EJ, Schunke Vigo J, Graham JD, Fong HHS, Pezzuto JM, Kinghorn AD.
Activity-guided isolation of constituents of Renealmia nicolaioides with potentials to induce
the phase II enzyme, quinone reductase. Journal of Natural Products, 2002 , 65:1616-1620.

192.

Li W, Chen S, Fabricant D, Angerhofer CK, Fong HHS, Farnsworth NR, Fitzloff JF. Highperformance liquid chromatographic analysis of black cohosh (Cimicifuga racemosa)
constituents with in-line evaporative light scattering and photodiode array detection. Analytica
Chimica Acta, 2002, 471:61-75.

193.

Burdette JE, Chen S, Lu ZZ, Xu H, White B, Fabricant DS, Liu J, Fong HHS, Farnsworth NR,
Constantinou AI, van Breemen RB, Pezzuto JM, Bolton JL. Black cohosh (Cimicifuga
racemosa L.) protects against menadione-induced DNA damage through scavenging of reactive
oxygen species: Bioassay directed isolation and characterizations of compounds. Journal of
Agricultural Food Chemistry, 2002, 50:7022-7028.

194.

Jang DS, Cuendet M, Hawthorne ME, Kardono LBS, Kawanishi K, Fong HHS, Mehta RG,
Pezzuto JM, Kinghorn AD. Prenylated flavanoids of the leaves of Macaranga conifera with
inhibitory activiy against cyclooxygenase-2. Phytochemistry, 2002, 61:867-872.

195.

Xu H, Fabricant DS, Piersen CE, Bolton JL, Pezzuto JM, Fong HHS, Totura S, Farnsworth NR,
Constantinou AI. A preliminary RAPD-PCR analysis of Cimicifuga species and other
botanicals used for womens health. Phytomedicine, 2002, 9:757-762.

196.

Li S-H, Zhang H-j, Niu X-M, Yao P, Yao P, Sun H-D, Fong HHS. Novel taxoids from the
Chinese yew,Taxus yunnanensis. Tetrahedron, 2003, 59:37-45.

197.

Zhang HJ, Tan GT, Vu DH, Nguyen VH, Nguyen MC, Soejarto DD, Pezzuto JM, Fong HHS.
Natural anti-HIV agents. Part III. Litseaverticillols A-H, novel sesquiterpenes from Litsea
verticillata. Tetrahedron, 2003, 59:141-148.

198.

Su B-N, Park EJ, Santarsiero BD, Mesecar AD, Schunke Vigo J, Graham JG, Cabieses F, Fong
HHS, Farnsworth NR, Pezzuto JM, Kinghorn AD. Activity-guided isolation of novel
norwithanolides from Deprea subtriflora with potential cancer chemopreventive activity.
Journal of Organic Chemsitry, 2003, 68:2350-2361.

199.

Li W, Sun Y, Joseph J, Fitzloff JF, Fong HHS, van Breemen RB. p-Hydroxybenzoic acid alkyl
esters in Andrographis paniculata herbs, commercial extracts and formulated products. Journal
of Agricultrual Food Chemistry, 2003, 51:524-529.

200.

Su B-N, Cuendet M, Nikolic D, Kristinsson H, Inglfsdttir K, van Breemen RB, Fong HHS,
Pezzuto JM, Kinghorn AD. NMR study of fumarprotocetraric acid, a complex lichen depsidone
derivative from Cladonia furcata. Journal of Marnetic Resonance in Chemistry, 2003, 41:391394.

201.

Soejarto DD, Xuan LT, Vu BM, Dac LX, Bich TQ, Southavong B, Sydara K, Bouamanivong S,
Zhang HJ, Fong HHS, Tan GT, Pezzuto JM, Franzblau S, Gyllenhaal C, Riley MC, Hiep NT,
Loc PK, Hung NV. Implementing IPR and benefit-sharing arrangements: Experience in the
University of Illinois at Chicago-Vietnam-Laos ICBG program. Proceedings of. The JBA/NITE
(Japan Bioindustry Association/National Institute of Technology and Evaluation) Symposium
2002. Tokyo November 12-14, 2002. pp 46-83.

202.

Adeniyi BA, Robert MF, Chai H, Fong HHS. In vitro cytotoxicity activity of diosquinone, a
naphthoquinone epoxide. Phytotherapy Research, 2003, 17:282-284

203.

Jang DS, Park EJ, Hawthorne ME, Schunke Vigo J, Graham JG, Cabieses, Santiseiero BD,
Mesecar AD, Fong HHS, Mehta RG, Pezzuto JM, Kinghorn AD. Potential cancer
chemopreventive constituents of the seeds of Dipteryx odorata (Tonka bean). Journal of
Natural Products, 2003, 66:583-587.

204.

Su B-N, Park EJ, Schunke Vigo J, Graham JG, Cabieses F, Fong HHS, Pezzuto JM, Kinghorn
AD. Activity-guided isolation of the chemical constituents of Muntingia calabura using a
quinone reductase-induction assay. Phytochemistry, 2003, 63:335-341.

205.

Zhang H-J, Tan GT, Santarsiero BD, Mesecar AD, Nguyen Van Hung, Nguyen Manh Cuong,
Soejarto DD, Pezzuto JM, Fong HHS. New sesquiterpenes from Litsea verticillata. Journal of
Natural Products. 2003, 66: 609-615.

206.

Li S-H, Zhang H-j, Niu X-M, Yao P, Sun H-D, Fong HHS. Chemical constituents from
Amenotaxus yunnanensis and Torreya yunnanensis. Journal of Natural Products, 2003, 66:
1002-1005.

207.

Gu J-Q, Li W, Kang Y-H, Su B-N, Fong HHS, van Breemen RB, Pezzuto JM, Kinghorn AD.
Structures, quinone reductase induction activities, and lc-ms-ms investigation as artifacts of
minor withanolides from Physalis philadelphiaca. Chemical and Pharmaceutical Bulletin,
2003, 51:530-539.

208.

Soejarto D, Fong H, Zhang H, Binh LT, Xuan LT, Hoang VD, Chien NQ, Hung NV, Hiep NT,
Bich TQ. Chuong trinh hop tac quoc t eve da dang sinh hoc ICBG. Tuyen Tap Bao Cao Khou
Hoc Ky Niem 25 Nam Thanh Lap Vien Hoa Hoc, Ha Noi, 2003, 9:94 - 110.

209.

Su B-N, Kang Y-H, Pinos RE, Santarsieno BD, Mesecar AD, Soejarto DD, Fong HHS, Pezzuto
JM, Kinghorn AD. Isolation and absolute stereochemistry of coussaric acid, a new bioactive
triterpenoid from the stems of Coussarea brevicaulis. Phytochemistry, 2003, 64:293-302

210.

Jang DS, Park EJ, Nikolic D, Schunke Vigo J, Graham JG, Cabieses F, van Breemen RB, Fong
HHS, Farnsworth NR, Pezzuto JM, Kinghorn AD. Isolation and characterization of
miscellaneous secondary metabolites of Deprea subtriflora. Journal of Natural Products,
2003, 66:1089-1093

211.

Liu J, Burdette J, Sun Y, Deng S, Schlecht SM, Zheng W, Nikolic D, Mahady GB, van
Breemen RB, Fong HHS, Pezzuto JM, Bolton JL, Farnsworth NR. Isolation of linoleic acid as
an estrogen-like compound from the fruits of Vitex agnus-castus L. (chaste berry).
Phytomedicine . 2004, 11:18-23.

212.

Soejarto DD, Gyllenhaal C, Tarzikan-Sorensen JA, Fong HHS, Xuan LT, Binh LT, Hiep NT,
Hung NV, Vu BM, Bich TQ, SouthavongB, Sydara K, Pezzuto JM. Bioprospecting
arrangement:Experience between the North and the South. Proceedings: The 2nd International
Conference on Medicinal Mushroom and the International Conference on Biodiversity and
Bioactive Compounds (BioThailand 2003), 17-19 July, 2003, Peach, Pattaya, Thailand, pp. 522. Biotec, NSTDA, and Ministry of Science and Technology, 561 pp.

213.

Jang DS, Park EJ, Kang Y-H, Hawthorne ME, Schunke Vigo J, Graham JG, Cabieses F, Fong
HHS, Mehta RG, Pezzuto JM, Kinghorn AD. Potential cancer chemopreventive flavonoids
from the stems of Tephrosia toxicaria. Journal of Natural Products, 2003, 66: 1166-1170.

214.

Carache-Blanco EJ, Kang Y-H, Park EJ, Su B-N, Kardono LBS, Riswan S, Fong HHS, Pezzuto
JM, Kinghorn AD. Constituents of the stem bark of Pongamia pinnata with the potential to
induce quinone reductase. Journal of Natural Products, 2003, 66: 1197-1202; (erratum: 2004,
67:126).

215.

Jang DS, Park EJ, Kang Y-H, Su B-N, Hawthorne ME, Schunke Vigo J, Graham JG, Cabieses
F, Fong HHS, Mehta RG, Pezzuto JM, Kinghorn AD. Compounds obtained from Sida acuta
with the potential to induce quinone reductase and to inhibit 7,12-dimethylbenz[a]anthracene-

induced preneoplastic lesions in a mouse mammary organ culture model. Archives of


Pharmaceutical Research, 2003, 26 (7):1-8.
216.

Su B-N, Park EJ, Nikolic D, Schunke Vigo J, Graham JG, Cabieses F, van Breemen RB, Fong
HHS, Farnsworth NR, Pezzuto JM, Kinghorn AD. Isolation and characterization of
miscellaneous secondary metabolites from Deprea subtriflora. Journal of Natural Products,
2003, 66;1089-1093.

217.

Su B-N, Park EJ, Santarsiero BD, Mesecar AD, Vigo JS, Graham JG, Cabieses F, Fong HHS,
Farnsworth NR, Pezzuto JM, and Kinghorn AD. Activity-guided isolation of novel
norwithanolides from Solanum altissimum with potential cancer chemopreventive activity.
Journal of Organic Chemistry. 2003, 68, 2350-2361.

218.

Muhammad I, Takamatsu S, Walker LA, Mossa JS, Fong HHS, El-Feraly FS. Cytotoxic and
antioxidant activities of alkylated benzoquinones from Maesa lanceolata. Phytotherapy
Research, 2003, 17:887-891.

219.

Asafu-Adjaye EB, Wong SK (Collaborators: Arnason J, Betz J, Breakell K, Chen JX, Fitzloff J,
Fong HHS, Kim CS, Kwan SY, Leung HW, Li GQ, Lin RC, Luo GA, Nicolidakis H, Park H,
Suen E, Wang XR, Wang ZT, Wen KC, Yeung HW). Determination of ginsenosides (ginseng
saponins) in dry root powder from Panax ginseng, Panax quinquefolius, and selected
commercial products by liquid chromatography: Interlaboratory study. AOAC International.
2003, 86:1112-1123.

220.

Jang DS, Cuendet M, Fong HHS, Mehta RG, Pezzuto JM, Kinghorn AD. Constituents of
Asparagus officinaleis (asparagus) with inhibitory activity against cyclooxygenase-2. Journal
of Agricultural Food Chemistry, 2004, 52: 2218-2222.

221.

Soejarto DD, Gyllenhaal C, Fong HHS, Xuan LT, Hiep NT, Hung, NV, Bich TQ, Southavong
B, Sydara K, Pezzuto JM. The UIC ICBG Memorandum of Agreement: A model of benefitsharing arrangement in natural products drug discovery and development. Journal of Natural
Products, 2004, 67: 294-299.

222.

Zhang H-J, Sydara K, Tan GT, Ma C, Southavong B, Soejarto DD, Pezzuto JM, Fong HHS.
Bioactive constituents from Asparagus cochinchinensis. Journal of Natural Products, 2004, 67:
194-200.

223.

Nguyen Quyet Chien, Nguyen Van Hung, Santoso BD, Mescar AD, Nguyen Manh Cuong,
Soejarto DD, Pezzuto JM, Fong HHS, Tan GT. New 3-O-Acyl betulinic acids from Strychnos
vanprukii. Craib (Loganiaceae). Journal of Natural Products, 2004, 67: 994-998.

224.

Jang DS, Cuendet M, Paulus A, Kardono LBS, Kawanishi K, Farnsworth NR, Fong HHS,
Pezzuto JM, Kinghorn AD. Potential cancer chemopreventive constituents of the leaves of
Macaranga triloba. Phytochemistry, 2004, 65:345-350.

225.

Jang DS, Cuendet M, Su B-N. Totura S, Riswan S, Fong HHS, Pezzuto JM, Kinghorn AD.
Constituents of the seeds of Hernandia ovigera with inhibitory activity against
cyclooxygenase-2. Planta Medica, 2004, 70:893-896.

226.

Jang DS, Park EJ, Kang Y-H, Schunke Vigo J, Graham JG, Cabieses F, Fong HHS, Pezzuto
JM, Kinghorn AD. Phenolic compounds obtained from stems of Couepia ulei with the potential
to induce quinone reductase. Archives of Pharmaceutical Research, 2004, 27:169-172.

227.

Su B-N, Jones W, Cuendet M, Kardono LBS, Ismail R, Riswan S, Fong HHS, Pezzuto JM,
Kinghorn AD. Constituents of the stems of Macrococculus pomiferus and their inhibitory
activities against cyclyoxygenases-1 and -2. Phytochemistry, 2004, 65: 2861-2866.

228.

Jang DS, Cuendet M, Su B-N, Totura S, Riswan S, Fong HHS, Pezzuto JM, Kinghorn AD.
Constituents of the seeds of Hernandia ovigera with inhibitory activity against
cyclyoxygenases-2. Planta medica 2004, 70: 893-896.

229.

Chadwick LR, Nikolic D, Burdette JE, Overk CR, Bolton JL, van Breemen RB, Frhlich R,
Fong HHS, Farnsworth NR, Pauli GF. Estrogens and Congeners from Spent Hops (Humulus
lupulus L.) Journal of Natural Products, 2004, 67:2024-2032.

230.

Ma CY, Case RJ, Wang YH, Zhang H-J, Tan GT, Nguyen Van Hung, Nguyen Manh Cuong,
Franzblau SG, Soejarto DD, Fong HHS, Pauli GF. Antituberculosis constituents from
Micromelum hirsutum. Planta medica. 2005, 71:261-267.

231.

Chen S-N, Fabricant DS, Fong HHS, Farnsworth NR, Paul GF. An approach to the synthesis of
cimicifugate B. Natural Product Research. 2005, 19:287-290.

232.

Zhang H-J, Nguyen Van Hung, Nguyen Manh Cuong, Soejarto DD, Pezzuto JM, Fong HHS,
Tan G. Sesquiterpenes and butenolides, natural anti-HIV constituents from Litsea verticillata.
Planta medica. 2005, 71:452-457.

233.

Inui, T, Case R, Chou E, Soejarto D, Fong HHS, Franzblau SG, Smith DC, Pauli GF. CCC in
the phytochemial analysis of anti-TB ethnobotanicals. Journal of Liquid Chromatography and
Related Technology, 2005, 28: 2017-2028.

234.

Chadwick LR, Fong HHS, Farnsworth NR, Pauli GF. CCC sample cutting for isolation of
prenylated phenolics from hops. Journal of Liquid Chromatography and Related Technology,
2005, 28: 1959-1969.

235.

Conway WD, Chadwick LR, Fong HHS, Farnsworth NR, Pauli GF. Extra-column volume in
countercurrent chromatography CCC. Journal of Liquid Chromatography and Related
Technology, 2005, 28: 1799-1818.

236.

Zhang H-J, Ma C, Nguyen Van Hung, Nguyen Manh Cuong, Tan G, Santarsiero BD, Mesecar
A, Soejarto D, Pezzuto JM, Fong HHS, Miliusanes, a novel class of cytotoxic agents from
Miliusa sinensis, Journal of Medicinal Chemistry, 2006, 49: 693-708.

237.

Homhual S, Zhang H-J, Bunyapraphatsara N, Kondratyuk T. Santarsiero BD, Mesecar AD,


Herunsalee A, Chaukul W, Pezzuto JM, Fong HHS. Bruguiesulfurol, A new sulfur compound
from Bruguiera gymnorrhiza. Planta Medica, 2006. 72: 255-260

238.

Jang DS, Su B-N, Pawlus AD, Jones WP, Kleps RA, Bunyapraphatsara N, Fong HHS, Pezzuto
JM, Kinghorn AD. Limnophilaspiroketone, a highly oxygenated phenolic derivative from
Limnophila geoffrayi. Journal of Natural Products, 2005, 68:1134-1136.

239.

Ma C, Nguyen Van Hung, Nguyen Manh Cuong, Zhang H-J, Tan G, Soejarto D, Fong HHS.
Antimalarial compounds from Grewia bilamellata, Journal of Natural Products, 2006, 69:346350.

240.

Soejarto DD, Fong HHS, Tan GT, Zhang HJ, Ma CY, Franzblau SG, Gyllenhaal C, Riley MC,
Kadushin MR, Pezzuto JM, Xuan LT, Hiep NT, Hung, NV, Vu BM, Loc PK, Dac LX, Binh
NQ, Chien NQ, Hai NV, Bich TQ, Cuong NM, Southavong B, Sydara K, Bouamanivong S, Ly
HM, Thuy TV. Rose WC, Dietzmaan GR. Etnobotany/Ethnopharmacology and mass
bioprospecting: Issues on intellectual property and benefit sharing. Journal of
Ethnopharmacology, 2005, 100:15-22.

241.

Jutiviboonsuk A, Zhang H, Tan GT, Ma C, Nguyen VH, Nguyen MC, Bunyapraphatsara N,


Soejarto DD, Fong HHS. Bioactive constituents from the roots of Bursera tonkinensis,
Phytochemistry , 2005, 66: 27452751

242.

He Z-D, Ma C, Zhang H-J, Tan G, Sydara K, Boumamanivong S, Southavong B, Soejarto D,


Pezzuto JM, Fong HHS, Antimalarial constituents from Nauclea orientalis (L.) L. Chemistry
and Biodiversity, 2005, 2:1378-1386.

243.

Fabricant DS, Nikolic D, Lankin DC, Chen S-N, Jaki B, Krunic A, van Breemen RB, Fong
HHS, Farnsworth NR, Pauli G. Cimipronidine: a cyclic guanidine alkaloid fom Cimicifuga
racemosa (L.Nutt). Journal of Natural Products, 2005, 68, 1266-1270.

244.

Jang DS, Su B-N, Pawlus AD, Kang, YH, Kardono LBS, Riswan S, Afriastini JJ, Fong HHS,
Pezzuto JM, Kinghorn AD. Beccaridiol, a 28-nortriterpenoid from the leaves of Diplectria
beccariana. Phytochemistry, 2006, 67:1832-1837.

245.

Deng S, Chen SN, Yao P, Nikolic D, van Breemen RB, Bolton JL, Fong HHS, Farnsworth NR,
Pauli GF. Characterization of the Serotonergic Active Principles of Angelica sinensis (Dang
Gui) roots. Journal of Natural Products, 2006, 69:536-541. PMCID: PMC1866289

246.

Deng S, Chen SN, Jian Lu J, Wang ZJ, Nikolic D, van Breemen RB, Bolton JL, Fong HHS,
Farnsworth NR, Pauli GF. A Novel GABAergic Phthalide Dimer from Angelica sinensis
(Oliv.) Diels. Phytochemical Analysis, 2006, 17:398-405.

247.

Soejarto DD, Zhang HJ, Fong HHS, Tan GT, Ma CY, Gyllenhaal C, Riley MC, Kadushin MR,
Franzblau SG, Bich TQ, Cuong NM, Hiep NT, Loc PK, Xuan LT, Hai NV, Hung, NV, Chien
NQ, Vu BM, Ly HM, , Southavong B, Sydara K, Bouamanivong S, Pezzuto JM, Rose WC,

Dietzmaan GR, Miller B, Thuy TV. Studies on Biodiversity of Vietnam and Laos' 1998-2005:
Examining the Impacts. Journal of Natural Products, 2006, 69: 473-481.
248.

Homhual S, Bunyapraphatsara N, Kondratyuk T. Herunsalee A, Chaukul W, Pezzuto JM, Fong


HHS. Zhang H-J. Bioactive dammarane triterpenes from the mangrove plant Bruguiera
gymnorrhiza. Journal of Natural Products, 2006, 69: 421-424.

249.

Xie J-T, Chang W-T, Wang C-Z, Mehendale SR, Li J, Ambihaipahar R, Ambihaipahar U, Fong
HHS, Yuan C-S. Curry leaf (Murraya koenigii Spreng.) reduces blood cholesterol and glucose
levels in ob/ob mice. The American Journal of Chinese Medicine, 2006, 34: 279284.

250.

He Z-D, Ma C-Y, Zhang H-J, Sydara K, Tan GT, Tamez P, Southavong B, Bouamanivong S, D.
DD, Pezzuto JM, Fong HHS. Rourinoside and rouremin, new antimalarial constituents from
Rourea minor. Phytochemistry. 2006, 67: 1378-1384.

251.

Jutiviboonsuk A, ZhangH-J, Kondratyuk TP, Herunsalee A, Chaukul W, Pezzuto JM, Fong HS,
Bunyapraphatsara N. Isolation and characterization of cancer chemopreventive compounds
from Barringtonia maunwongyathiae. Pharmaceutical Biology. 2007, 45 (3): 185-194.

252.

Chen S-N, Lankin D, Nikolic D, Fabricant DS, Lu Z-Z, Ramirez B, van Breemen RB, Fong
HHS, Farnsworth NR, Pauli GF. Chlorination diversifies Cimicifuga racemosa triterpene
glycosides. Journal of Natural Products. 2007, 70: 1016-1023. PMCID: PMC2596075

253.

van Breemen RB, Fong HHS, Farnsworth NR. The role of quality assurance and
standardization in the safety of botanical dietary supplements. Chemical Research in
Toxicology. 2007, 20:577-585. PMCID: PMC2570109 PMCID: PMC2570109

254.

Li WXX, Zhang H, Ma C, Fong H, van Breemen R, Fitzloff J. (2007). Secondary metabolites


from Andrographis paniculata. Chemical & Pharmaceutical Bulletin. 2007, 55: 455-8.

255.

van Breemen RB, Fong HHS, Farnsworth NR. Enssuring the safety of botanical dietary
supplements. American Journal of Clinical Nutrition, 2007, 87(2):509S-13S.

256.

Chan S S-K, Zhao M, Lao L, Fong HHS, Che C-T. Magnolol and hinokiol account for the
antispasmodic effect of Magnolia officinalis in isolated guinea pig ileum. Planta Medica.
2008, 74: 381-384.

257.

Amey Libman A, Zhang H-J, Ma C-Y, Southavong B, Sydara K, Bouamanivong S, Tan GT,
Fong HHS, Soejarto DD. A first new antimalarial pregnane glycoside from Gonoronema
napalense. Asian Journal of Traditional Medicine. 2008, 3:203-210.

258.

Ma C-Y, Musoke SF, Tan GT, Zhang H-J, Sydara K, Bouamanivong S, Southavong B, Soejarto
DD, Fong HHS. Study of Antimalarial Activity of Chemical Constituents from Diospyros
quaesita. Chemistry and Biodiversity, 2008, 5:2442-2448. PMCID: PMC2940840

259.

Nguyen Q Chien, Nguyen Van Tuyen, Nguyen Thi Minh Hang, Nguyen Van Hung,Tan GT,
Zhang HJ, Fong HHS, Soejarto DD. Studies on the bioactive constituents of Michelia

chapensis. VAST Proceeding of the International Scientific Conference on "Chemistry for


Development and Integration", Hanoi, September 12-14, 2008. Publishing House for Science
and Technology, Hanoi, pp. 389-398.
260.

Soejarto DD, Fong HHS, Zhang HJ, Franzblau SG, Gyllenhaal C, Kadushin MR, Pezzuto JM,
Tan GT, Rong L, Chien, NQ, Tuyen NV, Hang NTM, Hung NV. Scientific collaboration
between University of Illinois at Chicago and Institute of Chemistry under the ICBG Program:
Overview of accomplishment. VAST Proceedings of the Conference "Chemistry for
Development and Integration", Institute of Chemistry, Vietnamese Academy of Science and
Technology, Hanoi, September 11-21, 2008.Publishing House for Science and Technology,
Hanoi,. 93-121.

261.

Balunas MJ, Bin Su, Riswan S, Fong HHS, Brueggemeier RW, Pezzuto JM, Kinghorn AD.
Isolation and Characterization of Aromatase Inhibitors from Brassaiopsis glomerulata
(Araliaceae). Phytochemistry Letters, 2009, 2: 29-33. (PMCID: PMC2748821)

262.

Rajaiaha R, Lee D Y-W, Lao L, Fong HHS, Berman BM, Moudgil KD. Huo-Luo-Xiao-Ling
Dan modulates antigen-directed immune response in adjuvant-induced inflammation. Journal
of Ethnopharmacology, 2009, 123:4044. (PMCID: PMC2925191)

263.

Zhang R-X, Fan AY, Zhou A-N, Moudgil KD, Ma Z-Z, Lee D Y-W, Fong HHS, Berman BM,
Lixing Lao. Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant
arthritis in rats. Journal of Ethnopharmacology, 2009, 121:366371. PMCID: PMC2818782.

264.

Deng Y, Balunas MJ, Kim L-A, Lantvit DD, Chin Y-W, Chai H, Sugiarto S, Kardono LBS,
Fong HHS, Pezzuto JM, Swanson SM, Carcache de Blanco EJ, Kinghorn AD. Bioactive 5,6Dihydropyrone Derivatives from Hyptis brevipes. Journal of Natural Products. 2009, 72:
11651169. (PMCID: PMC2883770)

265.

Tjong Y-W, Ip S-P, Lao L, Wu J, Fong HHS, Sung JJY, Berman B, Che CT. Neonatal
maternal separation elevates thalamic corticotrophin releasing factor type 1 receptor expression
response to colonic distension in rat. to Neuroscience Letters, 2010, 31: 215-220, 2010.

266.

Ip S-P, Zhao M, Xian Y-F, Chen M-L, Zong Y-Y, Tjong Y-W, Tsai S-H, Sung JJY,
Bensoussan A, Berman B, Fong HHS, Che CT. Quality assurance for Chinese herbal
formulae: standardization of IBS-20, a 20-herb preparation. Chinese Medicine. 2010, 5:8. <
http://www.cmjournal.org/content/5/1/8 >; PMCID:PMC2845568

267.

268.

Yang Y-H, Rajaiaha R, Lee D Y-W, Ma Z, Yu H, Fong HHS, Lao L, Berman BM, Moudgil
KD. Suppression of ongoing experimental arthritis by an herbal formula (huo-luo-xiao-ling
dan) involves changes in antigen-induced immunological and biochemical mediators of

inflammation. Evidence Based Complementary and Alternative Medicine.


(ECAM/642027) (Volume 2011, Article ID 642027). PMCID: PMC2958519

2011

269.

270.

271.

272.

273.

274.

275.

276.

277.

278.

279.
280.

Cao H, Yu R, Choi Y, Ma Z-Z, Zhang HJ, Xiang W, Lee D Y-W, Berman BM, Moudgil KD,
Fong HHS, van Breemen RB. Discovery of cyclooxygenase inhibitors from medicinal plants
used to treat inflammation. Pharmacological Research. 2010,
61:519-524.
http://www.ncbi.nlm.nih.gov/pubmed/20188172 PMID: 20188172; PMCID: PMC2860736.

B.

Abstracts:
1.

N.R. Farnsworth, H.H.S. Fong, and R.N. Blomster. 1966. Catharanthus Alkaloid. XII.
Isolation of Catharanthine and Vincoline from C. lanceus. Lloydia 28:379E.

2.

M. Tin-Wa, H.H.S. Fong, R.N. Blomster, and N.R. Farnsworth. 1968. Catharanthus
Alkaloids. XXI. On the isolation of Lochnerinine, one of the cytotoxic principles of C.
pusillus. Lloydia 31:432A.

3.

A.B. Segelman, N.R. Farnsworth, and H.H.S. Fong. Catharanthus Alkaloids. XXIV. The
isolation and synthesis of 3,4-dimethoxyphenylacetamide, a cytotoxic principle from
Catharanthus lanceus. Lloydia 32:522B (1969).

4.

H.H.S. Fong, M. Tin-Wa, N.R. Farnsworth, and Blomster, R.N., Persinos, G.J., Quimby,
M.W., and O.B. Dokosi. . Biological and phytochemical evaluation of plants. Isolation of
constituents and antitumor activity of Maytenus senegalensis (Celastraceae). Lloydia
33:494A (1970).

5.

D.J. Abraham, J. Trojanek, H.-P. Munzing, H.H.S. Fong and N.R. Farnsworth. Structure
elucidation of Maytenonic acid, a new triterpene from Maytenus senegalensis (Celastraceae).
Lloydia 33:490D (1970).

6.

S.J. Smolenski, H. Silinis, H.H.S. Fong, J. Trojanek, M. Trojankova and N.R. Farnsworth.
Alkaloid Screening II. Lloydia 35:466 (1972).

7.

D.J. Abraham, R.D. Rosenstein, R.L. Lyon and H.H.S. Fong. The structure elucidation of
rhazinilam, a new class of alkaloid from the Apocynaceae. Lloydia 35:467B (1972).

8.

R.L. Lyon, H.H.S Fong and N.R. Farnsworth. A study on the alkaloids of the leaves of
Aspidosperma quebracho-blanco (Apocynaceae). Lloydia 35:467D (1972).

9.

W.M. Messmer, M. Tin-Wa, H.H.S. Fong, and N.R. Farnsworth. The isolation and structureelucidation of Fagaronine, a new alkaloid tumor inhibitor from Fagara zanthoxyloides
(Rutaceae). Lloydia 35:468C (1972).

10.

W.H. Marks, H.H.S. Fong, M. Tin-Wa, and N.R. Farnsworth. A study on the cytotoxic
principles of Parquetina nigrescens (Afzel.) Bullock (Asclepiadaceae). Lloydia 36:435C
(1973).

11.

R.H. Dobberstein, M. Tin-Wa, H.H.S. Fong, F.A. Crane and N.R. Farnsworth. Cytotoxic
flavones from Eupatorium altissimum (Compositae). Lloydia 37:640A (1974).

12.

H.T. Tai, G.H. Aynilian, M. Tin-Wa, H.H.S. Fong and N.R. Farnsworth.
Isolation of
erythrodiol monopalmitate from Tagetes C.V. Senator Dirkson. Lloydia 37:641 B (1974).

13.

O.T. Chang, G.H. Aynilian, M. Tin-wa, H.H.S. Fong and N.R. Farnsworth. Isolation of
heliparvifoline, heliparvine and flindersiamine from Helietta parvifolia (Rutaceae). Lloydia
37:643C (1974).

14.

O.T. Chang, G.H. Aynilian, M. Tin-wa, H.H.S. Fong and N.R. Farnsworth. A phytochemical
investigation of Thamnosma montana (Rutaceae). Lloydia 37:643D (1974).

15.

R.L. Lyon,H.H.S. Fong, F.A. Crane and N.R. Farnsworth. Phytochemical investigation of
Dianthus barbatus. 1974. Lloydia 37:646B (1974).

16.

A.S. Bingel, Fong, H.H.S., and N.R. Farnsworth. Antifertility screening of selected plants in
female rats. Lloydia 39:475C (1976).

17.

H.H.S. Fong. The plant kingdom as a potential source of new drugs for fertility regulation.
Proc. WHO-Mahidol Univ. Symposium on plants for fertility regulation. January 1984,
Bangkok, Thailand, pp. 8.

18.

C.L. King, Y.C. Kong, N.S. Wong, H.W. Yeung, H.H.S. Fong and U. Sankawa. Uterotonic
effect of Evodia rutaecarpa alkaloids. Chemistry in Asia 5:(1)16 (1981).

19.

S.M. Wong, M.B. Slaytor, H.H.S. Fong, G.A. Cordell and N.R. Farnsworth.
14-CGossypoI:Optimum conditions for synthesis in cotton seedlings. Abstr. 23rd Annual Meeting
American Society of Pharmacognosy, Pittsburgh, Pa., August 1-5, 1982.

20.

C.-t. Che, D.C. Lankin, G.A. Cordell and H.H.S. Fong. Aristolindiquinone-structure
elucidation of a new naphthoquinone through carbon-13 NMR spectroscopy. Abstr. 23rd
Annual Meeting American Society of Pharmacognosy, Pittsburgh, Pa., August 1-5, 1982.

21.

D.D. McPherson, G.A. Cordell, D.D. Soejarto, J.M. Pezzuto and H.H.S. Fong. Constituents of
Caesalpinia pulcherrima. Novel peltogynoids and homoisoflavanoids. Abstr. 23rd Annual
Meeting American Society of Pharmacognosy, Pittsburgh, Pa., August 1-5, 1982.

22.

D.P. Waller, N. Bunyapraphatsara and H.H.S. Fong. Effect of (+)gossypol on fertility in male
hamsters. Abstr. 24th Annual Meeting Amer. Soc. Pharmacognosy, University Missippi,
Oxford, July 24-28, 1983.

23.

X.D.Fang, J.M. Pezzuto, H.H.S. Fong, C.H. Phoebe, Jr., N.R. Farnsworth, B.Yellin and S.M.
Hecht.
Isolation, structure elucidation and evaluation of the cytotoxic potential of
cucurbitacins from Elaeocarpus dolichostylus. Abstr. 24 Annual Meeting Amer.Soc.
Pharmacognosy, University Mississippi, Oxford, July 24-28, 1983.

24.

G.B. Marcelle, G.A. Cordell and H.H.S. Fong. A method for the analysis of total gossypol in
plant materials. Abstr. 24th Annual Meeting Amer. Soc. Pharmacognosy, University Missippi,
Oxford, July 24-28, 1983.

25.

I.C. Kim, D.P. Waller and H.H.S. Fong. Specific inhibition of the testicular mitochondrial
respiratory chain in vitro by gossypol: J. Andrology. 5, No. 1: Program 23 (1984).

26.

X. Niu, D.P. Waller and H.H.S. Fong. Pharmacokinetics of gossypol in rats and hamsters.
The Pharmacologist, 26, No. 3: 167 (1984).

27.

I.C. Kim, D.P. Waller and H.H.S. Fong. In vitro spermicidal activities of the (-) and (+)
optical isomers of gossypol, racemic gossypol and gossypolone. The Pharmacologist, 26 No.
3: 134 (1984).

28.

G.B. Marcelle, G.A. Cordell and H.H.S. Fong. Resolution of racemic gossypol. International
Research Congress on Natural Product, University of North Carolina, Chapel Hill, N.C. July
7-12, 1985. Abstr. No. 142.

29.

C.-t. Che, D.D. McPherson, G.A. Cordell and H.H.S. Fong. Pulcherralpin, a new deterpene
ester from Caesalpinia pulcherrima stems. International Research Congress on Natural
Product, University of North Carolina, Chapel Hill, N.C. July 7-12, 1985. Abstr. No. 176.

30.

D.D.McPherson, G.A. Cordell, D.D. Soejarto, J.M. Pezzuto and H.H.S. Fong. New caesalpin
diterpenes from Caesalpinia pulcherrima roots. International Research Congress on Natural
Product, University of North Carolina, Chapel Hill, N.C. July 7-12, 1985. Abstr. No. 207 .

31.

Y. Oshima, S.M. Wong, C. Konno, G.A. Cordell, D.P. Waller, D.D. Soejarto and H.H.S. Fong.
1985. Leucanthanolide, a novel sesquiterpene lactone from Montanoa leucantha ssp.
leucantha. International Research Congress on Natural Product, University of North
Carolina, Chapel Hill, N.C. July 7-12, 1985. Abstr. No. 210.

32.

S.M. Wong, J.M. Pezzuto, H.H.S. Fong and N.R. Farnsworth. A new triterpene from Iris
missouriensis Nutt. International Research Congress on Natural Products, University of North
Carolina, Chapel Hill, N.C. July 7-12, 1985. Abstr. No. 33.

33.

S.M.Swanson, C.-t. Che, G.A. Cordell, H.H.S. Fong, and J.M. Pezzuto. Mutagenicity,
cytotoxicity andinhibition of DNA, RNA and protein synthesis by aristolochic acid and several
of its derivatives. International Research Congress on Natural Products, Chapel Hill, North
Carolina, July 7-12, 1985. Abstr. No. 160.

34.

L. Boonyaratanakornkit, C.-t. Che, H.H.S. Fong and N.R. Farnsworth. Constituents of Croton
crassifolius roots. 27th Annual Meeting of American Society of Pharmacognosy, July 27-30,
1986. Abstr. No. 28.

35.

S.M. Wong, C. Konno, Y. Oshima, J.M. Pezzuto, H.H.S. Fong and N.R. Farnsworth. Irisones
A & B: Two New Isoflavones from Iris missouriensis Nutt. (Iridaceae). 27th Annual Meeting
of American Society of Pharmacognosy, July 27-30, 1986. Abstr. No. 77.

36.

Z. Luo, L. Boonyaratanakornkit, C.-t. Che,C.A.J. Erdelmeier, H.H.S. Fong and N.R.


Farnsworth. Cytotoxic coumarins from Enkleia siamensis. 27th Annual Meeting of American
Society of Pharmacognosy, July 27-30, 1986. Abstr. No. 78.

37.

L. Boonyaratanakornkit, C.-t. Che, G.A. Cordell,H.H.S. Fong and N.R. Farnsworth.


Constituents of Enkleia siamensis roots. 27th Annual Meeting of American Society of
Pharmacognosy, July 27-30, 1986. Abstr. 79.

38.

C.Konno, H.-Z. Xue, Z.-Z. Lu, B.-X. Ma, C.A.J. Erdelmeier, G.A. Cordell, D.D. Soejarto, D.
Waller and H.H.S. Fong. New lignans from Larrea tridentata. 28th Annual Meeting of the
American Society of Pharmacognosy, Kingston, R.I., July 19-22, 1987.

39.

G.Topcu, N.R. Farnsworth and H.H.S. Fong.


Novel cytotoxic sesquiterpenes from
Montanoa tomentosa ssp. microcephala. 28th Annual Meeting of the American Society of
Pharmacognosy, Kingston, R.l., July 19-22, 1987.

40.

N.A. Nuzzo, A. Martin, C. Konno, C.D. Fakroddin, H.H.S. Fong and D.P. Waller. Effect of
nor-3'-demethoxyisoguaiacin (NDl) on fertility of female rats. Society for the Study of
Reproduction, Champaign, IL, July, 1987.

41.

Z.-Z. Lu, C. Konno, H.-Z. Lu, G.A. Cordell and H.H.S. Fong. Two new lignans from Larrea
tridentata. 7th Annual Meeting of the East China District, Changhai, PRC., Nov. 17-20, 1987.

42.

H.-Z.Xue, Z.-Z. Lu, C. Konno, D.D. Soejarto G.A. Cordell and H.H.S. Fong. Two novel
triterpenes from Larrea tridentata. 7th Annual Meeting of the East China District, Shanghai,
PRC., Nov. 17-20, 1987.

43.

C. Konno, A. Martin, B.-X. Ma, Z.-Z. Lu, H.-Z. Xue, C.A.J. Erdelmeier, N.A.Nuzzo, D.D.
Soejarto, G.A. Cordell, D.P. Waller and H.H.S. Fong. Search for fertility regulating agents
from Larrea tridentata. The First Princess Chulabhorn Science Congress, Bangkok, Thailand,
Dec. 10-13, 1987.

44.

C. Gyllenhaal, H.H.S. Fong, M.J. Huft, and C.-T. Che. Herbal cancer treatment currently
popular in the United States. The Thirtieth Annual Meeting of the Society for Economic Botany
and Satellite Symposium "New Directions in Crop Genetic Resource Conservation", University
of Tenessee, Knoxville, Tenn., June 12-14, 1989.

45.

I.-O. Mondranondra, A.M. Rimando, C.-T. Che, H.H.S. Fong and N.R. Farnsworth.
Sesquiterpene lactones and other constituents of Michelia floribunda. Thirtieth Annual
Meeting of the American Society of Pharmacognosy. San Juan, Puerto Rico, August 6-10,
1989.

46.

L.T Jonathan, M. Gbessor, C.-T. Che, G.C. LeBreton, D. Venton, H.H.S. Fong and N.R.
Farnsworth. Semiglabrin, a platelet aggregation inhibitor from Tephrosia semiglabra. Thirtieth
Annual Meeting of the American Society of Pharmacognosy. San Juan, Puerto Rico, August 610, 1989.

47.

E. Bejar, A. Amarquaye, C.T. Che, H.H.S. Fong, and M.H. Malone. Biologically active
compounds from the Mexican tree Byrsonima crassifolia (Malphigiaceae). International
Research Congress on Natural Products, The Thirty-Second Annual Meeting of the American
Society of Pharmacognosy, Chicago, IL. July 21-26, 1991. P-33.

48.

E. Bejar, A. Amarquaye, C.T. Che, H.H.S. Fong, and M.H. Malone. Flavonoids and piperidine
alkaloids from Byrsonima crassifolia (Malphigiaceae). antagonize serotonin effects on
isolated rat fundus. Thirty-Third Annual Meeting of the American Society of
Pharmacognosy,Colonial Williamsburg, VA, July 26-31, 1992. P-65.

49.

L. Luyengi, C.-t . Che, P.E. Bowen, D.P. Waller, C.W.W.Beecher, J.M. Pezzuto, and H.H.S.
Fong. Linusitamarin, a new phenylpropanoid glucoside from Linum usitatissimum L.
(Linaceae).Thirty-Third Annual Meeting of the American Society of Pharmacognosy, Colonial
Williamsburg, VA, July 26-31, 1992. P-68.

50.

C.W.W. Beecher, N.R. Farnsworth, H.HS. Fong, A.D. Kinghorn, R.G. Mehta, R.C. Moon,
R.M. Moriarty, J.M. Pezzuto, D.D. Soejarto, M.E. Wall, and M. Wani. Identification and
characterization of natural inhibitors of carcinogenesis. Proc. Am. Assoc. Cancer Res. 34:559
(1993) (84th Annual Meeting of the American Association for Cancer Research, Orlando, FL.,
May 19-22, 1993).

51.

L. Luyengi, I.-K. Lee, W. Mar, H.H.S. Fong, J.M. Pezzuto and A.D. Kinghorn. New
constituents of Mundulea sericea with ornithine decarboxylase activity. 34th Annual Meeting
of the American Society of Pharmacognosy,San Diego, CA, July 18-22, 1993.

52.

W. Mar, L. Luyengi, H.H.S. Fong, A.D. Kinghorn, R.C. Moon, R.G. Mehta and J.M. Pezzuto.
Systems for the detection of chemopreventive agents from plant leads. 34th Annual Meeting of
the American Society of Pharmacognosy,San Diego, CA, July 18-22, 1993.

53.

N. Suh, H.H.S. Fong, R.M. Moriarty and J.M. Pezzuto. Cell differentiation effects and
cytotoxicity of extracts for medicinal plants and vitamin D derivatives. 34th Annual Meeting of
the American Society of Pharmacognosy,San Diego, CA, July 18-22, 1993.

54.

L. Boonyaratanakornkit, C.-t. Che, G.A. Cordell, H.H.S. Fong and N.R. Farnsworth.
Constituents of Enkleia siamensis roots. XV International Botanical Congress, Yokohama,
Japan, August 28- Sept. 3, 1993.

55.

L. Orcheson, S. Rickard, M. Seidl, F. Cheung, L. Luyengi, H. Fong and L.U. Thompson. Estrus
cycling and organ changes in rats fed flaxseed, its mammalian lignan precursor or tomoxifen.
FASEB, 1993 (#1686).

56.

S. Rickard, L. Orcheson, M. Seidl, F. Cheung, L. Luyengi, H. Fong and L.U. Thompson.


Isolation and evaluation of a mammalian lignan precursor in flaxseed. FASEB, 1993 (#354).

57.

J.M. Pezzuto, W. Mar, L. Luyengi, A.D. Kinghorn, H.HS. Fong, A.G. Halline, R.G. Mehta, and
R.C. Moon. Rotenoid-mediated inhibition of ornithine decarboxylase activity as a mechanism
of chemopreventive activity. Proc. Am. Assoc. Cancer Res. 35:3739 (1994) (85th Annual
Meeting of the American Association for Cancer Research.

58.

W. Mar, N. Suh, L. cai, A.D. Kinghorn, H.HS. Fong, R.G. Mehta, R.C. Moon and J.M.
Pezzuto. Pentacyclic triterpene chemopreventive agents that stimulate protein kinase C activity.

Proc. Am. Assoc. Cancer Res. 35:3739 (1994) (85th Annual Meeting of the American
Association for Cancer Research.
59.

L. Luyengi, N. Suh, Y. Luo, S.K. Lee, H.H.S. Fong, J.M. Pezzuto and A.D. Kinghorn. Potential
cancer chemopreventive constituents from Dirca occidentalis . 35th Annual Meeting of the
American Society of Pharmacognosy, Halifax, Nova Scotia, Canada, July 31-August 4, 1994.

60.

M.S. Jang, L. Cai, A.D. Kinghorn, H.H.S. Fong, H. Wagner, A. Prbstle, and J.M. Pezzuto.
Bioassay-directed isolation of potential cancer chemopreventive agents utilizing inhibition of
cyclooxygenase activity as a monitor. 35th Annual Meeting of the American Society of
Pharmacognosy, Halifax, Nova Scotia, Canada, July 31-August 4, 1994.

61.

T. Pengsuparp, L. Cai, H.H.S. Fong, K. Ingolfsdottir, L.-Z. Lin, A.D. Kinghorn, J. M. Pezzuto
and G.A. Cordell. Natural products derived from plants that demonstrate potent inhibition of
HIV-1 reverse transcriptase. 35th Annual Meeting of the American Society of Pharmacognosy,
Halifax, Nova Scotia, Canada, July 31-August 4, 1994.

62.

S.K. Chaudhuri, F. Fullas, D.M. Brown, M.C. Wani, M.E. Wall, L. Cai, Y. Luo, K. Zaw,
H.H.S. Fong, J. M. Pezzuto, and A.D. Kinghorn. Pentacyclic triterpenoids from Maprounea
africana as potential inhibitors of chemical carcinogenesis. 35th Annual Meeting of the
American Society of Pharmacognosy, Halifax, Nova Scotia, Canada, July 31-August 4, 1994.

63.

N. Suh, C. Gerhuser, W. Mar, L. Cai, A.D. Kinghorn, H.H.S. Fong, R.G. Mehta, R.C. Moon,
and J.M. Pezzuto. Pentacyclic triterpene chemopreventive agents that stimulate protein kinase
C activity but antagonize responses mediated by 12-O-tetradecanoylphorbol-13-acetate (TPA).
35th Annual Meeting of the American Society of Pharmacognosy, Halifax, Nova Scotia,
Canada, July 31-August 4, 1994.

64.

C. Gerhuser, W. Mar, S.K. Lee, L. Luyengi, Z. Mbwambo, L. Cai, A.D. Kinghorn, H.H.S.
Fong, and J.M. Pezzuto. Discovery of plant-derived natural products that inhibit phorbol esterinduced ornithine decarboxylase (ODC) activity and reduce ODC mRNA expression in culture
mouse 308 cells. 35th Annual Meeting of the American Society of Pharmacognosy, Halifax,
Nova Scotia, Canada, July 31-August 4, 1994.

65

C. Gerhauser, S.K. Lee, J. Kosmeder, R.M. Moriarty, L. Luyengi,, H.H.S. Fong, A. D.


Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto. Transcriptional regulation mediated by
potent rotenoid chemopreventive agents. 86th Annual Meeting of the American Association for
Cancer Research.(1995)

66

R.B. van Breemen, C.-R. Huang, Z.-Z. Lu, A. Rimando, H.H.S. Fong and J.F. Fitzloff.
Electrospray liquid chromatography/mass spectrometry of ginsenosides.
43rd ASMS
Conference on Mass Spectrometry and Allied Topics, Atlanta, GA, May 21-26, 1995.

67

Gerhauser, H. Chai, S.K. Lee, I.S. Lee, T.E. Chagwedera, N.R. Farnsworth, G.A. Cordell,
C.W.W. Beecher, H.H.S.Fong, A.D. Kinghorn, D.M. Brown, M.C.Wani, M.E. Wall, T.J.
Hieken, T.K. Das Gupta, and J.M. Pezzuto. Discovery of betulinic acid as a selective inhibitor
of human melanoma that functions by induction of apoptosis. 36th Annual Meeting of the

American Society of Pharmacognosy, The University of Mississippi, Oxford, MS, July 23-27,
1995.
68.

L. Constant, L. Fang, S.K. Lee, H.H.S. Fong, N.R. Farnsworth, G.A. Cordell, J.M. Pezzuto,
A.D. Kinghorn, and C.W.W. Beecher. Dereplication of biologically active natural products
using electrospray HPLC/MS.
36th Annual Meeting of the American Society of
Pharmacognosy, The University of Mississippi, Oxford, MS, July 23-27, 1995.

69

S.-X. Qiu, Z.-Z. Lu, D. Kim, and H.H.S. Fong. A new flavonoid glycoside from Linum
usitatissimum. 36th Annual Meeting of the American Society of Pharmacognosy, The
University of Mississippi, Oxford, MS, July 23-27, 1995.

70

L. Luyengi, N. Suh, H.H.S. Fong, R.G. Mehta, R.C. Moon, J.M. Pezzuto and A.D. Kinghorn.
Potential cancer chemopreventive agents from Brucea javanica. 36th Annual Meeting of the
American Society of Pharmacognosy, The University of Mississippi, Oxford, MS, July 23-27,
1995.

71

S.K. Lee, J.W. Kosmeder, C. Gerhuser, W. Mar, L. Luyengi, R.M. Moriarty, H.H.S. Fong,
A.D. Kinghorn and J.M. Pezzuto. Structure-activity studies of rotenoids that inhibit phorbol
ester-induced ornithine decarboxylase (ODC) activity in cell culture. 36th Annual Meeting of
the American Society of Pharmacognosy, The University of Mississippi, Oxford, MS, July 2327, 1995.

72

L.M. Hong, C. K. Angerhofer, V. Wongpanich, M.V. Tri, L.T. Xuan, P.T. Huong, T.C. Khan,
H.B. Chai, d.D. soejarto, H.H.S. Fong, and J.M. Pezzuto. Evaluation of antimalarial and
cytotoxic activities of Vietnamese plants. 36th Annual Meeting of the American Society of
Pharmacognosy, The University of Mississippi, Oxford, MS, July 23-27, 1995.

73

C. Gerhuser, E.J. Kennelly, S.K. Lee, W. Mar, H.H.S. Fong, A.D. Kinghorn, R. G. Mehta,
R.C. moon, and J.M. Pezzuto. Inhibition of phorbol ester-induced ornithine decarboxylase
(ODC) activity in cultured mouse 308 cells by 4'-demethyldeoxypodophyllotoxin from
Amonoa oblongifolia stem bark. 36th Annual Meeting of the American Society of
Pharmacognosy, The University of Mississippi, Oxford, MS, July 23-27, 1995.

74

N. Suh, L. Luyengi, H.H.S. Fong, A.D. Kinghorn, R. G. Mehta, R.C. moon, and J.M. Pezzuto.
Potent chemopreventive activity by brusatol isolated from Brucea juvanica.. 36th Annual
Meeting of the American Society of Pharmacognosy, The University of Mississippi, Oxford,
MS, July 23-27, 1995.

75

M.S. Jang, E.J. Kennelly, L. Cai, H.H.S. Fong, A.D. Kinghorn, R. G. Mehta, R.C. moon, and
J.M. Pezzuto. Bioassay-directed isolation of potent cyclooxygenase inhibitors as potential
cancer chemopreventive agents.
36th Annual Meeting of the American Society of
Pharmacognosy, The University of Mississippi, Oxford, MS, July 23-27, 1995.

76

JM Pezzuto, CWW Beecher, HHS Fong, NR Farnsworth, AD Kinghorn, RG Mehta, RC Moon,


S. Hedayat, G.O. Udeani, and RM Moriarty. Discovery and charcterization of natural product

cancer chemopreventive agents. . 37th Annual Meeting of the American Society of


Pharmacognosy, University of California, Santa Cruz, CA, July 27-31, 1996.
77

S-X. Qiu, Y-M Shen, Y-J Hu, Z-Z Lu, HHS Fong and NR Farnsworth. Two new pregnane
steroids from Metaplexis hemsleyana. 37th Annual Meeting of the American Society of
Pharmacognosy, University of California, Santa Cruz, CA, July 27-31, 1996.

78

Chang LC, Pisha E, Kenelly EJ, Fong HHS, Pezzuto JM, Kinghorn AD. Antiestrogenic
Steroidal Alkaloids from Pachysandra procumbens, 38th Annual Meeting of the American
Society of Pharmacognosy, University of Iowa, Iowa, July 26-30, 1997.

79

Ito A, Shamon LA, Farnsworth NR, Fong HHS, Pezzuto JM, Kinghorn AD. Antimutagenic
Constituents of Casimiroa edulis, 38th Annual Meeting of the American Society of
Pharmacognosy, University of Iowa, Iowa, July 26-30, 1997.

80

Jang MS, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS,
Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Resveratrol, a Novel
Natural Cancer Chemopreventive Agent, 38th Annual Meeting of the American Society of
Pharmacognosy, University of Iowa, Iowa, July 26-30, 1997.

81

Chung HS, Mbwambo ZH, Shamon, Beecher CWW, Fong HHS, Pezzuto JM, Kinghorn AD.
Potent Antimutagenic Constituents of Mezoneuron cucullatum, 38th Annual Meeting of the
American Society of Pharmacognosy, University of Iowa, Iowa, July 26-30, 1997.

82

Chung HS, Lee SK, Shamon, Farnsworth NR, Fong HHS, Pezzuto JM, Kinghorn AD. Novel
Antioxidant Flavonoids from Chorizanthe diffusa, 38th Annual Meeting of the American
Society of Pharmacognosy, University of Iowa, Iowa, July 26-30, 1997.

83

Soejarto DD, Cordell GA, Farnsworth NR, Fong HHS, Kinghorn AD, Pezzuto JM.
International Collaborative Projects at PCRPS (Program for Collaborative Research in the
Pharmaceutical Sciences, 38th Annual Meeting of the American Society of Pharmacognosy,
University of Iowa, Iowa, July 26-30, 1997.

84

Tuyen NV, Kim DSHL,Wongpanich V, Angerhofer CK, Fong HHS, Soejarto DD, Tri MV,
Xuan LT. Discovery of Antimalarial Constituent from Ficus fistulosa, 38th Annual Meeting
of the American Society of Pharmacognosy, University of Iowa, Iowa, July 26-30, 1997.

84

Wongpanich V, Mata-Greenwood, Suh N, Chai HB, Fong HHS, Pezzuto JM, Angerhofer CK,
El Feraly F, Mossa JS. Correlation of the Antimalarial Activity of Artemisinins and Their
Potential to Induce Cell Differentiation, 38th Annual Meeting of the American Society of
Pharmacognosy, University of Iowa, Iowa, July 26-30, 1997.

85

Qiu S, Sun H, Lobkovsky E, Chai H, Fong HHS, Clardy J, Pezzuto JM, Farnsworth NR. A
Cytotoxic Diterpene from Isodon megathyrsus (Labiatae), 38th Annual Meeting of the
American Society of Pharmacognosy, University of Iowa, Iowa, July 26-30, 1997.

86

Leng-Chee Chang, Bhat KP, Pisha E., Fong HHS, Pezzuto,JM, Kinghorn AD. Additional
Antiestrogen Binding Site Inhitory Steroil Alkaloids from Pachysandra procumbens. 39th
Annual Meeting of the American Society of Pharmacognosy, Orlando, FL, July 19-24, 1998.

87

Lee SK, Qing WG, Mar W, Luyengi L, Mehta RG, Kawanishi K, Fong HHS, Beecher CWW,
Kinghorn AD, Pezzuto JM. Angoline and Chelerythrine, Benzophenanthridine Alkaloids that
do not inhibit Protein Kinase C.39th Annual Meeting of the American Society of
Pharmacognosy, Orlando, FL, July 19-24, 1998.

88

Qiu S-X, Yue X-j, Fong HHS, Farnsworth NR. Two new ceramides from Bupleurum
chaishoui. 39th Annual Meeting of the American Society of Pharmacognosy, Orlando, FL, July
19-24, 1998.

89

Chang LC, Bhat KPL, Fong HHS, Pezzuto JM, Kinghorn AD. Additional novel steroidal
alkaloids from Pachysandra procumbens, Interim Meeting of the American Society of
Pharmacognosy, Tunica, MS April 29-May 1, 1999.

90

Fong HHS. Perspectives on phytochemical collaborative research training in a natural product


drug discovery program. Advances in Natural Sciences, 2000, Vol. 1, Sup. 1:73-74.

91

Kardono LBS, Trisnamurti RH, Fong HHS. Studies on bioactive constituents from Indonesian
forest plants. Advances in Natural Sciences, 2000, Vol. 1, Sup. 1:109.

92

Lee D, Park EJ, Cuendet M,Axelrod F, Chavez PI, Fong HHS, Pezzuto JM, Kinghorn AD.
Bioactive constituents from the aerial parts of Antirhea acutata. 41st Annual Meeting of the
American Society of Pharmacognosy, 2000, Seattle, WA

93

Li, S; Zhang Hj, Yao P, Sun H, Fong, HHS, Farnsworth NR. Taxanes and Non-taxanes from
the Bark of Taxus yunnanensis, UNESCO Regional Symposium on Chemistry of Medicinal
Plants, March 17-19, 2000, Kunming, China, 249-253.

94

Lee D, Cuendet M, Graham J, Cabieses F, Schunke Vigo J, Fong HHS, Pezzuto JM, Kinghorn
AD. A novel cyclooxygenase-inhibitory stilbenolignan from the seeds of Aiphanes aculeata.
42d Annual Meeting of the American Society of Pharmacognosy, 2001, Mexico

95

Su B-N, Chang LC, Park EJ, Cuendet M, Santarsiero B, Mescar AD, Mehta RG, Fong HHS,
Pezzuto JM, Kinghorn AD. Bioactive constituents of the seeds of Brucea javanica. 222nd ACS
National Meeting, Chicago, IL. August 2001

96

Lee D, Cuendet M, Axelrod F, Chavez PI, Fong HHS, Pezzuto JM, Kinghorn AD. Novel 29nor-3,4-seco-cycloartane triterpene methyl esters from the aerial parts of Antirhea acutata. 42d
Annual Meeting of the American Society of Pharmacognosy, 2001, Mexico.

97

Gu J-Q, Gills JJ, Park EJ, Hawthorne ME, Axelrod F, Chavez PI, Fong HHS, Mehta RG,
Pezzuto JM, Kinghorn AD. Sesquiterpenoids from Tithonia diversifolia with potential cancer
chemopreventive activity. 42d Annual Meeting of the American Society of Pharmacognosy,
2001, Mexico.

98

Su B-N, Misico R, Park EJ, Santarsiero BD, Mescar AD, Fong HHS, Pezzuto JM, Kinghorn
AD. New constituents of the leaves and stems of Physalis philadelphica (tomatillos) with
potential cancer chemopreventive activity. 42d Annual Meeting of the American Society of
Pharmacognosy, 2001, Mexico.

99

Su B-N, Cuendet M, kardono LBS, Riswan S, Fong HHS, Pezzuto JM, Kinghorn AD.
Constituents of the bark of Artocarpus dadah with cyclooxygenase inhibitory activity. 42d
Annual Meeting of the American Society of Pharmacognosy, 2001, Mexico.

100

Zhang H-J, Tamez PA, Vu DH, Tan GT, Nguyen VH, Le TX, Le MH. Nguyen MC, Do TT,
Soejarto DD, Fong HHS, Pezzuto JM. Antimalarial compounds from Raphidophora decursiva.
42d Annual Meeting of the American Society of Pharmacognosy, 2001, Mexico.

101

Zhang H-J, Fan Z, Tan GT, Chai H-B, Pezzuto JM, Sun H, Fong HHS. New cytotoxic entkaurene diterpenoid from Isodon pseudoirrorata. 42d Annual Meeting of the American Society
of Pharmacognosy, 2001, Mexico.

102

Zhang H-J, Lu Z-Z, Tan GT, Qiu S-X, Farnsworth NR, Pezzuto JM, Fong HHS. Anti-HIV
agent a novel triterpene saponin from Panax ginseng C.A. Meyer. 42d Annual Meeting of the
American Society of Pharmacognosy, 2001, Mexico.

103

Soejarto DD, Gyllenhaal, C, Regalado, JC, Pezzuto, JM, Fong, HHS, Tan, GT, Nguyen Tien
Hiep, Le Thi Xuan, Do Quang Binh, Nguyen Van Hung, Truong Quang Bich, Nguyen Nghia
Thin, Phan Ke Loc, Bui Minh Vu, Southavong BH, Sydara K, Bouamanivong S, O'Neill MJ,
Lewis J, Xie X, Dietzman G. An international collaborative program to study the
pharmaceutical potential of plants of Laos and Vietnam. Presented at the Fifth Anticancer Drug
Discovery and Development Symposium, September 23-25, 1999, Josephine Ford Cancer
Center, Detroit, MI.

104

Gyllenhaal C, Soejarto DD, Xuan LT, Southavong BH, Bouamanivong, S, Pezzuto J, Fong
HHS, ONeill MJ, Tarzian-Sorensen JA, Tan GT, Hung NV. (2000) Ethnobotanical aspects of
an International Cooperative Biodiversity Group project in Asia. Invited paper in symposium,
Roots in the Past, Seeds Tomorrow: Sowing the Future of Economic . 41st Annual Meeting of
the Society for Economic Botany, Columbia, South Carolina, June 22, 2000.

105

Chen S-N, Fabricant DS, Liu J., Burdette J, Bolton J, Fong HHS, Farnsworth NR. Study on
chemical and bioactive constituents of Cimicifuga racemosa (L.Nutt). 42d Annual Meeting of
the American Society of Pharmacognosy, 2001, Mexico.

106

Su B-N, Chang LC, Park EJ, Cuendet M, Santarsiero BD, Mesecar AD, Mehta RG, Fong HHS,
Pezzuto JM, Kinghorn AD. Bioactive constituents of the the seeds of Brucea javenica. 222nd
American Chemical Society Meeting, Chicago, IL. Aug. 26-30, 2001, Abstr. No. MEDI-134.

107

Tamez PA, Zhang HJ, Tan GT, Xuan LT, Hung NV, Hiep NT, Bich TQ, Loc PK,
Bouamanivong S, Sydara K, Regalado JC, Gyllenhaal, C, Fong HHS, Soejarto DD, Pezzuto

JM. Antimalarial drug discovery from plants of Vietnam and Laos. 50th Annual Meeting of the
American Society of Tropical Medicine and Hygiene, Atlanta, GA. Nov. 11-15, 2001.
108

Booth N, Lu ZZ, Gu X, van Breemen RB, Bolton J, Fong HHS, Farnsworth NR, Zheng QY.
Challenges involved in predparing a standardized Trifolium pratense (Red Clover) extract for
clinical trials. International Scientific Conference on Complementary, Alternative and
Integrative Medicine Research, 17-19 May 2001, San Francisco. Alternative Therapies 2001,
7:S5.

109

Booth N, Burdette J, Zheng V, Jacinto S, Nikolic D, Bolton J, van Breemen RB, Fong HHS,
Farnsworth NR. Development of a chemically and biologically standardized clinical dosage
form ofTrifolium pratense (Red Clover). Second Annual Botanical Centers Directors Meeting,
6-8 July 2002, Bethesda, MD.

110

Gu J-Q, Park EJ, Totura S, Riswan S, Fong HHS, Pezzuto JM, Kinghorn AD. Constituents of
the twigs of Hernandia ovigera that inhibit the transformation of JB6 murine epidermal cells.
43d Annual Meeting of the American Society of Pharmacognosy, 2002, New Brunswick, New
Jersey.

111

Jang DS, Park EJ, Hawthorne ME, Schunke Vigo J, Graham JG, Cabieses F, Santarsiero BD,
Mesecar AD, Fong HHS, Mehta RG, Pezzuto JM, Kinghorn AD. Constituents of Musa
sapientum (Banana) with the potential to induce the phase II enzyme, quinone reductase. 43d
Annual Meeting of the American Society of Pharmacognosy, 2002, New Brunswick, New
Jersey

112

Su B-N, Park EJ, Mbwambo ZH, Santarsiero BD, Mesecar AD, Fong HHS, Pezzuto JM,
Kinghorn AD. New chemical constituents of Euphorbia quinquecostata and absolute
configuration assignment by a convenient Mosher ester procedure carried out in NMR tubes.
43d Annual Meeting of the American Society of Pharmacognosy, 2002, New Brunswick, New
Jersey

113

Gu J-Q, Park EJ, Schunke Vigo J, Graham JD, Fong HHS, Pezzuto JM, Kinghorn AD.
Activity-guided isolation of constituents of Renealmia nicolaioides with potentials to induce
the phase II enzyme, quinone reductase. 43d Annual Meeting of the American Society of
Pharmacognosy, 2002, New Brunswick, New Jersey

114

Jang DS, Cuendet M, Hawthorne ME, Kardono LBS, Kawanishi K, Fong HHS, Mehta RG,
Pezzuto JM, Kinghorn AD. Prenylated flavanoids of the leaves of Macaranga conifera with
inhibitory activiy against cyclooxygenase-2. 43d Annual Meeting of the American Society of
Pharmacognosy, 2002, New Brunswick, New Jersey

115

Zhang H-J, Tamez PA, Saikawa Y, Hashimoto K, Nakata M, Aydogmus Z, Ghee Teng
Tan,Nguyen Van Hung, Le Thi Xuan, Nguyen Manh Cuong, Soejarto DD, Pezzuto JM, Fong
HHS. Isolation of potent antimalarial trichothecenes from Ficus fistulosa and Rhaphidophora
decursiva. 43d Annual Meeting of the American Society of Pharmacognosy, 2002, New
Brunswick, New Jersey

116

Zhang H-J, Ghee Teng Tan, Vu Dinh Hoang, Nguyen Van Hung, Nguyen Manh Cuong,
Soejarto DD, Pezzuto JM, Fong HHS. Natural anti-HIV constituents from Litsea verticillata.
43d Annual Meeting of the American Society of Pharmacognosy, 2002, New Brunswick, New
Jersey

117

Zhang H-J, Ghee Teng Tan, Vu Dinh Hoang, Nguyen Van Hung, Nguyen Manh Cuong,
Soejarto DD, Pezzuto JM, Fong HHS. Natural anti-HIV constituents from Vatica cinera. 43d
Annual Meeting of the American Society of Pharmacognosy, 2002, New Brunswick, New
Jersey

118

Chen S-N, Burdette JE, Xu H-Y, Lu ZZ, Zhang HJ, Fabricant DS, Constantinou AI, Bolton JL,
Pezzuto JM, Fong HHS, Farnsworth NR. Cimiracemates A-D, novel phenylpropanoid esters
from the rhizomes ofCimicifuga racemosa. 43d Annual Meeting of the American Society of
Pharmacognosy, 2002, New Brunswick, New Jersey

119

Chen S-N, Fabricant DS, Fong HHS, Farnsworth NR. Synthesis of phenylpropanoid esters. 43d
Annual Meeting of the American Society of Pharmacognosy, 2002, New Brunswick, New
Jersey

120

Chadwick LR, Chen S-N, Burdette JE, Bolton JL, Pezzuto JM, Nikolic D, Sun Y, van Breemen
RB, Fong HHS, Farnsworth NR. Chemial and pharmacological standardization of hops. Part I:
Isolation and characterization of estrogenic constituents. 43d Annual Meeting of the American
Society of Pharmacognosy, 2002, New Brunswick, New Jersey

121

Li W, Sun Y, Chen S, Fabricant D, Fong HHS, Farnsworth NR, Fitzloff JF, van Breemen RB.
Characterization of chemical constituents of Cimicifuga racemosa (black cohosh) using high
performance liquid chromatography with mass spectrometry. 50th ASMS Conference on Mass
Spectrometry abd Allied Topics, June 2-6, 2002, Orlando, FL.

122

Li W, Sun Y, Joseph J, Fong HHS, Fitzloff JF, van Breemen RB. Identification of phydroxybenzoic acid alkyl esters in commercial Andrographis paniculata extracts and
products. Functional Foods for Health Program 11th Annual Conference, May 12-14, 2002,
Urbana-Champaign, IL.

123

Jang DS, Cuendet M, Fong HHS, Mehta RG, Pezzuto JM, Kinghorn AD. Constituents of
Asparagus officinaleis (asparagus) with inhibitory activity against cyclooxygenase-2. 44th
Annual Meeting of the American Society of Pharmacognosy, 2003, Chapel Hill, North
Carolina.

124

Jang DS, Park EJ, Kang Y-H, Choi JK, Hawthorne ME, Schunke Vigo J, Graham JG, Cabieses
F, Fong HHS, Mehta RG, Pezzuto JM, Kinghorn AD. Flavonoids from the stems of Tephrosia
toxicaria with the potential to induce the phase II enzyme, quinone reductase. 44th Annual
Meeting of the American Society of Pharmacognosy, 2003, Chapel Hill, North Carolina.

125

Su B-N, Cuendet M, Kardono LBS, Riswan S, Fong HHS, Pezzuto JM, Kinghorn. Constituents
of the stems of Macrococculus poiferus and the evaluation of their inhibitory activity against

both cyclooxygenases-1 and 2. 44th Annual Meeting of the American Society of


Pharmacognosy, 2003, Chapel Hill, North Carolina.
126

Carache-B;anco EJ, Kang YH, Park EJ, Su B-N, Kardono LBS, Riswan S, Fong HHS, Pezzuto
JM, Kinghorn. Constituents of the stem bark of Pongamia pinnata with the potential to induce
quinone reductase. 44th Annual Meeting of the American Society of Pharmacognosy, 2003,
Chapel Hill, North Carolina.

127

Su B-N, Kang Y-H, Pinos RE, Santarsieno BD, Mesecar AD, Soejarto DD, Fong HHS, Pezzuto
JM, Kinghorn AD. Isolation and absolute stereochemistry of coussaric acid, a new bioactive
triterpenoid from the stems of Coussarea brevicaulis. 44th Annual Meeting of the American
Society of Pharmacognosy, 2003, Chapel Hill, North Carolina.

128

Zhang H-J, Tan G. Nguyen Van Hung, Vu Dinh Hoang, Nguyen Manh Cuong, Do Thi Thao,
Soejarto DD, Pezzuto JM, Fong HHS, Natural anti-HIV constituents from from Litsea
verticillata. 44th Annual Meeting of the American Society of Pharmacognosy, 2003, Chapel
Hill, North Carolina.

129

Zhang H-J, Tan G. Vu Dinh Hoang, Nguyen Van Hung, Nguyen Manh Cuong, Do Thi Thao,
Soejarto DD, Pezzuto JM, Fong HHS, Natural anti-HIV constituents from from Vatica cinera.
44th Annual Meeting of the American Society of Pharmacognosy, 2003, Chapel Hill, North
Carolina.

130

He ZD, Ma CY, Sydara K, Bouamanivong S, Zhang HJ, Tan GT, Tamez P, Southavong B,
Soejarto DD, Pezzuto JM, Fong HHS. Antimalarial agents from plants. IV. New antimalarial
constituents from Sarocephalus cordatus. 44th Annual Meeting of the American Society of
Pharmacognosy, 2003, Chapel Hill, North Carolina.

131

He ZD, Ma CY, Sydara K, Bouamanivong S, Zhang HJ, Tan GT, Tamez P, Southavong B,
Soejarto DD, Pezzuto JM, Fong HHS. New antimalarial compounds from Rourea minor. 44th
Annual Meeting of the American Society of Pharmacognosy, 2003, Chapel Hill, North
Carolina.

132

Jang DS, Su BN, Pawlus AD, Jones WP, Kleps RA, Bunyapraphatsara N, Fong HHS, Pezzuto
JP, Kinghorn AD. Limnophilaspiroketone, a highly oxygenated structurally novel phenolic
derivative from Limnophila geoffrayi. 2004 International Congress on Natural Products
Research, 2004, Phoenix, Arizona.

133

Ma CY, Case RJ, Wang YH, Zhang H-J, Tan GT, Nguyen Van Hung, Nguyen Manh Cuong,
Franzblau SG, Soejarto DD, Fong HHS, Pauli GF. Antituberculosis constituents from
Micromelum hirsutum. 2004 International Congress on Natural Products Research, 2004,
Phoenix, Arizona.

134

Chen SN, Pauli GF, Fong HHS, Schlecht S, Farnsworth NR. Chemical constituent study on
Vitex agnus-costus. 2004 International Congress on Natural Products Research, 2004,
Phoenix, Arizona.

135

Chen SN, Fabricant DS, Lu ZZ, Fong HHS, Pauli GP, Farnsworth NR. 3-O--D-Xyloside-16epi-cimigenol, a new stereoisomereic triterpene glycoside from Cimicifuga racemosa. 2004
International Congress on Natural Products Research, 2004, Phoenix, Arizona.

136

Fabricant DS, Nikolic D, Chen SN, Fong HHS, van Breemen R, Farnsworth NR, Pauli GP.
Isolation of a novel alkaloid from Cimicifuga racemosa (L) Nutt. 2004 International
Congress on Natural Products Research, 2004, Phoenix, Arizona.

137

Zhang HJ, Ma C, Hung NV, Cuong NM, Tan GT, Soejarto DD, Pezzuto JP, Fong HHS,
Bioactive constituents from Miliusa sinensis. 2004 International Congress on Natural
Products Research, 2004, Phoenix, Arizona.

138

Leung WK, Wu JCY, Chan LS, Chan FKL, Xie H, Fung SSL, Liang SM, Lao L, Fong H,
Berman B, Che CT, Sung JJY. Treatment of diarrhea-predominant irriable bowel syndrome
with traditional Chinese medicine: a randomized double-blind placebo controlled trial. Asian
Pacific Digestive Week, Oct. 4-7, 2004, Beijing, China.

139

Ma C, Nguyen Van Hung, Nguyen Manh Cuong, Zhang H-J, Tan G, Soejarto D, Fong HHS.
Antimalarial compounds from Grewia bilamellata. 46th Annual Meeting of the American
Society of Pharmacognosy, 2005, Corvallis, Oregon.

140

Deng S, Chen SN, Yao P, Lu J, Nikolic D, Wang ZJ, Bolton JL, van Breemen RB, Fong HHS,
Farnsworth NR, Pauli GF. New bioactive constituents from Angelica sinensis. 46th Annual
Meeting of the American Society of Pharmacognosy, 2005, Corvallis, Oregon.

141

Chen S-N, Chadwick LR, Jaki BU, Lankin D, Fong HHS, Farnsworth NR, Paul GF.
Estrogenicity and stability of desmethylxangthohumol (DMX) a qNMR study. 46th Annual
Meeting of the American Society of Pharmacognosy, 2005, Corvallis, Oregon.

142

Zhang H-J, Ma C, Tan G, Nguyen Van Hung, Nguyen Manh Cuong, Soejarto D, Fong HHS.
Bioactive constituents from Radermachera boniana. 46th Annual Meeting of the American
Society of Pharmacognosy, 2005, Corvallis, Oregon.

143

Chen S-N, Fabricant DS, Lu ZZ, Fong HHS, Farnsworth NR, Paul GF. The phytochemistry of
black cohosh inventory and challenges of an herb dietary supplement. 46th Annual Meeting of
the American Society of Pharmacognosy, 2005, Corvallis, Oregon.

144

Olmedo DA, Vazquez Y, Gupta MP, del Olmo E, Lopez-Perez J, Fong HHS, San Feliciano A.
Activida citotixica y estrogenica/antiestrogenica de fenilcoumarinas. National Congress of
Science and Technology, Panamanian Association for the Advancement of Science, Panama,
17-20 August 2005.

145

Zhangh H, Sudarat H, Jutiviboonsuk A, Kondratyuk T, Herunsalee A, Chaukul W, Pezzuto JM,


Fong HHS, Bunyapraphatsara N. Cancer chemopreventive triterpenes from Bruguiera
gymnorrhiza and Barringtonia maunwongyathiae. 47th Annual Meeting of the American
Society of Pharmacognosy, August 5-9, 2006, Arlington, Virginia.

146

Ma C, Musoke FS, Tan GT, Zhang H, Sydara K, Bouamanivong S, Southavong B, Soejarto


DD, Fong, HHS. Antimalarial compounds of Adinandra rubropunctata. 47th Annual Meeting
of the American Society of Pharmacognosy, August 5-9, 2006, Arlington, Virginia.

147

Chen S, Turner A, Jaki BU, Nikolic D, Fong HHS, FarnsworthNR, Van Breemen, RB.; Pauli
GF. Subtraction of bioactive constituents: selective removal of benzoic acid in elucidating the
action mechanism of cranberry juice. 47th Annual Meeting of the American Society of
Pharmacognosy, August 5-9, 2006, Arlington, Virginia.

148

Ma Z, CroyVL, Kondratyuk T, Cuendet M, Caceres A, Fong HHS, Pezzuto JM, Chang CJ.
Bioactive constituents from Sambucus mexicana. 47th Annual Meeting of the American
Society of Pharmacognosy, August 5-9, 2006, Arlington, Virginia.

149

Webster DE, Liu J, Chen SN, Fong HHS, Soejarto DD, Farnsworth NR, Wang ZJ.
Microscopic, chemical, and pharmacological comparison of Vitex agnus-castus L., V. negundo
L., V. rotundifolia L.f., and V. trifolia L. 47th Annual Meeting of the American Society of
Pharmacognosy, August 5-9, 2006, Arlington, Virginia.

150

Pezzuto JM, Fenical W, Cushman M, Chang C-j, Craig B, Moon R, Mesecar A, van Breemen,
RB, Fong HHS. Discovery of natural products as inhibitors of carcinogenensis. 47th Annual
Meeting of the American Society of Pharmacognosy, August 5-9, 2006, Arlington, Virginia.

151

Lee DYW, Ma ZZ, Zhang HJ, Xiang W, Cao HM, van Breemen RB, Fong HHS, and Berman
B. Herbal therapies in immune mediated arthritis: Chemistry and in vitro study of Chinese
medicine HLXL. NCCAM CERC Meeting, April, 2007.

152

Balunas MJ, Su B, Riswann S, Fong HHS, Brueggemeier RW, Pezzuto JM, Kinghorn AD.
Isolation and characterization of aromatase inhibitors from Brassaiopsis glomerulata (Blume)
Regel. 48th Annual Meeting of the American Society of Pharmacognosy, July14-18, 2007,
Portland, Maine.

153

Zhang H-J, Aydogmus Z, Huong LM, Tamez PA, Tan GT, Nguyen VH, Xuan LT, Nguyen
MC, Soejarto DD, Pezzuto JM, Fong HHS. Trichothecenes versus antimalarial activity. 48th
Annual Meeting of the American Society of Pharmacognosy, July14-18, 2007, Portland,
Maine.

154

Zhao M, Ip PSP, Zhang H-J, Xiang W, Fong HHS, Che CT. QA/QC analyses of a 20-herb
Chinese formula for IBS by HPLC/LC-MS. 48th Annual Meeting of the American Society of
Pharmacognosy, July14-18, 2007, Portland, Maine.

155

Lee D Y-W, Ma ZZ, Zhang H-J, Xiang W, Cao H-, Choi Y,. van Breemen RB, Berman B, Fong
HHS. Herbal therapies in immune mediated arthritis: Chemistry and in vitro study of Chinese
medicine Hou-Lou-Xiao-lin (HLXL) Dan. 48th Annual Meeting of the American Society of
Pharmacognosy, July14-18, 2007, Portland, Maine.

156

Qiu M, Zhang H-J, Nguyen VH, Nguyen MC, Tan GT, Soejarto DD, Franzblau SG, Fong
HHS. Anti-TB bioactive compounds from Ardisia gigantifolia. 48th Annual Meeting of the
American Society of Pharmacognosy, July14-18, 2007, Portland, Maine.

157

Ip PSP, Zhao M, Tsai SH, Zong Y, Bensoussan Alan, Fong HHS; Che, C-T. Quality assurance
program for standardization of a Chinese herbal formula used in the pre-clinical and clinical
studies of irritable bowel syndrome. Society for Acupuncture Research Conference. University
of Maryland at Baltimore, November 8-11, 2007, Baltimore, MD

158

Chan Sunny S-K, Zhao M, Fong HHS, Lao L, Che, C-T. The anti-spasmodic effect of
Magnolia officinalis is determined by its magnolol and honokiol contents. Society for
Acupuncture Research Conference. University of Maryland at Baltimore, November 8-11,
2007, Baltimore, MD

159

Zhao M, Ip PSP, Fong HHS, Che, C-T. Qualitative and Quantitative Analyses of a Chinese
Herbal Formula by Combined High Performance Liquid Chromatography Mass
Spectrometry. Society for Acupuncture Research Conference. University of Maryland at
Baltimore, November 8-11, 2007, Baltimore, MD

160

Lee D Y-W, Ma ZZ, Zhang H-J, Xiang W, Cao H-, Choi Y,. van Breemen RB, Berman B, Fong
HHS. Herbal therapies in immune mediated arthritis: Chemistry and in vitro study of Chinese
medicine Hou-Lou-Xiao-lin (HLXL) Dan. Society for Acupuncture Research Conference.
University of Maryland at Baltimore, November 8-11, 2007, Baltimore, MD

161

Pezzuto JM, Chang CJ, Craig BA, Cushman MS, Fenical W, Fong HHS, Mesecar A, Moon
RC, Van Breemen RB. Isolation and evaluation of natural product cancer chemopreventive
agents. Sixth Annual AACR International Conference, Frontiers in Cancer Prevention
Research, December 5-8, 2007, Philadelphia, Pa.

162

Chan SSK, Zhao M, Lao L, Fong HHS, Bensoussan A, Che C-T. Challenges in Studying
Polyprescriptions of Chinese Medicine Quality and Pharmacology Issues. Intenational
Congress on Complementary Medicinal Research, Sydney, Australia, March 2008.

163

Cao H, Choi Y, Nikolic D, Tao Y, Zhang H, Xiang W, Ma Z, Lee Y-W, Berman B, Fong H,
van Breemen RB. Screening Chinese botanicals for COX-2 inhibitors using LC-MS. The 56th
ASMS conference on Mass Spectrometry, Denver, Colorado, June 1-6, 2008. Journal of the
American Society for Mass Spectrometry, Supplement, 2008, 19 (55):S37 (MP 248).

164

Pezzuto JM, Chang CJ, Craig BA, Cushman MS, Fenical W, Fong HHS, Mesecar A, Moon
RC, Van Breemen RB. Natural product cancer chemopreventive agents. Annual Meeting of the
Phytochemical Society of North America, June 25-30, 2008, Washington State University,
Pullman, WA

165

Soejarto DD, Fong HHS, Hongjie Zhang, Franzblau SG, Gyllenhaal C, Kadushin MR, Pezzuto
JM, Tan GT, Rong L, Nguyen Quyet Chien, Nguyen Van Tuyen, Nguyen Thi Minh Hang,
Nguyen Van Hung. Scientific collaboration between University of Illinois at Chicago and
Institute of Chemistry under the ICBG program: Overview of accomplishments. International

Conference on Chemistry for Development and Integration, 30th Anniversary of the Institute of
Chemistry, VAST, September 12-14, 2008, Hanoi, Vietnam.
166

Deng Y, Balunas MJ, Kim L-A, Lantvit DD, Chin Y-W, Chai H, Sugiarto S, Kardono LBS,
Fong HHS, Pezzuto JM, Swanson SM, Carcache de Blanco EJ, Kinghorn AD. Bioactive 5,6Dihydropyrone Derivatives from Hyptis brevipes. 50th Annual Meeting of the American
Society of Pharmacognosy, June 27-July 1, 2009, Honolulu, Hawaii.

167

Qiu X, Choi Y, Zhang H, Chen Y, Fong H, van Breemen RB. Screening of botanical extracts
for ligands to quinone reductase-2 using ultra-filtration LC-MS. The 57th ASMS Conference
on Mass Spectrometry, Philadelphia, Pennsylvania May 31 - June 4, 2009.

168

C.

169

Yang Y-H, Rajaiaha R, Lee D Y-W, Ma Z, Yu H, Fong HHS, Lao L, Berman BM, Moudgil
KD. The anti-arthritic activity of an herbal hixture involves suppression of antigen-induced IL17. ACR Abstract #16403 - American College of Rheumatology Scientific Meeting, Oct 17-21,
2009, Philadelphia. Pa.

170

Fong HHS. The 4th International Symposium of the Western Pacific Regional Forum for the
Harmonization of Herbal Medicine, Hong Kong, China, 30 Oct. 2010. Perspectives on the
Current Regulation and Research on Herbs/Botanicals in the USA.

171

Ip IPP, Zhao M, Zong Y, Bensoussan A, Fong HHS, Che CT. A quality assurance program for
a Chinese herbal formulation used in the pre-clinical and clinical studies of irritabl;e bowel
syndrome. The 4th International Symposium of the Western Pacific Regional Forum for the
Harmonization of Herbal Medicine, Hong Kong, China, 30 Oct. 2010.

172

Zhao M, Zong Y, Ip IPP, Fong HHS, Che CT. Chemical standardization of a Chinese formula
by LC-MS. The 4th International Symposium of the Western Pacific Regional Forum for the
Harmonization of Herbal Medicine, Hong Kong, China, 30 Oct. 2010.

173

Tjong YW, Ip IPP, Lao L, Fong HHS, Che CT. Effect of a Chinese herbal formula on the
sensory response to colonic distension in a rat model of irritable bowel syndrome. The 4th
International Symposium of the Western Pacific Regional Forum for the Harmonization of
Herbal Medicine, Hong Kong, China, 30 Oct. 2010.

Review Articles:
1.

N.R. Farnsworth, A.S. Bingel, G.A. Cordell, F.A. Crane and H.H.S. Fong. 1975. Potential
value of plants as sources of new antifertility agents. I. Journal of Pharmaceutical Sciences,
64:535-598.

D.

2.

N.R. Farnsworth, A.S. Bingel, G.A. Cordell, F.A. Crane and H.H.S. Fong. 1975. Potential
value of plants as sources of new antifertility agents. II. Journal of Pharmaceutical Sciences,
64:717-753.

3.

N.R. Farnsworth, A.S. Bingel, H.H.S. Fong, A.A. Saleh, G.M. Christenson, and S.M.
Saufferer. 1976. Oncogenic and tumor-promoting spermatophytes and pteridophytes and their
active principles. Cancer Treatment Report, 60:1171-1214.

4.

N.R. Farnsworth, H.H.S. Fong and E. Diczfalusy. 1983. New fertility regulating agents of
plant origin. In: Proc. International Symposium - Research on the regulation of Human
Fertility - Needs of Developing Countries and Priorities for the Future, Diczfalusy E. and A.
Diczfalusy (Eds.), Scriptor, Copenhagen, 1983, pp. 776-809.

5.

H.H.S. Fong. 1984. Current status of gossypol, zoapatanol and other plant derived fertility
regulating agents. In: Alfred Benzon Symposium 20 Natural Products and Drug Development.
Krogsgaard-Larsen, P., S. Brogger Christensen and H. Kofod (Eds.).
Munksgaard,
Copenhagen, 1984, pp. 355-373.

6.

Mahady GB, Gyllenhaal CG, Fong HHS, Farnsworth NR. Ginsengs: A review of safety and
efficacy. Nutrition and Clinical Care 3(2):90-101, 2000.

7.

Mahady GB, Qato DM, Gyllenhaal CG, Chadwick L, Fong HHS. Echinacea:
Recommendations for its use inprophylaxis and treatment of respiratory tract infections.
Nutrition and Clinical Care, 2001, 4(4):199-208.

8.

Fong HHS, Bauman JL. Hawthorn in cardiovascular disease.


Nursing. 2002, 16(4):1-8.

9.

Fong HHSF. Integration of herbal medicine into modern medical practices:


prospects. Integrative Cancer Therapies 2002, 1(3): 287-293.

Journal of cardiovascular

issues and

Chapters in Books:
1.

Bingel AS, Fong HHS. Potential Fertility Regulating Agents from plants. In: Economic and
Medicinal Plant Research. Vol. 2. Wagner H, Hikino H, Farnsworth NR (eds). London,
Academic Press, 1988.

2.

Kinghorn AD, Fong HHS, Farnsworth NR, Mehta RG, Moon RC, Moriarty RM, Pezzuto JM.
Cancer chemopreventive agents discovered by activity-guided fractionation: A review. Current
organic chemistry, Hilversum, The Netherlands, Bentham Science Publishers, 1998.

3.

Pezzuto JM, Beecher CWW, Fong HHS, Farnsworth NR, Mehta RG, Moon RC, Hedayat S,
Udeani GO, Moriarty RM, Kinghorn AD. Discovery and characterization of natural product
cancer chemopreventive agents. In: Atta-ur-Rahman, Iqbal M (eds). New Trends in Natural
Products Chemistry. Chur, Switzerland, Harwood Academic Publishers, 1998.

E.

4.

Soejarto DD, Gyllenhaal C, Tarzikan-Sorensen JA, Fong HHS, Xuan LT, Binh LT, Hiep NT,
Hung NV, Vu BM, Bich TQ, SouthavongB, Sydara K, Pezzuto JM. Bioprospecting
arrangement:Experience between the North and the South. Manual on Best Practices on
Intellectual Prioperty. In: MIHR (Centre for Management of Intellectual Property ih Health
Research and Developmnent), 2004, Appendix.

5.

Chadwick L, Fong HHS. Herb quality assurance and standardization in herb-drug interaction
evaluation and documentation. In: Lam YWF, Huang S-M, Hall SD (eds). Herbal Supplement
Drug Interactions. New York, Taylor & Francis, 2006.

6.

Fong HHS, Pauli GF, Bolton JL, van Breemen RB, Banuvar S, Shulman L, Geller SE,
Farnsworth NR. Evidence-based herbal medicine: Challenges in efficacy and safety
assessments. In: Leung P-C, Fong H, Xue CC (eds). Current Review of Chinese Medicine,
Annals of Traditional Chinese Medicine, Vol. 2. World Scientific, Singapore, 2006.

7.

Soejarto DD, Gyllenhaal C, Tarzikan-Sorensen JA, Fong HHS, Xuan LT, Binh LT, Hiep NT,
Hung NV, Vu BM, Bich TQ, SouthavongB, Sydara K, Pezzuto JM. Bioprospecting
arrangement:Experience between the North and the South. In: Krattiger A, RT Mahoney, L
Nelsen, JA Thomson, AB Bennett, K Satyanarayana, GD Graff, C Fernandez and SP Kowalski
(eds.). Intellectual Property Management in Health and Agricultural Innovation: A Handbook
of Best Practices . MIHR: Oxford, U.K., and PIPRA: Davis, U.S.A. Available online at
<http://www.iphandbook.org/>www.ipHandbook.org. 2007.

8.

Fong HHS, Mahady G. Botanicals for aging. In: Leung P-C (ed). Healthy Aging, Annals of
Traditional Chinese Medicine, Vol. 4. World Scientific, Singapore, 2010. Pp 56-92.

9.

Zhang AL, Xue CC, Fong HHS. Integration of Herbal Medicine into Evidence-based Clinical
Practice; Current Status and Issues. In: Wachtel-Galor S, Benzie I (eds). Herbal Medicine:
Biomolecular and Clinical Aspects. 2nd ed. Taylor & Francis Group, LLC, 2011.

Books Edited:
1.

Pharmacognosy Titles V. 1970. Farnsworth, N.R. and H.H.S. Fong (Eds). College of
Pharmacy, University of Illinois at the Medical Center, Chicago, Illinois 60612.

2.

Pharmacognosy Titles VI. 1971. Farnsworth, N.R. and H.H.S. Fong (Eds.). College of
Pharmacy University of Illinois at the Medical Center, Chicago, Illinois 60612.

3.

Pharmacognosy Titles VII. 1972. Farnsworth, N.R., Fong, H.H.S., and M. Tin-wa (Eds.).
University of Illinois at the Medical Center, Chicago, Illinois 60612.

4.

Pharmacognosy Titles VIII. 1973. Farnsworth, N.R., Fong, H.H.S. and M. Tin-wa (Eds.).
University of Illinois at the Medical Center, Chicago, Illinois 60612.

F.

5.

Pharmacognosy Titles IX. 1974. Farnsworth, N.R., Fong, H.H.S. and G.A. Cordell, (Eds.).
University of Illinois at the Medical Center, Chicago, Illinois 60612.

6.

Phytochemical Screening (Laboratory Manual). 1973. Harry H.S. Fong, Maung Tin-Wa and
Norman R. Farnsworth. College of Pharmacy, University of Illinois at the Medical Center,
Chicago, Illinois 60612.

7.

Phytochemical Screening Methods (Laboratory Manual). 1977. H.H.S. Fong, M. Tin-Wa,


N.R. Farnsworth and R.H. Dobberstein. College of Pharmacy, University of Illinois at the
Medical Center, Chicago, Illinois 60612.

8.

Mahady GB, Fong HHS, Farnsworth NR. Eds. WHO Monographs on Selected Medicinal
Plants. Volume 1, World Heald Organization, Geneva, Switzertland, 1999.

9.

Mahady GB, Fong HHS, Farnsworth NR. Eds. WHO Monographs on Selected Medicinal
Plants. Volume 2, World Health Organization, Geneva, Switzertland, 2002.

10.

Mahady GB, Fong HHS, Farnsworth NR. Eds. WHO Monographs on Selected Medicinal
Plants. Volume 3, World Health Organization, Geneva, Switzertland, 2007.

11.

Mahady GB, Fong HHS, Farnsworth NR. Botanical Dietary Supplements: Quality, Safety and
Efficacy. Lisse, Swets & Zeitlinger, 2001

12.

Mahady GB, Fong HHS, Farnsworth NR. Eds. WHO Monographs on Selected Medicinal
Plants. Volume 3, World Health Organization, Geneva, Switzertland, 2004 (in press).

13.

Mahady GB, Fong HHS, Farnsworth NR. Eds. WHO Monographs on Selected Medicinal
Plants. Volume 4, World Health Organization, Geneva, Switzertland, 2009 (in press).

14.

Anon. WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal
Plants. Geneva, Switzerland, World Health Organization, 2003. (Initial draft prepared by Fong
HHS, Simon JE, Regalado J).

15.

Leung P-C, Fong H, Xue CC. Eds. Annals of Traditional Chinese Medicine, Vol. 2. Current
Review of Chinese Medicine. World Scientific, Singapore, 2006.

16.

Leung P-C, Fong H. Eds. Annals of Traditional Chinese Medicine, Vol. 3. Alternative
Treatment for Cancer. World Scientific, Singapore, 2007.

Patents:
1. Spermicidal Composition. Waller, D.P., Fong, H.H.S., and L.J.D. Zaneveld. 1981. Patent-US-81
4,297,341.
2. New anticancer maytansinoids with two fused macrocyclic rings. Zhang HJ, Soejarto DD, Fong
HHS. 2007. US Patent Serial No. 60/968,813, August 29, 2007.

3. Compositions and Methods for Treatment of Liver Disease. Fong HHS. Dec. 25, 2008. United
States Patent and Trademark Office, US. 1. 20080319042.

G.

H.

Professional/Educational Articles:
1.

H.H.S. Fong. 1973. Isolation of hesperidin from Citrus sinensis. Experiments in the
Pharmaceutical Biological Sciences. M.H. Malone & J.L. McLaughlin (Eds.), Univ. of
Pacific, Stockton, 1973:32-33.

2.

H.H.S. Fong. 1973. Isolation of Betulin from Birch bark (Betula alba). Experiments in the
Pharmaceutical Biological Scienes. M.H. Malone & J.L. McLaughlin & J.L. McLaughlin
(Eds.), Univ. of Pacific, Stockton, 1973:33-35.

3.

H.H.S. Fong. 1973. Phytochemical screening: I-VIII. Experiments in the Pharmaceutical


Biological Sciences. M.H. Malone & J.L. McLaughin (Eds.), Univ. of Pacific, Stockton,
1973:43-51.

4.

N.R. Farnsworth, C. W.W. Beecher and H.H.S. Fong. 1995. The NAPRALERT database:
Linking traditional and modern medicine. Essential Drugs Monitor. no. 20:2-3 , WHO Action
Programme on Essential Drugs, Geneva, Switzerland.

5.

Hall T, Lu Z-Z, Yat PN, Fitzloff JF, Arnason JT, Awang DVC, Fong HHS, Blumenthal M. An
introduction to the ginseng evaluation program. HerbalGram, 2001, 52:27-30.

6.

Hall T, Lu Z-Z, Yat PN, Fitzloff JF, Arnason JT, Awang DVC, Fong HHS, Blumenthal M.
Evaluation of consistency of standardized Asian ginseng products in the ginseng evaluation
program. HerbalGram, 2001, 52:31-45.

7.

Fong HHS. Botanicals for health. A regulatory dilemma in the USA. Current aspects and the
development of traditional medicine and public health, 2003:1-9 (Daegu Haany University,
Korea)

Book Reviews:
1.

H.H.S. Fong. Bioactive Carbohydrates. John Wiley & Sons, Inc., New York, 331 pp. Amer.
J. Pharm. 48:347 (1984).

2.

H.H.S. Fong. Alkaloids: chemical and biological perspective. Vol. 2. John Wiley & Sons,
Inc., New York, 490 pp. Amer. J. Pharm. Ed. 49:229-330 (1985).

3.

H.H.S. Fong. Medicinal Plants of China, Vol. 1 and 2. J.A. Duke and E.S.
Reference Publications, Algonac, MI 48001. Econ. Bot. 40:133-134 (1986).

Ayensu.

I.

J.

4.

H.H.S. Fong. Plant Drug Analysis. H. Wagner, S. Bladt & E.M. Zgainski. Springer-Verlag,
New York, 320 pp. Journal of Pharmaceutical Sciences 75:829-830 (1986).

5.

H.H.S. Fong. Pharmacognosy 9th Edition. V.E. Tyler, L.R. Brady & J.E. Robbers. Lea &
Febiger, Philadelphia PA, 519 pp. Amer. J. Pharm. Ed. 53:102-103 (1989).

6.

H.H.S. Fong. Handbook of Natural Toxins. Toxicology of Plant and Fungal Compounds. Vol.
6. R.F. Keeler and A.T. Tu. Mercel Dekker, Inc., New York, 665 pp. Amer. J. Pharm. Ed.
(1992).

7.

H.H.S. Fong. Natural Products: A Laboratory Guide, Second Edition. R. Ikan. Academic Press,
San Diego, CA., 360 pp. Phytochem. Anal. 4:137 (1993).

8.

G. Mahady and H.H.S. Fong. Encyclopedia of Common Natural Ingredients Used in Food,
Drugs and Cosmetics, Second Edition. A.Y. Leung and S. Foster. John Wiley and Sons, New
York, NY., 649 pp. Amer. J. Pharm. Ed. 60: 227 (1996).

Non-Technical Papers - Traditional Medicine - NAPRALERT:


1.

H.H.S. Fong, D.P. Waller and 0. Akerele. 1986. WHO/Danida InterRegional Workshop.
Internat. Traditional Medicine Newsletter, 1:3-5.

2.

H.H.S. Fong. 1986. Herbal Formulary. Internat. Traditional Medicine Newsletter, 1:4-5.

Ph.D. Dissertations Directed/Co-Directed:


1.

R.L. Lyon. 1973. A search for natural analgesic principles of Dianthus barbatus
(Caryophyllaceae) and Aspidosperma quebracho-blanco (Apocynaceae). University of Illinois
Medical Center 202, pp.

2.

P.T.O. Chang. 1976. Phytochemical studies on Helietta parviflia (A. Gray) Benth.
(Rutaceae), Thamnosma montana Torr. & Frem. (Rutaceae) and Xylosma velutina (Tul) Tr.
& Pl. (Flacourtiaceae). University of Illinois Medical Center, 119 pp.

3.

C.-t. Che. 1982. Phytochemical investigations of Aristolochia indica Linn. and Caulophyllum
thalictroides (L.) Michaux. University of Illinois Medical Center, 190 pp.

4.

I.C. Kim. 1985. Studies on the site and mechanism of antifertility action of gossypol.
University of Illinois at Chicago, 130 pp.

5.

D.D. McPherson. 1987. Studies on Caesalpinia pulcherrima and DNA Lignand Interactions.
University of Illinois at Chicago, 99 pp.

6.

A. Amarquaye. 1993. Isolation of spasmogenic principles from Byrsonima crassifolia Richard


ex Jussieu (Malpighiaceae). University of Illinois at Chicago, 135 pp.

7.

K.

MS Theses Directed/Co-Directed:
1.

L.

S.-X. Qiu. 1998. Phytochemical studies on Aster pilosus and other medicinal plants. University
of Illinois at Chicago, 205 pp.

W.H. Marks. 1973. The cytotoxic principles of Parquetina nigrescens (Asclepiadaceae).


University of Illinois Medical Center, 66 pp.

MS Thesis:
H.H.S. Fong. 1961. Alkaloids assay methods and hematological studies of alkaloid extracts from
Vinca major L. var. major Pich. N.R. Farnsworth, Advisor. University of Pittsburgh, 31
pp.

M.

Ph.D. Dissertation:
H.H.S. Fong. 1965. Phytochemical investigation of the non-phenolic tertiary and quaternary alkaloids
of Thalictrum rochebrunianum Franc. and Sav. (Ranunculaceae). J.L. Beal, Advisor. Ohio State
University, 166 pp.

EXTRAMURAL FUNDING

1970
National Institute of Health, CA-12432, 9/1/70 - 8/31/71, Direct costs ($23,111), Principal Investigator,
Isolation of antitumor substances from plants.
1971
National Institute of Health, CA-12432, 9/31/71 - 12/31/71, Direct cost ($7,880), Principal Investigator,
Isolation of antitumor substances from plants
1972
National Institute of Health, CA-12432, 1/1/72 - 8/31/72, Direct costs ($15,405), Principal Investigator,
Isolation of antitumor substances from plants.
1977-1978
World Health Organization, 77918C, 11/1/77-12/31/78, Direct costs
Principal Investigator, A
six centre collaborative approach for the isolation of fertility regulating compounds from plants (77918) Task Force on Indigenous Plants.
1979
World Health Organization, 77918C, 1/1/79 - 12/31/79, Direct Costs
Principal Investigator, A Six
centre collaborative approach for the isolation of fertility regulating compounds from plants (77918)- Task
Force on Indigenous Plants.
1980
World Health Organization, 77918C, 1/1/80-12/31/80, Direct costs (
, Principal Investigator, A
six centre collaborative approach for the isolation of fertility regulating compounds from plants (77918) Task Force on Indigenous Plants.
World Health Organization, 77918C, 1/1/80-12/31/80, Direct costs
Principal Investigator, Research
training of Dr. Sam S. Kang, Seoul Centre, Natural Products Research Institute, Seoul, Korea.
World Health Organization, 6/1/80-5/31/81, Direct costs
effect of gossypol and its related impurities in the male hamster.

Principal Investigator, The antifertility

1981
World Health Organization, 77918C, 1/1/81-12/31/81, Direct costs
multicentre approach for the isolation of fertility regulating agents from plants.

, Principal Investigator, A

World Health Organization, 77918C, 1/1/81-12/31/81 Direct cost


multicentre approach for the isolation of fertility regulating agents from plants.

Principal Investigator, A

1982
World Health Organization, 77918C, 1/1/82-12/31/82. Direct cost
multicentre approach for the isolation of fertility regulating agents from plants.

Principal Investigator, A

1983
World Health Organization, 77918C, 1/1/83-12/31/83. Direct cost
multicentre approach for the isolation of fertility regulating agents from plants.

. Principal Investigator, A

World Health Organization, 77918C Supplement. 1/6/83-12/31/83. Direct cost (


Investigator, A multicentre approach in the isolation of fertility regulating agents from plants.
World Health Organization, 82027.
on gossypol.

1/1/83-12/31/83. Direct cost

Principal

. Principal Investigator, Studies

National Institute of Health, NOI-HD-3-2815, 1/6/83-31/5/84. Direct


Investigator, Development of a method to separate plus and minus gossypol.

cost ($10,000), Principal

1984
World Health Organization, 77918C, 1/1/84-12/31/84, Direct cost
multicentre approach for the isolation of fertility regulating agents from plants.

, Principal Investigator, A

World Health Organization, 77918C, 1/1/84-12/31/84, Direct cost Supplement


Investigator, A multicentre approach for the isolation of fertility regulating agents from plants.

Principal

1985
World Health Organization, 77918C, 1/1/85-12/31/85, Direct cost
multicentre approach for the isolation of fertility regulating agents from plants.
Berry Brooke Associates, 1/1/85-12/31/85, Direct cost
Ginseng.
Kirkwood Associates, 1/1/85-12/31/85,
Analysis and Pharmacology of Ginseng.

Direct cost

Principal Investigator, A

, Co-Principal Investigator, Tissue Culture of

Co-Principal Investigator, Chemistry,

World Health Organization, 77928C Supplement. 1/1/85-12/31/85, Direct cost


Principal
Investigator, A multicentre collaborative approach for the isolation of fertility regulating agents from plants.
1986

World Health Organization, 77918C, 1/1/86-12/31/86, Direct cost


Isolation of Fertility Regulating Agents from Plants.

, Principal Investigator, The

World Health Organization, 77918C, 1/1/86-12/31/86, Direct cost


Isolation of (+)-Gossypol.

, Principal Investigator,

World Health Organization, 77918C, 1/1/86-12/31/86, Direct cost


, Principal Investigator,
Collaborative Studies on the Antifertility Effect and Pharmacokinetic of ()- and (-)-Gossypol Formulations.
World Health Organization, 77918C, 1/1/86-3/31/86, Direct cost (
, Principal Investigator, A
multicentre collaborative approach for the isolation of fertility regulating agents from plants.
Sichuan Institute of Materia Medica, 10/1/85-2,28/87, Direct cost (
Sichuan Institute of Materia Medica Collaborative Research Program.
D.L. Watson, 5/1/85-6/30/86, Direct cost
plants.

, Principal Investigator,

Principal Investigator, Propagation and cultivation of

1987
World Health Organization 77918C, 1/1/87-12/31/87, Direct cost
multicentre approach for the isolation and fertility regulating agents from plants.

Principal Investigator, A

1988
World Health Organization 77918C, 1/1/87-12/31/87, Direct cost
, Principal Investigator, A
multicentre approach for the isolation and fertility regulating agents from plants.
D.L. Watson, 10/1/87-10/31/88, Direct cost
plants.

, Principal Investigator, Propagation and cultivation of

1989
World Health Organization, PAHO, 1/1/89-12/31/89, Direct cost

, Research Training Provision.

Jiffy Products of American, Inc., West Chicago, IL, 4/1/89-3/31/90, Direct cost
cultivation of herbs and medicinal plants.
NAPROTECH, Inc., Wood Dale, IL, 1/1/89-12/31/89, Direct cost
subcontract.

, Propagation and

, Antitumor literature surveillance

World Health Organization, PAHO, 9/5/89-10-2/89, Direct cost


efficacy and safety of traditional medicines.

Workshop on assessment of

World Health Organization, TRM, 05/01/89-04/30/90, Direct Cost


AIDS screening, (Co-PI).

, Provisions of plants for anti-

1990
IIT Research Institute, 01/01/90-12/31/90, Direct Costs
Purity and Stability of Natural Product
Added to Animal Feed, (Co-PI). (A subcontract of "Chemoprevention of MNU-induced mammary tumors in
the rat with selected chemopreventive agents", NCI No. CN-95151-02, Dr. Richard Moon, Principal
Investigator).
National Cancer Institute, 1990-1995, No budget, MAA "Clinical evaluation of fruit and vegetable based
experimental food supplements", National Cancer Institute, Master Agreement; Co-Investigator (Principal
Investigator: P.E. Bowen).
National Cancer Institute, 1990-1995, No budget, MAA "Special studies facilitating the flow of preclinical
research leads into clinical practice" National Cancer Institute, Master Agreement- Sub Contract; Co-PI
(Principal Investigator: R. Mehta, IITRI).
National Cancer Institute (NCI No. NO1-CN-05291-01, 10/01/90-09/30/91, Direct Costs ($140,587),
Modulatory influences of dietary flaxseed on human arachidonic acid metabolism, (Co-Investigator), (Dr.
Phyllis Bowen, Principal Investigator),.
1991
National Institute of Health, PO1 CA 48112-01A3, 9/15/91-8/31/94, Direct Cost /Year 1 ($32,834), Project
Leader, Project 1. Chemopreventive agents: Provision of source materials. (Part of a Program Project
"Natural inhibitors of carcinogenesis", Total Direct Cost/Year 1 ($649,577), J.M. Pezzuto, Principal
Investigator)
World Health Organization, 01/07/91-12/31/91, Direct Costs
Huang's research training, (Principal Investigator).

, Laboratory expenditures for Hu Bi-

1992
National Institute of Health, PO1 CA 48112-01A3, 9/15/91-8/31/94, Direct Cost /Year 2 ($38,419), Project
Leader, Project 1. Chemopreventive agents: Provision of Source materials. (Part of a Program Project
"Natural inhibitors of carcinogenesis", J.M. Pezzuto, Principal Investigator)
National Cancer Institute, NIH, 06/01/92 -05/31/97, no budget submitted, MAA NO. NCI-CN-25418-51,
"Master Agreement for preclinical evaluation of intermediate endpoints and their modulation by
chemopreventive agents, Co-Investigator, (T.K. Das Gupta, PI) (No budget)
National Cancer Institute, NIH, 06/01/92 -05/31/97, no budget submitted, MAA NO. NCI-CN-25414-33,
"Evaluation of chemopreventive agents by in vitro techniques, Co-Investigator, (J.M. Pezzuto, PI) (No
budget)
1993

National Institute of Health, PO1 CA 48112-01A3, 9/15/91-8/31/94, Direct Cost /Year 3 ($39,956), Project
Leader, Project 1. Chemopreventive agents: Provision of source materials. (Part of a Program Project
"Natural inhibitors of carcinogenesis", J.M. Pezzuto, Principal Investigator)
National Cancer Institute, NIH, 11/01/93 -10/31/96, MAO/RFP NO. NCI-CM-37876-26, "Feasibility studies
on the cultivation of the Cameroon plant, Ancistrocladus korupensis"," Consultant (J.E. Simon [Purdue
University], PI)
Kellogg Company, 6/1/93-5/31/94, Direct Cost (
), Co-Investigator. Characterization of estrogenic
agents in wheat bran. (C.W.W. Beecher, Principal Investigator)
1994
National Institute of Health, PO1 CA 48112-04, 9/15/94-8/31/98, Direct Cost /Year 4 ($72,690), CoInvestigator, Project 1. Chemopreventive agents: Provision of source materials. (Part of a Program Project
"Natural inhibitors of carcinogenesis", J.M. Pezzuto, Principal Investigator)
American Botanical Council, 12/1/93-11/30/94. Direct Cost/Year
development and analysis of ginsenosides in OTC products.

). Principal Investigator. Methods

Revolving - Phytochemical analysis and bioassay services. 12/15/93- present, Direct Cost ($ Variable).
INPC, National Centre for Scientific Research, Vietnam - John D. & Catherine T. MacArthur Foundation,
7/1/94-6/30/95. Direct Cost
). Co-Investigator. Collaborative studies on potential medicinal values of
plants of the Cuc Phuong National Park toward their sustainable utilization and conservation.
AMOCO BioProducts Corp., 4/1/94-3/31/95. Direct Cost (
transgenic plants.

). Principal Investigator. Propagation of

Phytochemical Analysis and Bioassay-REV. 1/1/94 - 12/31/94. Total Receipt (


). Co-Principal
Investigator. "Development of analytical methods for the qualitative and quantitative chemical and/or
biological evaluation of phytochemicals that may be used as markers in functional foods and other plant
source materials".
1995
National Institute of Health, PO1 CA 48112-04, 9/15/94-8/31/98, Direct Cost /Year 5 ($75,237), CoInvestigator, Project 1. Chemopreventive agents: Provision of source materials. (Part of a Program Project
"Natural inhibitors of carcinogenesis", J.M. Pezzuto, Principal Investigator, Total grant = $807,135)
American Botanical Council, 12/09/94-11/30/95. Direct Cost/Year (
development and analysis of ginsenosides in OTC products.

). Co- Investigator. Methods

American Botanical Council, 12/01/95-05/31/96. Direct Cost/Year (


development and analysis of ginsenosides in OTC products.

. Co- Investigator. Methods

Revolving - Phytochemical analysis and bioassay services. 01/01/95 - 12/31/95, Direct Cost (
(H. Fong and J.M. Pezzuto).

). Co-PIs

INPC, National Centre for Scientific Research, Vietnam - John D. & Catherine T. MacArthur Foundation,
7/1/95-6/30/96. UIC Direct Cost (
). Co-Investigator. Collaborative studies on potential medicinal
values of plants of the Cuc Phong National Park toward their sustainable utilization and conservation. (Total
grant =
RDCAC-LIPI, Serpong, Indonesia- John D. & Catherine T. MacArthur Foundation, 7/1/95-6/30/96. UIC
Direct Cost (
). Principal-Investigator. Collaborative studies on potential Bioactive Terrestrial Natural
Products of Siberut Island (Sumatra, Indonesia) for their sustainable utilization and conservation. (Total grant
=
)
World Health Organization. 1/1/95-12/31/95. Direct Cost (
). Co-Investigator. Preparation of Samples
of Model Monographs on Widely Used Medicinal Plants. (N. R. Farnsworth, Principal Investigator).

1996
National Institute of Health, PO1 CA 48112-04, 9/15/94-8/31/98, Direct Cost /Year 6 ($77,870), CoInvestigator, Project 1. Chemopreventive agents: Provision of source materials. (Part of a Program Project
"Natural inhibitors of carcinogenesis", J.M. Pezzuto, Principal Investigator, Total grant = $835, 385)
Revolving - Phytochemical analysis and bioassay services. 01/01/96 - 12/31/96, Direct Cost (
(H. Fong and J.M. Pezzuto).

). Co-PIs

INPC, National Centre for Scientific Research, Vietnam - John D. & Catherine T. MacArthur Foundation,
7/1/96-6/30/97. UIC Direct Cost (
). Co-Investigator. Collaborative studies on potential medicinal
values of plants of the Cuc Phuong National Park toward their sustainable utilization and conservation. (Total
grant =
)
RDCAC-LIPI, Serpong, Indonesia- John D. & Catherine T. MacArthur Foundation, 7/1/96-6/30/97. UIC
Direct Cost (
. Principal-Investigator. Collaborative studies on potential Bioactive Indonesian
Terrestrial Natural Products for their sustainable utilization and conservation. (Total grant =
GlaxoWellcome Research and Development Ltd, 3/1/96-3/1/99. Direct Cost/Year 1
Investigator. An Ethnobotanically Based Acquisition of Plants for Biological Evaluation.

. Principal-

1997
National Institute of Health, PO1 CA 48112-04, 9/15/94-8/31/98, Direct Cost /Year 7 ($80,917), CoInvestigator, Project 1. Chemopreventive agents: Provision of source materials. (Part of a Program Project
"Natural inhibitors of carcinogenesis", J.M. Pezzuto, Principal Investigator, Total grant = $802, 713)
Revolving - Phytochemical analysis and bioassay services. 01/01/97 - 12/31/97, Direct Cost
Co-PIs (H. Fong and J.M. Pezzuto).

GlaxoWellcome Research and Development Ltd, 3/1/96-3/1/99. Direct Cost/Year 2 (


Investigator. An Ethnobotanically Based Acquisition of Plants for Biological Evaluation.

). Principal-

INPC, National Centre for Scientific Research, Vietnam - John D. & Catherine T. MacArthur Foundation,
7/1/97-6/30/99. UIC Direct Cost (
). Co-Investigator. Collaborative studies on potential medicinal
values of plants of the Cuc Phuong National Park toward their sustainable utilization and conservation. (Total
grant = $85,000). (APPROVED).
RDCAC-LIPI, Serpong, Indonesia- John D. & Catherine T. MacArthur Foundation, 7/1/97-6/30/98,
Collaborative studies on potential Bioactive Indonesian Terrestrial Natural Products for their sustainable
utilization and conservation. (Total grant =
) (APPROVED)
World Health Organization. 9/1/97-8/31/99. Direct Cost (
). Co-Investigator. Preparation of WHO
Monographs on Selected Medicinal Plants, Vol. 2. (N. R. Farnsworth, Principal Investigator).

1998
National Institute of Health, PO1 CA 48112-04, 9/15/94-8/31/98, Direct Cost /Year 7 ($80,917), CoInvestigator, Project 1. Chemopreventive agents: Provision of source materials. (Part of a Program Project
"Natural inhibitors of carcinogenesis", J.M. Pezzuto, Principal Investigator, Total grant = $802, 713)
Revolving - Phytochemical analysis and bioassay services. 01/01/98 - 12/31/98, Direct Cost
($ xxxxx). Co-PIs (H. Fong and J.M. Pezzuto).

1-UO1-TW01015-01 International Cooperative Biodiversity Group (ICBG) "Studies on Biodiversity of


Vietnam and Laos." Fogarty International Center, NIH, August 1998-July 2003; first year DC (
);
Project 3 budget: first year DC =
, Project 3 Co-Investigator.
World Health Organization. 9/1/97-8/31/99. Direct Cost
. Co-Investigator. Preparation of WHO
Monographs on Selected Medicinal Plants, Vol. 2. (N. R. Farnsworth, Principal Investigator).
INPC, National Centre for Scientific Research, Vietnam - John D. & Catherine T. MacArthur Foundation,
7/1/97-6/30/99. UIC Direct Cost (
. Co-Investigator. Collaborative studies on potential medicinal
values of plants of the Cuc Phuong National Park toward their sustainable utilization and conservation. (Total
grant =
). (APPROVED).
RDCAC-LIPI, Serpong, Indonesia- John D. & Catherine T. MacArthur Foundation, 7/1/97-6/30/00,
Collaborative studies on potential Bioactive Indonesian Terrestrial Natural Products for their sustainable
utilization and conservation. (Total grant =
1999
3 PO1 CA48112 (J. M. Pezzuto, PI) 4/1/99-1/31/00, NIH/NCI, $704,767 (direct ) Program Project "Natural
inhibitors of carcinogenesis". Co-Investigator, Project 1. Chemopreventive agents: Provision of source
materials.

1-UO1-TW01015-02 (Soejarto. PI), 10/1/98-9/30/03, NIH/Fogarty International Center $2,390,578 (direct +


indirect costs), Studies of Biodiversity of Vietnam and Laos (ICBG)
OD-99-007 (N.R. Farnsworth,PI), 12/01/99 - 11/30/04, NIH/ODS, $5,127,273 (direct),Center for Dietary
Supplement Research on Botanicals - Botanical Dietary Supplements for Womens Health
World Health Organization. 9/1/97-8/31/99. Direct Cost (
). Co-Investigator. Preparation of WHO
Monographs on Selected Medicinal Plants, Vol. 2. (N. R. Farnsworth, Principal Investigator).
HQ/97/401952 (N.R. Farnsworth, PI), 9/1/99-8/31/01, World Healt Organization,
Preparation of Volume III of the WHO Monographs on Selected Medicinal Plants

(direct),

RDCAC-LIPI, Serpong, Indonesia- John D. & Catherine T. MacArthur Foundation, 7/1/97-6/30/00,


Collaborative studies on potential Bioactive Indonesian Terrestrial Natural Products for their sustainable
utilization and conservation. (Total grant =
)
Revolving - Phytochemical analysis and bioassay services. 01/01/99- 12/31/99, Direct Cost
PI.

2000
3 PO1 CA48112 (J. M. Pezzuto, PI) 2/1/00-1/31/01, NIH/NCI, $764,231 (direct ) Program Project "Natural
inhibitors of carcinogenesis". Co-Investigator, Project 1. Chemopreventive agents: Provision of source
materials.
1-UO1-TW01015-03 (Soejarto. PI), 10/1/98-9/30/03, NIH/Fogarty International Center $2,390,578 (direct +
indirect costs), Studies of Biodiversity of Vietnam and Laos (ICBG). Co-Investigator, Associate Project 3.
OD-99-007 (N.R. Farnsworth,PI), 12/01/99 - 11/30/04, NIH/ODS, $5,127,273 (direct),Center for Dietary
Supplement Research on Botanicals - Botanical Dietary Supplements for Womens Health. Co-Investigator,
Project 1.
World Health Organization. 9/1/99-8/31/00. Direct Cost
). Co-Investigator. Preparation of WHO
Monographs on Selected Medicinal Plants, Vol. 3. (N. R. Farnsworth, Principal Investigator).
RDCAC-LIPI, Serpong, Indonesia- John D. & Catherine T. MacArthur Foundation, 7/1/97-6/30/00,
Collaborative studies on potential Bioactive Indonesian Terrestrial Natural Products for their sustainable
utilization and conservation. (Total grant =
)
Revolving - Phytochemical analysis and bioassay services. 01/01/00- 12/31/00, Direct Cost
($ T-B-D). PI.
2001

3 PO1 CA48112 (J. M. Pezzuto, PI) 2/1/01-1/31/02, NIH/NCI, $764,231 (direct cost) Program Project
"Natural inhibitors of carcinogenesis". Co-Investigator, Project 1. Chemopreventive agents: Provision of
source materials.
1-UO1-TW01015-04 (Soejarto. PI), 10/1/98-9/30/03, NIH/Fogarty International Center $2,390,578 (direct +
indirect costs), Studies of Biodiversity of Vietnam and Laos (ICBG). Co-Investigator, Associate Project 3.
OD-99-007 (N.R. Farnsworth,PI), 12/01/99 - 11/30/04, NIH/ODS, $5,127,273 (direct),Center for Dietary
Supplement Research on Botanicals - Botanical Dietary Supplements for Womens Health. Co-Investigator,
Project 1.
PAR-01-034 (A. Mescar, PI) 2001, NIH, $273,800 (direct), Small Molecule X-Ray Diffraction
Instrumentation. Co-Inestigator.
R21 AT00563 (C.S. Yuan. PI, University of Chicago) 04/01/02-03/31/04, NIH/NCCAM, $250,000 (direct),
Anti-diabetic effects of Panax ginsneg (Consultant).

2002
OD-99-007 (N.R. Farnsworth,PI), 12/01/99 - 11/30/04, NIH/ODS, $5,127,273 (direct),Center for Dietary
Supplement Research on Botanicals - Botanical Dietary Supplements for Womens Health. Co-Investigator,
Project 1.
3 PO1 CA48112 (J. M. Pezzuto, PI) 2/1/02-1/31/03, NIH/NCI, $1,294,764, Program Project "Natural
inhibitors of carcinogenesis". Co-Investigator, Project 1. Chemopreventive agents: Provision of source
materials.
1-UO1-TW01015-04 (D.D. Soejarto, PI), 10/1/98-9/30/03, NIH/Fogarty International Center $2,390,578
(direct + indirect costs), Studies of Biodiversity of Vietnam and Laos (ICBG). Co-Investigator/Project Leader,
Associate Project 3.
R21 AT00563 (C.S. Yuan. PI, University of Chicago) 04/01/02-03/31/04, NIH/NCCAM, $250,000 (direct),
Anti-diabetic effects of Panax ginsneg (Consultant).
2003
OD-99-007 (N.R. Farnsworth,PI), 12/01/99 - 11/30/04, NIH/ODS, $5,127,273 (direct),Center for Dietary
Supplement Research on Botanicals - Botanical Dietary Supplements for Womens Health. Co-Investigator,
Project 1.
3 PO1 CA48112 (J. M. Pezzuto, PI) 2/1/02-1/31/03, NIH/NCI, $1,294,764, Program Project "Natural
inhibitors of carcinogenesis". Co-Investigator, Project 1. Chemopreventive agents: Provision of source
materials.

1-UO1-TW01015-04 (D.D. Soejarto, PI), 10/1/98-9/30/03, NIH/Fogarty International Center $2,390,578


(direct + indirect costs), Studies of Biodiversity of Vietnam and Laos (ICBG). Co-Investigator/Project Leader,
Associate Project 3.
R21 AT00563 (C.S. Yuan. PI, University of Chicago) 04/01/02-03/31/04, NIH/NCCAM, $250,000 (direct),
Anti-diabetic effects of Panax ginsneg (Consultant).
R21 AT001943 (B. Berman, PI, University of Maryland), 09/22/03 - 03/31/05, NIH/NCCAM, $125,000 DC
(04/01/04 - 03/31/05), Functional Disorders in Chinese Medicine, Co-Investigator.

2004
P50 AT00155 (N.R. Farnsworth, PI), 09/30/99 - 07/31/04, NIH/ODS $1,756,943 DC, (08/01/03-07-31-04)
Center for Dietary Supplements Research: Botanicals, Co-Investigator, Project 1.
3 PO1 CA48112 (J. M. Pezzuto, PI), 9/15/91-7/31/04, NIH/NCI, $1,156,839 DC, (02/03/-07-31-04),
Program Project "Natural inhibitors of carcinogenesis", Co-Investigator, Project 1.
RFA-TW03-004 (D.D.Soejarto, PI), 10/1/03-9/30/08, NIH/Fogarty International Center, $629,710 DC
(10/1/03-4/30/04), Studies of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug
Discovery, (Project Leader): Total Direct Cost, $1,837,566 , 10/1/03-4/30/04 Direct Cost, $295,667]
RFA-TW03-004 (D.D.Soejarto, PI), 10/1/03-9/30/08, NIH/Fogarty International Center, $657,293 DC
(5/1/04-4/30/05), Studies of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug
Discovery, (Project Leader): AP-3 Direct Cost, 5/1/04-4/30/05 Direct Cost, $376,117]
R21 AT001943 (B. Berman, PI, University of Maryland), 09/22/03 - 03/31/05, NIH/NCCAM, $125,000 DC
(09/22/03 - 03/31/04), Functional Disorders in Chinese Medicine, Co-Investigator.

2005

3 PO1 CA48112 (J. M. Pezzuto, PI), 4/1/05-3/31/10, NIH/NCI, $5,744,500 DC, ($1,069,175, 4/1/053/31/10), Program Project "Natural inhibitors of carcinogenesis", Co-Investigator, Core C.

RFA-TW03-004 (D.D.Soejarto, PI), 10/1/03-9/30/08, NIH/Fogarty International Center, $657,293 DC


(5/1/05-4/30/06), Studies of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug
Discovery, Project Leader: AP-3 Direct Cost, 5/1/05-4/30/06, $396,189]
R21 AT001943 (B. Berman, PI, University of Maryland), 09/22/03 - 03/31/05, NIH/NCCAM, $125,000 DC
(04/01/04 - 03/31/05), Functional Disorders in Chinese Medicine, Co-Investigator.
1 P01 AT002605-01A1, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$4,949,702 DC, Arthritis and Traditional Chinese Medicine

Role: Co-Investigator (Project 1: Dose Escalation Study of Chinese Herbs in OA of the Knee); CoInvestigator (Botanical Core Standardization of Botanicals, 9/30/05-8/31/06, $62,300 DC)
1 U19 AT003266-01, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$3,736,925 TC, International Center for Research on Complementary and Alternative Medicine (ICRC), CoPrincipal Investigator (Botanical Core Standardization of Botanicals, 9/30/05-8/31/06, $ 62,677 DC)

2006

3 PO1 CA48112 (J. M. Pezzuto, PI), 4/1/05-3/31/10, NIH/NCI, $5,744,500 DC, ($1,069,175, 4/1/053/31/10), Program Project "Natural inhibitors of carcinogenesis", Co-Investigator, Core C.
RFA-TW03-004 (D.D.Soejarto, PI), 10/1/03-9/30/08, NIH/Fogarty International Center, $657,293 DC
(5/1/05-4/30/06), Studies of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug
Discovery, Co-Investigator: AP-3 Direct Cost, 5/1/05-4/30/06, $396,189]
1 P01 AT002605-01A1, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$4,949,702 DC, Arthritis and Traditional Chinese Medicine
Role: Co-Investigator (Project 1: Dose Escalation Study of Chinese Herbs in OA of the Knee); CoInvestigator (Botanical Core Standardization of Botanicals, 9/30/05-8/31/06, $62,300 DC)
1 U19 AT003266-01, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$3,736,925 TC, International Center for Research on Complementary and Alternative Medicine (ICRC), CoPrincipal Investigator (Botanical Core Standardization of Botanicals, 9/30/05-8/31/06, $ 62,677 DC)

2007

3 PO1 CA48112 (J. M. Pezzuto, PI), 4/1/05-3/31/10, NIH/NCI, $5,744,500 DC, ($1,069,175, 4/1/053/31/10), Program Project "Natural inhibitors of carcinogenesis", Co-Investigator, Core C. (3/30/20063/31/2007, $75,005 TC)
RFA-TW03-004 (D.D.Soejarto, PI), 10/1/03-9/30/08, NIH/Fogarty International Center, $657,293 DC
(5/1/05-4/30/06), Studies of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug
Discovery, Co-Investigator: AP-3 Direct Cost, 5/1/06-4/30/07, $430,439 TC]
1 P01 AT002605-01A1, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$4,949,702 DC, Arthritis and Traditional Chinese Medicine
Role: Co-Investigator (Project 1: Dose Escalation Study of Chinese Herbs in OA of the Knee); CoInvestigator (Botanical Core Standardization of Botanicals, 9/30/06-8/31/07, $96,699 DC)

1 U19 AT003266-01, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$3,736,925 TC, International Center for Research on Complementary and Alternative Medicine (ICRC), CoPrincipal Investigator (Botanical Core Standardization of Botanicals, 9/30/06-8/31/07, $ 97,330 TC)

2008
3 PO1 CA48112 (J. M. Pezzuto, PI), 4/1/05-3/31/10, NIH/NCI, $5,744,500 DC, ($1,069,175, 4/1/053/31/10), Program Project "Natural inhibitors of carcinogenesis", Co-Investigator, Core C. (3/30/20073/31/2008, $ 33,617 DC)
RFA-TW03-004 (D.D.Soejarto, PI), 10/1/03-9/30/08, NIH/Fogarty International Center, $657,293 DC
(5/1/05-4/30/06), Studies of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug
Discovery, Project Leader: AP-3 Direct Cost, 5/1/07-4/30/09, $603,370 ($366.750+$236,620 Supplements
DC)
1 P01 AT002605-01A1, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$4,949,702 DC, Arthritis and Traditional Chinese Medicine
Role: Co-Investigator (Project 1: Dose Escalation Study of Chinese Herbs in OA of the Knee); CoInvestigator (Botanical Core Standardization of Botanicals, 9/30/07-8/31/08, $33,920 DC)
1 U19 AT003266-01, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$3,736,925 TC, International Center for Research on Complementary and Alternative Medicine (ICRC), CoPrincipal Investigator (Botanical Core Standardization of Botanicals, 9/30/07-8/31/08, $ 33,617 DC).
NIH/NCCAM P01 AT004418 (C.S. Yuan, PI, University of Chicago), 9/30/08 - 7/31/13 Center for herbal
research on colorectal cancer, Consultant (Botanical Core).
2009
3 PO1 CA48112 (J. M. Pezzuto, PI), 4/1/05-3/31/10, NIH/NCI, $5,744,500 DC, ($1,069,175, 4/1/053/31/10), Program Project "Natural inhibitors of carcinogenesis", Co-Investigator, Core C. (04/01/0903/31/10, $95,215 DC)
RFA-TW03-004 (D.D.Soejarto, PI), 10/1/03-9/30/10, NIH/Fogarty International Center, $1,656,792 DC
(04/01/03 - 03/31/10), Studies of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug
Discovery, Project Leader], AP-3: $380,315 DC (04/01/08 - 04/30/10)
3 U01 TW001015-10S1 (Soejarto, DD) 05/01/08 - 04/30/10, NIH/Fogarty International Center, Studies of
Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug Discovery, Project Leader], AP-3:
$148,086 (Supplement-1)
3 U01 TW001015-10S2 (Soejarto, DD)
05/01/09 - 04/30/10, NIH/Fogarty International Center, Studies
of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug Discovery, Project Leader], AP-3:
$88,534 (Supplement-2)

1 P01 AT002605-01A1, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$4,949,702 DC, Arthritis and Traditional Chinese Medicine
Role: Co-Investigator (Project 1: Dose Escalation Study of Chinese Herbs in OA of the Knee); CoInvestigator (Botanical Core Standardization of Botanicals, 09/01/09 08/31/10, $37,861 DC)
1 U19 AT003266-01, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$3,736,925 TC, International Center for Research on Complementary and Alternative Medicine (ICRC), CoPrincipal Investigator (Botanical Core Standardization of Botanicals, 09/30/09 09/29/10, $ $23,118 DC).
NIH/NCCAM P01 AT004418 (C.S. Yuan, PI, University of Chicago), 9/30/08 - 7/31/13 Center for herbal
research on colorectal cancer, Consultant (Botanical Core).
2010
3 PO1 CA48112 (J. M. Pezzuto, PI), 4/1/05-3/31/11, NIH/NCI, $5,744,500 DC, ($1,069,175, 4/1/053/31/10), Program Project "Natural inhibitors of carcinogenesis", Co-Investigator, Core C. (04/01/0903/31/10, $95,215 DC)
RFA-TW03-004 (D.D.Soejarto, PI), 10/1/03-9/30/10, NIH/Fogarty International Center, $1,656,792 DC
(04/01/03 - 03/31/10), Studies of Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug
Discovery, Project Leader], AP-3: $380,315 DC (04/01/08 - 04/30/10)
3 U01 TW001015-10S1 (Soejarto, DD), 05/01/08 - 04/30/10, NIH/Fogarty International Center, Studies of
Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug Discovery, Project Leader], AP-3:
$148,086 (Supplement-1)
3 U01 TW001015-10S2 (Soejarto, DD), 05/01/09 - 04/30/10, NIH/Fogarty International Center, Studies of
Biodiversity of Vietnam and Laos (ICBG), [Associate Program 3, Drug Discovery, Project Leader], AP-3:
$88,534 (Supplement-2)
2 U01 TW001015-11 (Soejarto, DD) ,
09/01/09 - 08/31/11, NIH/Fogarty International Center,
(ARRA), Bioactive Compounds from the Biodiversity of China and Vietnam (ICBG), $428,888 DC
(09/01/09-08/31/11), $214,444 DC (09/01/09-08/31/10)
1 P01 AT002605-01A1, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$4,949,702 DC, Arthritis and Traditional Chinese Medicine. Role: Co-Investigator (Project 1: Dose
Escalation Study of Chinese Herbs in OA of the Knee); Co-Investigator (Botanical Core Standardization of
Botanicals, 09/01/09 08/31/10, $37,861 DC)
1 U19 AT003266-01, (B. M. Berman, PI, University of Maryland), 09/30/05 08/31/10 NIH/NCCAM,
$3,736,925 TC, International Center for Research on Complementary and Alternative Medicine (ICRC), CoPrincipal Investigator (Botanical Core Standardization of Botanicals, 09/30/09 09/29/10, $ $23,118 DC).
NIH/NCCAM P01 AT004418 (C.S. Yuan, PI, University of Chicago), 9/30/08 - 7/31/13 Center for herbal
research on colorectal cancer, Consultant (Botanical Core).

NHMRC #616609 (C. Xue, Chief Investigator, RMIT U., Melbourne, Aus), 2010-2013, Aus $632,750 TC, A
standardized ginseng extract, G115, for chronic obstructive disease: a randomized, double-blind, placebocontrolled trial, (Associate Investigator)

You might also like